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Thesis summary  
The sinus infection, chronic rhinosinusitis (CRS), has a prevalence ranging from 4.9% to 
10.9% worldwide. When a nasal cavity (NC) is exposed to pathogens carried by inhaled 
aerosols, the attached sinuses, especially the maxillary sinus (MS), are highly prone to 
infection. The MS, a hollow organ attached to the NC, plays the role of thermal insulation in 
a human skull and affects the quality of the human voice. The only opening, which connects 
the NC to the MS, is a circular slit-like opening called the ostium, with a channel of <5 mm 
in diameter. The narrowness of the ostium is a significant challenge for drug delivery to the 
MS for the treatment of CRS. Various non-invasive devices, including nasal sprays and jet 
nebulizers, are available for drug delivery to the MS; however, due to the poor accessibility 
of the MS and the narrowness of the ostium, the efficiency of drug delivery to the MS is very 
low.  
Acoustic drug delivery (ADD) is a modern pathway for topical drug delivery to the 
MS, demonstrated to enhance drug delivery. This technology, using a fixed acoustic 
frequency, is currently available as a pre/post-surgical therapy but has not been able to 
demonstrate the full potential of delivering sufficient drug particles to the sinuses in most 
CRS cases. Several researchers investigated the effects of fixed acoustic frequencies, 45 Hz 
and 100 Hz, and reported an increase of 2 to 3-fold in the aerosol deposition in the MS when 
compared with conventional drug delivery. However, it has recently been hypothesised that 
the underlying mechanism of ADD is based on the Helmholtz resonator principle, where the 
air plug in the ostium oscillates when an external acoustic field is applied to the nostril. 
Oscillation of the air plug in the ostium leads to the delivery of the aerosols (nebulised drugs) 
from the NC to the MS. Accordingly, the maximum delivery of aerosols into the MS occurs 




maximum amplitude of the oscillation of the air plug in the ostium occurs at the resonance 
frequency of the NC-MS combination. In a limited number of the studies, the equation for a 
Helmholtz resonator (derived for a combination of a spherical cavity and a cylindrical neck), 
was used for predicting the resonance frequency of the NC-MS combination, which was 
superimposed onto the nebulised medication entering the nostril. Under this method, the 
efficiency of drug delivery to the MS increased 5-fold at most, when compared with non-
acoustic drug delivery. In a more recent study, an acoustic frequency sweep was applied to 
the nostril, which showed a 10-fold increase in the aerosol deposition in the MS compared 
with conventional drug delivery. Such an increase in drug delivery efficiency is still 
insufficient for the treatment of CRS. Hence, it is important to predict the resonance frequency 
of the NC-MS combination accurately to increase the ADD efficiency significantly. 
The main aim of this thesis is to improve the efficiency of ADD to the MS by 
application of targeted excitation frequencies of the NC-MS combination to the nostril. 
Initially, the resonance frequency of an NC-MS combination was predicted as accurately as 
possible, and then the effect of various acoustic frequencies on ADD efficiency was 
investigated. In this thesis, several numerical models were explored, along with experimental 
testing. The numerical models include finite element analysis (FEA), computational fluid 
dynamics (CFD), and the Helmholtz resonator equation. The resonance frequencies of several 
simplified NC-MS combinations were predicted by this numerical model and compared with 
the experimental data to determine the most accurate numerical model. It was found that the 
Helmholtz resonator equation and FEA overpredict the resonance frequency of the NC-MS 
combination by 41% (depending on the size of the ostium and MS) compared with the 
experimental data. The CFD approach underpredicted the resonance frequency of the NC-MS 
combination by 8% compared with in-house experimental data, which proved to be the most 




equation and FEA were shown not to provide an accurate prediction of the resonance 
frequency of the NC-MS combination because the equations of the Helmholtz resonator and 
the linearised Eulerian equation used in FEA do not account for the effect of the shape of the 
MS and the presence of the NC, while the Navier-Stokes equation used in CFD does. Using 
the CFD model, the effect of geometrical parameters such as the ostium length/diameter, MS 
shape/volume, and the NC width on the resonance frequency of an NC-MS combination were 
also studied.  
To examine the importance of the resonance frequency of the NC-MS combination 
on the ADD efficiency, a CFD model was developed to investigate the effect of various input 
frequencies, including the resonance and off-resonance frequencies, on the transport of 
particles from NC to the MS using an Eulerian-Lagrangian particle tracking scheme. 
Moreover, the effect of amplitude of the acoustic source and the inlet flow rate (at the nostril) 
on the transport of particles from the NC to the MS were investigated using a CFD model in 
a simplified NC-MS combination. The results showed that the highest transport of particles 
from the NC to the MS occurred when the inlet frequency was identical to the resonance 
frequency. It has been shown that the amplitude of the acoustic source has a monotonic 
relationship with the transport of particles from the NC to the MS; however, the airflow rate 
has an inverse relationship with it. Moreover, the effect of particle diameters and density on 
the penetration of particles in the MS were investigated using CFD modelling. It was found 
that increasing the particle diameter and density decreases the penetration of particles into the 
MS; the reason is that, in the presence of an acoustic field, increasing the particle 
diameter/density decreases the particle entrainment coefficient, which increases the acoustic 
Stokes number. An increase in the Stokes number reduces the ability of the particles to follow 




To explore the feasibility of ADD in practice, a 3D printed model of a realistic NC-
MS combination was used to conduct the experiments to investigate the effect of resonance 
frequency on particle deposition in the MS, where a 2.5% sodium fluoride (NaF) was used to 
as the drug tracer. A loudspeaker was used to generate the acoustic field of interest, which 
was then applied to the nostril. The results show that when an acoustic field at a frequency 
equal to the resonance frequency of the NC-MS (obtained experimentally) is applied to the 
nostril, the particle deposition in the MS increases by 75-fold when compared with 
conventional drug delivery. The effect of input acoustic amplitude on particle deposition was 
also studied using a 3D printed model. The experimental data shows that increasing the input 
acoustic amplitude increases the particle deposition in the MS; however, increasing the 
amplitude above 120dB does not have a significant effect on the deposition. This might imply 
that at certain acoustic amplitudes a saturation point for aerosol deposition is reached.  
In the CFD simulation for a realistic NC-MS model, it was found that in the presence 
of an external acoustic field, not only does the air plug in the ostium oscillate but also a portion 
of the air plug in the middle meatus oscillates.  Hence, to increase the ADD efficiency, it is 
important to transport particles to the middle meatus as much as possible. To do so, the effect 
of inlet flow parameters, as well as the impact of the diameter of the nozzle that injects the 
particles at the nostril, on the drug delivery to MM-Ostium regions was investigated. The 
term MM-Ostium refers to a region in the middle meatus (MM) where the ostium connects 
the MM to the MS. An increase in particle retention criterion in the MM-Ostium region was 
calculated to quantify the increase in the drug delivery to the MS region. The results have 
shown that the effect of turbulence at the inlet of the NC on drug delivery to the MM-Ostium 
region is negligible. It was also demonstrated that increasing the flow swirl at the inlet 
improves the total particle deposition due to the generation of centrifugal force, which acts 




efficiency to the MS can be increased by using a swirling flow with a moderate swirl number 
of 0.6. Finally, it was found that decreasing the nozzle diameter can increase drug delivery to 
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 Background and motivation 
The term "nasal cavity (NC)" refers to one of the two separate parallel sides of the nose, or to 
a combination of both sides, which play an important role in the operation of the respiratory 
system for different physiological functions. Anatomical misalignments, such as septum 
deviation, explain why infections carried by aerosols during inhalation can cause the NC to 
malfunction, which can then lead to diseases emerging in the NC. One of the most common 
diseases in human upper airways is Chronic Rhinosinusitis (CRS), having a prevalence 
ranging from 4.9% to 10.9% worldwide (Bhattacharyya, 2012; Cho et al., 2010; Laube, 2007; 
Liu et al., 2018; Pilan et al., 2012). For example, statistics show that in the United States 
around 30 million CRS cases are diagnosed annually and about 0.6 million CRS patients 
undergo surgery (Lam et al., 2014).  
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CRS patients endure obstructed airways due to infections in the sinuses (Huang et al., 
2005). The sinuses are hollow organs in the human skull and are categorised into four types: 
frontal, sphenoid, ethmoid, and maxillary sinuses (see Figure 1.1 (a-b)). The maxillary sinuses 
(MS) are the largest of all the sinuses and are located below the cheek and closer to the nostril 
than the other sinuses. Given their location, the MS are exposed to a wider range of diseases 
compared with the other sinuses, including bacterial colonisation and viral infection. In 
addition, MS infections can spread to the ethmoid sinuses (ES), frontal sinuses (FS), and 
maxillary teeth due to the proximity of the MS to these regions (Harbo et al., 1997).  
Topical therapy with anti-inflammatory drugs (antibiotics) forms the mainstay of 
treatments of CRS. Various drug delivery methods are used, including nasal douching 
(Taccariello et al., 1999), nasal pump sprays and nebulisation (Moffa et al., 2019). In the nasal 
douching technique, the NC is irrigated with a drug solution to remove the infections from 
the sinuses and nose (Taccariello et al., 1999). Nasal douching is beneficial in reducing 
congestion of the NC, removing bacteria and viruses from the sinuses, and reducing the need 
for functional endoscopic sinus surgeries; however, washing the nose also flushes out the 
good mucus containing antimicrobial agents, which can lead to an increase in the frequency 
of acute infections (Moidee, 2019). Also, nasal douching is not a cost-efficient method for 
sinus drug delivery due to the large amount of drug waste (Snidvongs et al., 2008). To 
overcome the significant drug waste, pump sprays and nebulisers are potential candidates for 
new forms of sinus drug delivery.  
Nasal pump sprays are usually used to deliver the drug solution locally in the NC for 
conditions such as nasal congestion and allergic rhinitis. Nasal pump sprays produce 
particles/droplets with a median aerodynamic diameter (MAD) of 50-100 µm. The majority 
of the droplets produced by sprays are deposited on the nasal valve and anterior regions of 
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the NC and cannot reach the posterior NC regions and poorly-ventilated areas, such as sinuses 
(Möller et al., 2014), where the efficiency of drug delivery is near zero (Suman et al., 1999).  
(a) (b)  
 
(c)  (d)  
  
Figure 1.1: A schematic of the paranasal sinuses: (a) sagittal view; (b) front view; (c) section 
B-B’ representing the maxillary sinuses (MS), ostium, superior meatus (SM), middle meatus 
(MM), main passage, (MP), and inferior meatus (IM), reproduced from Xi et al. (2017) with 
permission from Elsevier; (d) an overview of the NC representing the nasal vestibule, nostril, 
nasal valve region, the respiratory region, olfactory region, ostiomeatal complex (OMC) and 
nasopharynx, reprinted from Shi et al. (2007) with permission from Elsevier.  
On the other hand, nebulisers produce finer particles/droplets in a range of 1-30 µm, 
which can be transported beyond the nasal valve and reach the posterior regions of the NC, 
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Conventional nebulisers have proven advantageous for drug delivery to the superior meatus 
(SM), middle meatus (MM), and inferior meatus (IM), as well as the olfactory region (Hilton 
et al., 2008; Wofford et al., 2015). However, for topical drug delivery to the sinuses, 
particularly the MS, conventional nebulisers are likely to be an inefficient method due to the 
poor accessibility of the MS (Hyo et al., 1989; Möller et al., 2014; Wofford et al., 2015). The 
MS is connected to the NC through a narrow opening called the ostium. The diameter and 
length of the ostium are usually in the range 2-6 mm and 4-12 mm, respectively (Cannon et 
al., 2013). The small size of the ostium limits drug delivery to the MS (see Figure 1.1(c)) 
(Frank et al., 2013).  
A novel technique called acoustic drug delivery (ADD) has recently been employed to 
overcome the low efficiency of conventional nebulisers for drug delivery to the MS (Leclerc 
et al., 2014). In ADD, the MS behaves like a Helmholtz resonator, an acoustic device 
composed of a cavity attached to a neck. In an NC-MS combination, the MS and the ostium 
play the role of the cavity and the neck of the Helmholtz resonator, respectively. When an 
external acoustic wave is applied to an NC-MS combination (Helmholtz resonator), the air 
plug in the ostium oscillates at a frequency equal to the frequency of the external acoustic 
waves (von Helmholtz et al., 1875). Based on the theory of the Helmholtz resonator, the 
amplitude of the oscillation of the air plug in the ostium becomes maximal when the 
frequency of the external acoustic wave is identical to the resonance frequency. Accordingly, 
when the combination of the NC and MS is at resonance, it is expected that the air exchange 
between the NC and the MS is increased, which leads to the highest penetration of nebulised 
medications to the MS. 
Limited studies have investigated the efficacy of ADD for drug delivery to the MS, in 
which a fixed acoustic frequency (i.e. 45 Hz & 100 Hz) was applied at the nostril (Granqvist 
et al., 2006; Laube, 2007; Möller et al., 2011; Si et al., 2013; Xi et al., 2017). These studies, 
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using ADD with fixed frequencies, demonstrated an insignificant (2- to 3-fold) increase in 
the penetration of nebulised medications into the MS when compared with non-acoustic drug 
delivery (non-ADD) (Leclerc et al., 2014); however, the penetration of the drug into the MS 
varies for different sizes of the ostium and MS (Xi et al., 2017). The reason for the low 
efficiency of ADD with fixed frequencies of 45 Hz and 100 Hz might be due to the fact that 
the oscillation of the air plug in the ostium is not at resonance at these fixed frequencies.  
In several studies, a classic Helmholtz resonator equation was used to predict the 
resonance frequency of the combination of the NC and MS in order to apply the obtained 
resonance frequency to the nostril (Durand et al., 2012; Maniscalco et al., 2006; Möller et al., 
2010; Möller et al., 2014; Möller et al., 2008; Xi et al., 2017). In-vitro studies in the literature 
demonstrate that the penetration of the nebulised medication to the MS was not increased 
significantly compared with a non-ADD, even with the application of an acoustic wave at the 
resonance frequency of the NC-MS combination predicted by the Helmholtz resonator 
equation (Moghadam et al., 2018). The classic equation for the resonance frequency of a 
Helmholtz resonator is based on the volume of a spherical cavity and the length and diameter 
of a cylindrical neck, while the geometry of the MS and ostium are irregular. Therefore, the 
classic Helmholtz resonator equation will not accurately predict the resonance frequency of 
a specific geometry, leading to reduced efficiency of ADD. 
An alternative to fixed-frequency is to apply a frequency sweep to the nostril. The 
frequency sweep covers a broader frequency range, so there should be an input frequency that 
either matches or is close to the resonance frequency of the NC-MS combination. In a recent 
ADD study by Moghadam et al. (2018), using a 3D printed model of a realistic nose-sinus 
model, the application of a frequency sweep (100-850 Hz) to the MS demonstrated an 
increase in the deposition of nebulised medications in the MS when compared with non-ADD. 
Although the frequency sweep technique increased the overall deposition of the nebulised 
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drugs in the MS, the total amount of the injected nebulised medications increased, and the 
treatment time was significantly extended in comparison with the application of a fixed 
frequency, which can lead to an increased risk of adverse side effects in the respiratory 
system. 
Single fixed acoustic frequency (i.e., 45 Hz & 100 Hz) ADD technology is currently 
available as a topical therapy but has not yet been shown to enable the delivery of a sufficient 
amount of nebulised medications to the MS in most of the CRS cases. The primary motivation 
of this thesis is to develop a well-resolved model to understand the mechanisms underlying 
the ADD technique. The goals of the research are not only to develop a model to better 
understand the ADD technique but also to determine the potential geometric and aero-
acoustic parameters influencing the efficiency of ADD in drug delivery to the MS. 
All previous studies considered a uniform airflow entering the nostril for drug delivery 
applications. However, Ari et al. (2015) showed experimentally that different inhalation mask 
shapes affect the performance of drug delivery to the lung, which implies that the inlet flow 
parameters and distribution of the injected particles at the nostril can have an impact on the 
deposition and transport of the particles in different regions of the NC. Previous studies showed 
that the ventilation of both MM is much lower than the ventilation of the main nasal passage and 
IM, which contributes to a low drug delivery to the MS. The secondary aim of this project is to 
develop an understanding of the effect of the inlet flow parameters, such as a turbulent or 
swirling inlet flow, as well as the effect of the nozzle diameter (the diameter of the particles’ 
injection at the nostril) on the flow structure and the particle transport/deposition patterns in 
the NC. 
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  Objectives of the research 
The main aim of this study is to develop a deep understanding of the mechanisms underlying 
ADD to the MS in order to increase the efficiency of this delivery technique, as well as to 
investigate the effect of inlet airflow patterns on flow features in the NC and sinuses. To 
achieve this aim, the following objectives are defined: 
• To develop a well-resolved numerical model to investigate the effect of different 
geometrical parameters on the resonance frequency of the NC-MS combination.  
To maximise drug delivery efficiency in ADD, it is crucial to accurately predict the 
resonance frequency of the NC-MS combination. It has been demonstrated that the 
efficiency of ADD is not increased significantly when the input acoustic frequency is 
equal to the resonance frequency predicted by the Helmholtz resonator equation. 
Therefore, the classic Helmholtz resonator equation cannot predict an accurate 
resonance frequency of the NC-MS combination. Hence, a well-resolved model is 
required to accurately predict the resonance frequency of an NC-MS combination. 
Finite element analysis and computational aero-acoustics are potential candidates for 
this purpose. Once an accurate model is developed, the effect of different geometrical 
parameters on the resonance frequency of the nose-sinus model can be investigated to 
identify the important geometrical parameters in resonance frequency prediction. 
• To develop an understanding of airflow behaviour in a simplified NC-MS combination 
in the presence of an external acoustic field in order to investigate the effect of aero-
acoustic parameters on the efficiency of ADD.  
To do so, a well-developed numerical model is required to simulate the effect of aero-
acoustic parameters, including the input acoustic frequency, input sound pressure 
level, and inlet mean flow rate on the particle dispersion and deposition patterns. The 
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particle dispersion and deposition patterns in the MS are representative of the 
efficiency of ADD.  
• To fabricate a well-designed experimental setup using a 3D printed model of a 
realistic NC-MS model to examine the efficacy of ADD in drug delivery to the MS.  
Considering the vital aero-acoustic parameters identified in the second objective, the 
feasibility of ADD to the MS will be investigated and the optimal aero-acoustic 
parameters will be identified. The effect of the aero-acoustic parameters on the 
efficacy of ADD will be investigated and the deposition rates of nebulised drug 
particles/droplets will be compared with those obtained during non-ADD. 
• To develop a computational fluid dynamics (CFD) model to investigate the effect of 
the inlet flow parameters and the nozzle diameter on particle transport/deposition in 
a realistic NC-MS combination.  
To increase ADD efficiency, not only it is necessary to predict the accurate resonance 
frequency of the NC-MS combination and to optimise the aero-acoustic parameters, 
but also important to attain sufficient nebulised medication (particles) dispersed in the 
middle meatus region where the ostium is located. The effect of different inlet flow 
parameters (i.e., turbulence and swirl), as well as the effect of the diameter of the 
nozzle used for injecting the particles into the nostril, on the particle 
transport/deposition patterns in the middle meatus region will be studied.  
 Structure of the thesis 
The thesis is formatted as a collection of manuscripts that have been published in or submitted 
to high-quality journals and peer-reviewed conference proceedings.  
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In Chapter 2, a comprehensive literature review is carried out to establish a detailed 
framework for this research. The anatomy of the human respiratory system is initially 
discussed to understand the functions and important anatomical parameters of the NC and 
sinuses. The diseases related to the NC and sinuses are then introduced with a focus on 
chronic nose-sinus diseases such as CRS. The existing targeted drug delivery (TDD) methods 
are reviewed in detail to determine the most efficient, non-invasive, and feasible method of 
drug delivery to the NC and sinuses for the treatment of CRS. The airflow features, and 
aerosol transport pattern and deposition of aerosol in the NC and sinuses, are also discussed 
to understand the existing gaps and questions in nasal drug delivery in order to improve the 
efficiency of ADD. 
In Chapter 3, as an initial step for improving drug delivery efficiency, a CFD model, 
cross-validated with experimental data, is presented to estimate the resonance frequency of 
the NC-MS combination. It is assumed that to achieve the highest ADD efficiency it is crucial 
to obtain an accurate resonance frequency of the NC-MS combination. Various numerical 
models, including FEA, CFD, and analytical, are used to determine the most accurate method 
for estimating the resonance frequency of the NC-MS combination. Then, a parametric study 
is conducted to investigate the effect of the geometrical parameters of the NC and MS on the 
resonance frequency of the NC-MS combination. Finally, the effect of the middle meatus on 
the estimation of resonance frequency is examined in a realistic NC-MS combination using a 
CFD model.   
In Chapter 4, the aero-acoustic behaviour of a simplified NC-MS combination is 
studied using CFD modelling through the Eulerian-Lagrangian particle tracking approach. 
The CFD model is validated against experimental data, based on the estimation of the 
resonance frequency of the NC-MS combination. A parametric study is conducted to examine 
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the effect of various parameters such as input acoustic frequency, amplitude, and airflow rate 
on the efficiency of ADD for drug delivery to the MS. The effect of those parameters on the 
flow features in the NC, ostium, and MS is investigated. Furthermore, the effect of the 
particles and density on the efficiency of ADD is examined using assessment of the acoustic 
Stokes number.  
In Chapter 5, a realistic NC-MS model is used to conduct a set of in-vitro experiments 
to investigate the application of acoustic excitation in drug delivery to the MS. The resonance 
frequency of the realistic NC-MS combination was measured experimentally. Then, the 
effects of input frequency (including the resonance and off-resonance frequencies), 
amplitude, and nebulisation flow rate on the deposition of aerosol in the MS are investigated. 
Nebulised 2.5wt% sodium fluoride (NaF) is used as the drug tracer. The deposited NaF in the 
MS is detected using a fluoride ion-selective electrode, together with an Ion-Selective 
Electrode (ISE) meter. Finally, an optimised acoustic wave and an optimum nebulisation flow 
rate are obtained to achieve the highest drug delivery efficiency for the NC-MS geometry of 
this study. 
In addition to the aero-acoustic parameters, the efficiency of ADD is highly dependent 
on the number of particles dispersed in the MM region.  In Chapter 6, the effect of inlet flow 
parameters on airflow structure and particle transport/deposition in a realistic NC-MS 
combination is investigated. A CFD model is developed to conduct a parametric study to 
assess the effect of a turbulent and swirling inlet flow, as well as the effect of nozzle diameter 
on drug delivery to the MS. The CFD model is validated against published experimental data, 
based on the pressure distribution in the NC.  
Finally, the key conclusions and the main findings that have been documented 
throughout this thesis are presented in Chapter 7, along with suggestions for future research. 
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 Thesis format 
This thesis is based on the collection of the manuscripts produced during the PhD program 
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 Human respiratory system 
The human respiratory system is categorised into two sections; the upper and lower airways. 
The upper airway, also known as the extra-thoracic zone, consists of the nasal cavity (NC), 
paranasal sinuses, the throat (or pharynx), and larynx (see Figure 2.1 (a)). The oral cavity is 
also partially related to the upper airway, as it can be used for respiration. The lower airway 
includes the trachea, bronchi, bronchioles, and alveoli (see Figure 2.1 (b-c)). Gas exchange is 
the main function of the human respiratory system, which takes place due to the differences 
in the air pressure between the alveolar spaces and the surrounding air.  
The diaphragm is the main muscle of respiration located underneath the lungs, and its 
contraction enlarges the chest cavity leading to the air pressure in the lungs falling below the 
surrounding atmospheric pressure. This pressure difference causes the surrounding air to be 
pushed into the NC from outside, which forms the inhalation process. During inhalation, the 
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air moves through the main passage of the NC, pharynx, larynx, and trachea, and then enters 
the bronchi and bronchial tubes and finally reaches the alveoli. Then, the oxygen in the air 
diffuses into the blood through the walls of the alveoli ducts and the carbon dioxide is diffused 
from the blood to the alveoli ducts, completing the inhalation process.  
(a) (b) (c) 
 
 
Figure 2.1: Schematic of a human respiratory system (a) sagittal view representing the upper 
airways including the nasal cavity, oral cavity, pharynx, and larynx; (b) frontal view 
representing the lower airways including the trachea, bronchi, and bronchioles, lung, and the 
diaphragm; (c) zoomed-in view of the alveoli and alveolar duct, reprinted from Tu et al. 
(2013), with permission from Springer Nature. 
After completion of the inhalation process, the diaphragm relaxes and the volume of 
the lung is reduced, leading to higher air pressure in the lung than the atmospheric pressure 
in the surrounding air. The difference between the air pressure in the lung and the surrounding 
air causes the air to move from the lung into the NC and, finally, it is expelled through the 
nostrils, which forms the exhalation process (Stammberger, 1989). The airflow rate during 
respiration is high or low, depending on the magnitude of the pressure difference between the 
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2.1.1 Anatomy and function of the nasal cavity  
The human nose consists of an external and internal sections. The external section is called 
the nose, which protrudes from the face (see Figure 2.2 (a)). The internal section of the nose 
is termed the nasal cavity. The nose is the sole part of the respiratory organs that is visible, 
and located above the upper lip. The nose is a pyramid-shaped structure, which is composed 
of cartilaginous and bony parts. The superior part of the nose is made of a bony structure and 
the inferior part is cartilaginous. There are two openings at the base of the nose called nostrils. 
The nostrils are the gateway of the respiratory system, where the air and aerosols enter the 
NC to be transported to the lungs. They are separated via cartilage, namely the nasal septum 
(see Figure 2.2 (b)). 
The NC is divided into two parts via a septum forming left and right nasal cavities. 
These cavities are not symmetrical, although their volumes are approximately equal. The roof 
of the NC is composed of the frontal bone, nasal cartilages, nasal bones, and the cribriform 
plate of the sphenoid and ethmoid bones. The cribriform plate is a sieve-like structure that is 
located between the NC and anterior cranial cavity. The cribriform plate is perforated by 
several small holes that allow the olfactory nerves to pass from the brain to the roof of the 
NC. The olfactory nerves are responsible for sending olfactory sensory information to the 
brain. The floor of the NC includes the horizontal parts of the palatine bones and the palate 









Figure 2.2: (a) Oblique view of the nose; and (b) frontal view of the NC at a frontal cross-
section of the internal nasal valve, reprinted from Wong et al. (2021), with permission from 
Springer Nature. 
The schematic diagrams of different regions of the NC are presented in Figure 2.3 (a-
f). In each NC, the main airway consists of the vestibule, olfactory, and respiratory regions. 
The vestibule begins from the nostril opening, extending to the nasal valve, which is the 
narrowest part of the NC. The region between the nasal valve and the nasopharynx is called 
the respiratory region, which includes the superior meatus (SM), middle meatus (MM), and 
inferior meatus (IM), where the paranasal sinuses are attached. The olfactory region, which 
is located at the roof of the NC, is covered by the olfactory epithelium. The main functions 
of the NC are temperature adjustment and humidification of the inhaled air, filtering the 
inhaled air to clean it from foreign particulates and accommodate the olfactory nerve for 
sensing smells.  
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Figure 2.3: A schematic diagram of (a) nasal and oral cavities (isometric view) and their 
location in the skull; (b) roof, floor, and lateral walls of the nasal cavity; (c) airflow in the 
right nasal cavity ; (d) nasal vestibule, olfactory and respiratory regions; (e) coronal section 
of the nasal cavity; (f) turbinates on lateral walls, reprinted from Drake et al. (2020), with 
permission from Elsevier. 
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In terms of filtration, the nasal hairs are the initial organs that trap foreign particulates, 
which enter the NC through inhalation. The subsequent filtration occurs due to the convoluted 
passage of the airflow through the complicated anatomy of the NC. To be more specific, the 
direction of the airflow turns from vertical at the vestibule to horizontal at the nasal valve, 
then the airflow passes through the complicated anatomy of the meatuses, where the 
deposition of particulates is increased on the wall of the NC (see Figure 2.3 (c-d)). The 
deposited particulates are transported to the nasopharynx via mucociliary transport, to be 
swallowed and enter the stomach (Randell et al., 2006).   
The surface of the main airway of the NC (i.e., the surfaces of SM, MM, and IM) is 
covered by a ciliated epithelium, which consists of different layers. The upper layer of the 
epithelium is lined by jelly mucus, located on the watery saline layer covering the cilia (see 
Figure 2.4), which beat 7-8 times per second (Zhou et al., 2009). The viscoelastic 
characteristic of the cilia enables the conversion of the energy from beating to transport of the 
mucus toward the nasopharynx (see Figure 2.4). About 125 mL of mucus is produced per 
day, which transports continuously towards the nasopharynx at a speed of 1-2 cm/h (Illum, 
2003; Mistry et al., 2009; Ugwoke et al., 2005). 
Although mucociliary transport is a vital mechanism in the filtration process, it 
negatively impacts the efficiency of nasal drug delivery, since it transports the deposited 
medication to the gastrointestinal system. This reduces the time for the medication to be 
diffused into the blood (F. Fry et al., 1973; Schmidt et al., 1998). Recently, the use of 
medications employing polymer-coated nanoparticles has demonstrated an increase in the 
efficiency of the diffusion of the drug particles into the blood after deposition on the wall of 
the NC and sinuses (Illum, 2012).  
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Figure 2.4: An overview of the structure of the nasal mucosa and the mechanism of 
mucociliary transport, reprinted from Zhang et al. (2011), with permission from Elsevier: a 
minor modification has been applied to the original figure in terms of labelling and particle 
trajectories. 
2.1.2 Paranasal sinuses 
An NC is surrounded by sphenoid sinuses (SS), ethmoid sinuses (ES), frontal sinuses 
(FS), and maxillary sinuses (MS). Figure 2.5 (a-b) shows the paranasal sinuses and their 
location in the skull. The sinuses are hollow cavities that are filled with air and are named 
after their surrounding bones. The sinuses are coated with mucus to protect the NC from 
drying out. SS are developed after adolescence. SS are two hollow cavities contained in the 
sphenoid bone, which is located between the eyes and behind the nose. ES, which are present 
at birth and develop with the body’s growth, are a collection of small cavities surrounded by 
spongy ethmoid bone, located in the superior portion of the nose and between the eyes. FS, 
which are developed after the age of seven, are situated above the eye sockets (orbit) and 
behind the brow ridges. MS are the most voluminous of the paranasal sinuses and are situated 
on either side of the nose, above the teeth and underneath the cheeks. MS, which are not equal 
in size, exist at birth and develop throughout childhood to reach their final size at around the 
age of seventeen or eighteen. The MS are connected to the NC through a narrow channel 
called the ostium.  
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Figure 2.5: (a) A schematic diagram of the nasal cavity and paranasal sinuses (isometric 
view), reprinted from Drake et al. (2020), with permission from Elsevier; (b) coronal section 
represents the paranasal sinuses (frontal view), reprinted from Singh et al. (2017) with 
permission from Medscape Drugs & Diseases. 
The main functions of the paranasal sinuses are as follows: lightening the skull, 
resonating speech sounds, and producing lysozyme, which protects the nasal mucus from 
bacterial infections (Boysen, 1982; Tu et al., 2012). One of the first reliable figures of the 
paranasal sinuses was drawn by Leonardo da Vinci in 1489. His drawing had good agreement 
with a contemporary figure of the paranasal sinuses (Crowe, 2005). Later on, in 1651, an 
accurate illustration of the MS was introduced by Highmore, called the antrum (hollow) of 
Highmore (Blanton et al., 1969). In ancient times, the secretions coming from the nose were 
suspected to stem from the brain, then flow into the NC; however, Schneider found that the 
secretions coming out from the nostril are produced by the sinuses’ mucosa, which could be 












Chapter 2. Literature review 
24 
2.1.3 Chronic Rhinosinusitis 
Chronic Rhinosinusitis (CRS) is a prevalent disease related to the human nose, originating 
from inflammation of the mucosa in the sinuses and the NC. According to the American 
Academy of Otolaryngology-Head and Neck Surgery, CRS refers to a condition where the 
symptoms of the inflammation exist for more than 12 weeks in a year, while persistence of 
symptoms for durations of 4 weeks and 4-12 weeks are defined as acute and subacute 
rhinosinusitis, respectively (Rosenfeld et al., 2007). To diagnose CRS, at least two of the 
following symptoms should be observed: facial fullness (70-85%), hyposmia (61-69%), nasal 
secretions (51-83%), and obstruction of the NC (81-95%) (Meltzer et al., 2004; Rosenfeld et 
al., 2007).  
Historically, it was believed that CRS originated from bacterial infection as a result 
of obstruction of the sinus ostium. However, it is currently understood that CRS occurs due 
to different predisposing factors, such as local host factors (e.g., polyps, obstruction of the 
nasal anatomy, and tumours), environmental factors, (e.g., bacteria, pollution, fungi, and 
allergens), general host factors (e.g., immune deficiency, cystic fibrosis, defects, and 
genetics) (Marple et al., 2009; Rosenfeld et al., 2007). In fact, CRS, rather than being a single 
disease, is a group of symptoms stemming from different reasons, which has a prevalence 
ranging from 4.9-10.9% of the world population (Bhattacharyya, 2012; Cho et al., 2010; T. 
Liu et al., 2018; Pilan et al., 2012).  
The available methods for the treatment of CRS are topical drug delivery, systemic 
drug delivery, and sinus surgery (Moghadam et al., 2018). The choice of a treatment method 
depends on several factors, such as the severity of the disease and nasal anatomy, as well as 
the patient’s compliance. Corticosteroids, saline nasal douching (nasal irrigation), and 
antibiotics form the primary treatments associated with the medical management of CRS 
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(Benninger et al., 1997; Lund, 2005). However, for drastic cases where the CRS-related 
disorder affects the quality of life of the patients, functional endoscopic sinus surgery (FESS), 
with a success rate of 70-90% is exercised (Iro et al., 2004; Stammberger et al., 1990). Figure 
2.6 (a-b) illustrates computed tomography (CT) images of CRS before and after surgery. This 
Figure shows that the infections in the MS (see Figure 2.6 (a)) were removed completely after 
FESS (see Figure 2.6 (b)).  
Post-surgical treatment is crucial for FESS. Insufficient post-surgical treatment may 
lead to an additional surgery or more and the entire treatment may be unsuccessful 
(Moghadam et al., 2018). Using a topical steroid spray for long-term treatment, a reduction 
in the inflammation of the sinuses and NC and an improvement of the symptoms of the CRS 
have been achieved (Grzincich et al., 2004; Lund, 2005). Using topical daily nasal steroids 
results in reducing the side-effects; however, long-term use of this medication leads to 
significant adverse side-effects (Gillespie et al., 2004; Grzincich et al., 2004). Therefore, it is 
crucial to develop a targeted drug delivery (TDD) technique to increase the efficiency of the 
drug delivery to the NC and sinuses and obtain the minimum number of adverse side effects. 
In the following sections, the available TDD techniques were reviewed in detail and the most 










Figure 2.6: Frontal view of the NC of a CRS patient (a) before; and (b) after functional 
endoscopic sinus surgery (FESS), reprinted from Hamilos (2011), with permission from 
Elsevier. 
 Targeted drug delivery 
In the conventional drug delivery method, medications are usually either injected into the 
blood circulation system or taken orally, known as systemic drug delivery. In this method, 
the drugs are not distributed topically but are distributed throughout the entire body. Such a 
drug distribution can damage healthy tissue and cells, which counts as an adverse side-effect. 
To avoid some side-effects, targeted drug delivery (TDD) provides an alternative smart 
technique for delivering medications to the human body, in which the concentration of the 
medications in a target site is greater than for other locations within the body.  
In TDD, the medications are guided to the diseased tissue/cells and the healthy 
tissue/cells are less-likely to be affected, leading to a significant reduction in adverse side-
effects. Reducing the adverse side-effects is crucial in many diseases such as in cancer therapy 
Infected MS before FESS Healthy MS after FESS 
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and is advantageous in the treatment of diverse illnesses, such as nervous system disorders, 
sudden hearing loss and so on (YaLi Liu et al., 2019; Rosenblum et al., 2018; Shapiro et al., 
2014; Venugopal et al., 2017). The main drawbacks of TDD are its cost and sometimes the 
complexity of instruments and the discomfort of patients.  
The main aim of the TDD is to provide a safe, longer, localised and targeted 
interaction between the drug and diseased cells or tissues. In TDD, the medications are 
released at or delivered to a target site in the form of dosage, but in conventional drug delivery, 
the medications are absorbed through the biological membranes (Tan et al., 2015). For 
example, in chemotherapy, about 1% of the medications administered reach the tumour 
location, while 99% of the therapeutic agents are distributed to other locations in the body, 
which can damage healthy organs (Trafton, 2009). Hence, it is important to develop and use 
an efficient TDD for the treatment of such localised diseases (Bertrand et al., 2012).  
The NC possesses a large vascularized surface area, which makes it an excellent choice 
for administration of pharmaceutical drug particles for treatment purposes (Suman, 2013). 
The NC is also the best route for the topical delivery of aerosolised medications in the 
treatment of local ailments related to the paranasal sinuses and the nose, such as CRS and 
allergic rhinitis. Moreover, the NC is an attractive pathway for systemic drug delivery and 
needle-free vaccination, especially when rapid effectiveness and quick absorption are 
required (Djupesland, 2013). For most drug delivery purposes, in which the medications are 
used for vaccines, local action, and systemic absorption, a broad drug distribution on the 
surfaces of the mucosal NC appears suitable (M. Vidgren et al., 1998). However, for some 
diseases, such as nasal polyposis and chronic rhinosinusitis, TDD to the SM and MM is more 
desirable because the nasal polyps originate from the SM and the ostium of the MS is located 
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in the MM (Laube, 2007). For cases where nose-to-brain delivery is required, TDD to the 
olfactory region is believed to be necessary (Aggarwal et al., 2004). 
To perform TDD, it is important to account for the following criteria: the disease, the 
pathway considered for the delivery of the medication, the characteristics of the drug, the 
potential adverse side-effects, and the targeted organ. TDD is usually classified into two 
categories: passive targeting and active targeting (Hadilou et al., 2018; Lewis Jr et al., 2007; 
Sengupta et al., 2018). These TDD approaches are explained and reviewed in the following 
sections.  
2.2.1 Passive targeting 
In nasal drug delivery using the passive targeting approach, the medications are directed to a 
target site in the airways (such as the lung, nasal cavity, MS, olfactory regions, etc.) by 
modification of the dosage of the medication, size of the droplets (e.g., aerosol), the timing 
of the injection of the aerosolized medications, inhalation flow rate (breathing pattern), and 
the inhaled gas density (Dolovich et al., 2011). Several different methods/devices are 
available that exploit the passive targeted drug delivery (PTDD) approach for drug delivery 
to different parts of the NC, sinuses, and olfactory regions. These methods/devices are briefly 
described in the following sections and the most efficient PTDD method for drug delivery to 
the NC and MS is identified.  
2.2.1.1 Drop delivery with a pipette 
Delivery of drops and vapour to the nose is one of the oldest nasal drug delivery techniques 
that use the PTDD approach. Historically, drops of breast milk were dripped in an infant's 
nose to treat nasal congestion, and methanol vapour was used to awaken fainted people 
(Djupesland, 2013). Although the drops have mostly been switched to metered-dose spray 
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pumps, inexpensive and over-the-counter saline and decongestants are still produced in the 
form of blow-fill-seal pipettes. Drop delivery is an efficient method for treating polyps, since 
the drug liquids need to be delivered to the MM where the polyps usually appear (Keith et al., 
2000; Penttilä et al., 2000). Although drop delivery is an efficient PTDD technique for the 
treatment of some diseases such as polyps, it results in discomfort since the patient must 
locate themselves in a head-down body position to assist with the deposition of drops driven 
by gravity (Aggarwal et al., 2004). Using this method of drug delivery is not prescribed for 
patients suffering from CRS because the head-down position causes increased headaches and 
inconvenience (Merkus et al., 2006). 
2.2.1.2 Liquid delivery with a rhinyle catheter 
Liquid delivery to the NC using a rhinyle catheter and squirt tube is a simple drug delivery 
method such that the medications (in the form of a liquid) are deposited at the target site by 
inserting the tip of a micropipette or a catheter into the target site and squirting the drug liquid 
into that region. This method is usually employed in animal studies, when they are sedated. 
It can also be used for drug delivery in the human NC, even without sedation, but care should 
be taken to avoid direct contact with the vulnerable mucosal layer (Bakke et al., 2006). 
However, this drug delivery technique is not convenient for patients if self-administration is 
required.  
Using 200 µl of liquid desmopressin, Harris et al. (1986) investigated the effect of a 
pipette and rhinyle catheter on drug absorption in the NC for the treatment of diabetes 
insipidus. For the rhinyle catheter, the liquid medication was placed into a thin plastic tube. 
A dropper was designed and located at one end of the tube and the other end of the tube was 
designed such that it fitted the mouth for blowing. The tube with the dropper was placed into 
the nostril where the medication was injected into the NC in forms of the drops or liquid-jet 
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driven by blowing into the other end of the tube (Harris et al., 1986). Using gamma 
scintigraphy, they found that the drug absorption in the target site after using the rhinyle 
catheter was greater than that after using the pipette (Harris et al., 1986). Nonetheless, given 
the considerable low accuracy of this method in terms of dosing and due to its cumbersome 
process, it is neither an attractive nor a popular method of nasal drug delivery.  
2.2.1.3 Squeeze bottles 
Squeeze bottles are simple devices composed of a plastic bottle that is partly filled with the 
drug and air, and a nozzle for expelling the liquid drug. The nozzle is located in the nostril 
and, when the plastic bottle is squeezed, the liquid is injected into the nose. The dose of the 
liquid injected to the nose changes with the force applied to squeeze the bottle. Then, releasing 
the pressure used for squeezing the bottle creates suction to draw the nasal discharges into the 
bottle, where dried nasal mucus and infections in the nose can be suctioned into the bottle and 
infect the liquid medication in the bottle (M. Vidgren et al., 1998). The squeeze bottle is a 
convenient, efficient, and simple device for the treatment of typical nasal congestions using 
over-the-counter decongestants. However, because 90% of the atomised medication deposits 
on the anterior region of the NC, such as the nasal valve, and due to the inconsistent doses of 
injected medications, it is not an efficient method for the treatment of severe nasal diseases 
such as CRS (Newman et al., 1987, 1988). For efficient treatment of CRS, a considerable 
amount of the administered drug should be transported beyond the anterior region.  
2.2.1.4 Multi-dose spray pumps 
Multi-dose spray pumps dominate the market for nasal drug delivery. They were first 
introduced about 40 years ago. They usually generate small particles (fine droplets) at a size 
of 50-100 µm and sprinkle 0.25-2 ml of the medication per spray (Moffa et al., 2019). In this 
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method, the geometry of the spray plume and the size of the particles can alter depending on 
factors such as the characteristics of the actuator orifice, the force implemented on the pump, 
and the viscosity of the medication (M. Vidgren et al., 1998).  
The multi-dose spray pump has been demonstrated to be an efficient method for the 
delivery of corticosteroids for the treatment of seasonal allergic rhinitis and nasal polyps 
(Berger et al., 2007; Newman et al., 1987). To keep the conformity of the required dose, 
multi-dose spray pumps should be slightly overfilled and require some degree of priming. 
Hence, they are not well-suited for expensive vaccines and medications, which require careful 
control of the dose and single-administration. For such applications, single-dose or dual-dose 
spray pumps are recommended (Mutsch et al., 2004; Nichol et al., 1999).  
In general, conventional devices, including pipettes, rhinyle catheters, squeeze bottles 
and spray pumps, are not efficient PTDD methods for delivering drugs to a target site, 
especially to the sinuses, since most of the drug deposits in the anterior region (i.e., the nasal 
valve), septum and the nasopharynx (Suman, 2013). Using multi-dose spray pumps, several 
in-vivo studies examined the efficiency of these devices for drug delivery to the NC. By using 
gamma scintigraphy technology, they demonstrated that a very small portion (<10%) of the 
injected aerosols reaches the posterior region of the NC, middle and superior meatuses, and 
the paranasal sinuses, since a significant portion of the aerosols is deposited in the anterior 
part of the NC (Hardy et al., 1985; Harris et al., 1988; Newman et al., 1987, 1988; Thorsson 
et al., 1993; P. Vidgren et al., 1991). 
The deposition of the most aerosols in the anterior part of the NC when using spray 
pumps is not only due to the large particle size (50-100 µm) but also because of the mismatch 
between the spray plume geometry and the geometry of the anterior part of the NC, such as 
the nasal valve. When the spray pump is actuated by an external force acting on it, the 
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medication (in the form of liquid) flows into the swirl chamber, then comes out through the 
nozzle located at the tip of the spray pump (Inthavong et al., 2008). Due to the radial and axial 
velocities of the egressed liquid, a swirling cone-shaped sheet is formed at the proximity of 
the nozzle, which breaks up into ligaments after a short distance (known as the break-up 
length) and then the particles are generated (see Figure 2.7 (a-b)) (Shrestha et al., 2020). It 
should be noted that the particles are mainly generated at the margin of the cone-shaped 
geometry (known as the spray plume).  
The performance of the spray plume, which affects the particle deposition pattern in 
the NC, is highly influenced by the following key factors: the swirl intensity, the break-up 
length, nozzle diameter, and the cone angle of the spray. Using CFD simulation, Inthavong 
et al. (2008) estimated the diameter of the cone-shaped plume of a nasal spray at the break-
up point. For a spray with a cone angle of 30°, nozzle diameter of 0.5 mm, and a break-up 
length of 3.5 mm, they estimated the diameter of the spray cone as 4 mm (Inthavong et al., 
2008). In an in-vitro study, Suman et al. (2006) measured the smallest diameter of the spray 
cone of a spray pump with a spray angle of 54.6° at a specific distance from the nozzle. They 
reported that the spray cone diameter at a distance of 25 mm from the nozzle was obtained as 
30.8 mm and at a distance of 10 mm from the nozzle it is 19.2 mm (Suman et al., 2006). 
Hence, even though the tip of the nasal pump is inserted in the nose at a distance of 10-15 
mm from the nostril, the spray plume size (with diameter≈20 mm) and shape are mismatched 
with the narrow nasal valve, which has a triangular shape and a hydraulic diameter of 4-10 
mm (Hosseini et al., 2020). Therefore, because most of the particles are at the margin of the 
cone-shaped plume, a significant number of particles deposit in the anterior region, especially 
in the nasal valve, resulting in a low deposition in the posterior region, such as the middle 
meatus and sinuses. 





Figure 2.7: (a) Raw image of the formation of spray; (b) post-processed image of the 
formation of spray, adapted from  Spray plume development during pre-stable phase by 
Shrestha et al. (2020), licensed under CC BY 4.0. 
2.2.1.5 Nebulizers 
To overcome the issue of the large particles (50-100 µm) associated with nasal spray pumps, 
nebulisers are used. Nebulisers generate fine aerosol particles within a range of 1-30 µm using 
mechanical power or compressed gasses (Wofford et al., 2015). Nebulisers have been 
demonstrated to have a higher efficiency of drug delivery to the superior meatus, middle 
meatus, and paranasal sinuses when compared with spray pumps, which is primarily due to 
the smaller particle size and slower speed of the aerosols (Hilton et al., 2008; Laube, 2007).  
Given the very small size of the nebulised particles, more than 60% of the administered 
medications are transported to the posterior region, which implies that nebulisers are the most 
efficient PTDD devices for drug delivery to the paranasal sinuses and olfactory regions 
(Suman et al., 1999).  
2.2.2 Active targeting 
Using an active targeting drug delivery (ATDD) approach, the efficiency of drug delivery can 
be significantly increased when compared with the PTDD approach. Several different 
methods can be adopted to accomplish active targeting. One way is to identify the features of 
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the receptor on the targeted cancer/tumour cell to be able to use the cell-specific ligands that 
can be conjugated to the drug-loaded nanoparticles. Then, the nanoparticles will be able to 
attach to cancer/tumour cells having the complementary receptor (Galvin et al., 2012). As a 
result, the amount of medications delivered to the target site increases significantly when 
compared with the passive method where non-ligands-conjugated nanoparticles are used.  
Furthermore, a triggering mechanism that is specifically associated with the target 
region can be utilised to accomplish active targeting. For example, pH-responsive materials 
can be used as the drug-carrier nanoparticles. More specifically, the pH level is almost neutral 
in most of the body; however, in some regions of the body, the pH level is more acidic. Hence, 
using pH-responsive materials enables the drug-loaded nanoparticles to release the 
medications when they reach a region with a specific pH level (Galvin et al., 2012). In 
addition to the abovementioned methods for implementation of active targeting, which are 
mostly associated with chemical and biological factors, some physical and environmental 
resources, such as magnetic, electric, and acoustic fields, can also be used as the triggering 
mechanism to deliver medication to a targeted site actively (Vasir et al., 2005). The available 
ATDD methods are briefly described in the following sections. 
2.2.2.1 Magnetic drug delivery  
The first use of magnetic fields in disease treatment goes back to 1941, when Gilchrist et al. 
(1957) designed an in-vitro experiment to investigate the thermal effects of small magnetic 
particles (Fe2O3) on lymph nodes for cancer and tumour therapy. They injected magnetic 
microparticles into the body and then applied an electromagnetic field to increase the 
temperature of the particles, using hysteresis loss, to destroy the tumour/cancer (Häfeli, 
2004). Later on, in the 1970s, when microparticles coated with polymer were first developed, 
magnetic drug targeting (MDT) using drug-loaded microparticles attracted great attention 
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from many researchers seeking to elaborate on drug delivery options to targeted sites. MDT 
is an active targeting approach, in which an external magnetic field manipulates the magnetic 
drug carriers (MDCs) to deliver a drug to targeted locations in the body and retains them there 
(see Figure 2.8). The MDCs contain the magnetic substances that react to magnetic fields, 
such as ferric oxide nano/microparticles. Transmission of the magnetic fields through the 
body is safe, which enables the manipulation of MDCs to target locations at deep tissue level 
(YaLi Liu et al., 2019).  
The first clinical trial of MDT was carried out in 1996 for the treatment of tumours, 
when a magnetic field with a density of 0.8 T was located at the vicinity of the skin surface 
to concentrate drug-loaded magnetic nanoparticles (Lübbe et al., 1996). Since then, over the 
past two decades, many researchers have focused on MDT for the treatment of 
cancer/tumours and other diseases (Bose et al., 2013; Hedayati et al., 2018; Larimi et al., 
2016; Lübbe et al., 1996; Mathieu et al., 2006; Riegler et al., 2011; Riegler et al., 2010; 
Shapiro et al., 2014). 
 
Figure 2.8: Magnetic drug targeting in the recirculation system for killing cancer cells, 
reprinted from Mondal et al. (2018), with permission from John Wiley and Sons. 
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Most previous studies of MDT have involved drug delivery to diseased sites 
associated with the blood circulation system, where the drug-loaded particles are injected into 
the artery or vein and are transported in the blood flow (see Figure 2.8). For MDT through 
the blood circulation system, the viscous drag force implemented by the blood flow must be 
overcome by the magnetic force acting on the particles under the effect of the external 
magnetic field so that the drug-loaded particles are not passed away from the target location 
(Ally, 2010).  
Given that the only fluid surrounding the particles in the blood circulation system is 
the blood, the mechanisms of both the deposition and the retention of the particles at the target 
location are similar. However, MDT is more complicated for drug delivery through the 
airways (from the mouth/nostril to the lung) because of the drug-loaded magnetic particles 
that are suspended in the airflow (gas phase) deposit on the walls of the airways, which are 
lined by a mucus layer (liquid phase). When a drug particle deposits on a mucus-lined wall, 
it moves towards the nasopharynx under the effect of the mucociliary transport mechanism; 
however, in the blood circulation system, the walls of the arteries are not lined with a mucus 
layer where the deposited particles do not move. Therefore, in practice, the deposition and 
retention of particles in the airways should be considered separately when MDT is used, 
which makes MDT in the respiratory system more complicated than MDT in the blood 
circulation system.  
 Ally (2010) investigated the effect of magnetic fields on the deposition and retention 
of polymer-coated magnetic microparticles on the wall of a pipe, to emulate the trachea. In 
their study, a thin layer of agar was coated on the wall of the target site to simulate the mucus 
layer; also, a very thin layer of water was caused to flow above the agar bed with a very slow 
velocity (0.1 mm/s) to simulate the transportation of mucus. They demonstrated that a high-
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gradient magnetic field is needed for the deposition of particles in the lung. They reported a 
negligible particle deposition using a uniform magnetic field.   Pourmehran et al. (2016) used 
a realistic lung model consisting of the oral cavity, larynx, pharynx, trachea, and six 
generations of the lungs to investigate the deposition pattern in human tracheobronchial 
airways under the effect of an external magnetic field using computational fluid dynamics 
(CFD) modelling. They developed the optimal magnetic drug characteristics and magnetic 
source coordinates for efficient magnetic drug delivery in human airways, where the 
efficiency of drug delivery to the second bifurcation of the left lung (the targeted site) was 
increase more than 80% when compared with conventional drug delivery without the 
application of the MDT.  
Xi, Zhang, et al. (2015) used numerical modelling to investigate the effect of a 
magnetic field on drug delivery to the olfactory region, where the medications can directly 
enter the brain, for treatment of diseases associated with the brain and spinal cord. They 
demonstrated that by using a well-designed MDT system (see Figure 2.9), the efficiency of 
drug delivery to the olfactory region increased 64-fold compared with conventional drug 
delivery that did not have a magnetic field. However, due to the complexity of the NC 
anatomy and the secluded location of the sinuses, the implementation of MDT for drug 
delivery to the sinuses is likely to be more complicated, for which no previous study has been 
conducted.  
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Figure 2.9: Schematic of magnetic drug targeting to the olfactory region, reprinted from  Xi, 
Zhang, et al. (2015), with permission from Dove Medical Press. 
2.2.2.2 Electrically-charged particle (drug) delivery 
Electrically charged particle (drug) delivery (ECDD) is an ATDD approach, which can only 
be implemented in the respiratory system. In ECDD, a set of electrodes are located in a 
specific region outside the body with a well-designed configuration. The drug particles are 
charged electrically, then released into the NC through the nostril. The charged particles are 
directed to a target region using the electrostatic forces acting on them through the external 
electric fields. In the process of the generation of aerosol, electrical charges can be induced 
through conduction or induction. An atomizer usually produces aerosol droplets that are 
highly charged (Bologa et al., 2001). Also, for inhaled pharmaceutical powders, the fine 
particles are in contact with the wall of the device and with each other. Due to the different 
potentials of the surfaces, such contacts cause the particles to become charged through 
electron exchange (Karner et al., 2011).  ECDD cannot be applied to the circulation system 
because the blood discharges the particles. The transport and deposition patterns of the 
inhaled aerosols highly depend on the electric charges carried by the particles. Since humidity 
dissipates the electric charges of individual particles, the electrostatic effects of the charges 
carried by particles are likely to be significant in the upper airways, where the humidity is 
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The concept of using electrically charged particles to increase particle deposition in 
human airways was first proposed by Wilson (1947). Later on, Vincent et al. (1981) used 
mechanical dispersion to charge fibrous asbestos up to a relatively moderate level. Then they 
exposed rats to these charged particles to investigate the particle deposition in the rats’ lungs. 
They reported an enhancement in particle deposition in rats’ lungs after inhaling the fibrous 
asbestos dust. Ferin et al. (1983) showed that the retention of the particles in the rats’ lungs 
could be enhanced significantly when they inhaled charged polymetric particles.  Using an 
ECDD in clinical studies, Melandri et al. (1983) and Prodi et al. (1985) reported an 
enhancement in the aerosol deposition in the airways of humans after inhaling charged 
pharmaceutical particles.  
In addition to ECDD to the lung and upper airways, the system has also been 
considered for nasal drug delivery (F. Fry, 1970; Xi et al., 2014). Using numerical modelling, 
Xi et al. (2014) conducted a feasibility study to investigate the effect of external electric fields 
on drug delivery to the olfactory region. They injected particles (500 nm in diameter) with a 
point-released injection pattern at the nostril, where the particles were directed to the olfactory 
region using external electrodes located at specific locations on the nose skin. By 
implementing appropriate electrophoretic guidance, they demonstrated a significant increase 
in the deposition of particles in the olfactory region, in which 90% of the injected particles 
were deposited in the olfactory region, while the deposition fraction for uncharged particles 









Figure 2.10: (a) The location of OMC and ostium opening in an NC; (b) schematic of 
electrode layouts for drug delivery to the ostiomeatal complex (OMC) using ECDD, 
reprinted from Xi, Yuan, et al. (2015), with permission from Dove Medical Press. 
In another study, Xi, Yuan, et al. (2015) examined the effect of external electric fields 
on drug delivery to the ostiomeatal complex (OMC), which is important for drug delivery to 
the MS (see Figure 2.10 (a-b). Since the MS is connected to the NC through the ostium, which 
is located in the OMC, an increase in drug delivery to the OMC can contribute to increasing 
the efficiency of drug delivery to the MS. Using an optimised design of the electrodes 
generating the desired electric field (see Figure 2.10 (b)), they demonstrated that the 
deposition of electrically charged particles in the OMC can be increased up to 10-fold when 
compared with conventional nasal drug delivery methods. To summarise, although 
electrically charged particle delivery is an effective ATDD method for increasing the particle 
deposition in the OMC, it cannot deliver drug particles into the MS (Xi, Yuan, et al., 2015).  
2.2.2.3 Acoustically-driven drug delivery  
The use of acoustics in biomedical practices has been expanded from diagnostic applications 
to non-invasive drug delivery. The use of acoustics in drug delivery procedures can be divided 
into two categories: ultrasonic-enhanced drug delivery (known as high-intensity focused 
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acoustic frequency (f) that is used for the drug delivery falls in the spectrum of f > 20 kHz, 
which is beyond the threshold of human hearing. In the latter drug delivery method (i.e., 
ADD), the low frequencies refer to frequencies below 2 kHz, which can be sensed by the 
human ear.  
The utilisation of HIFU for treatment purposes was first suggested by Lynn et al. (1942); 
however, it was first applied for the treatment of subcutaneous neuroma in a clinical trial in 
1960 (Ballantine et al., 1960; W. Fry et al., 1960). Nevertheless, this technique was unable to 
obtain broad acceptance from clinicians until the 1990s (ter Haar et al., 2007). A schematic 
of the mechanism of HIFU for the treatment of a tumour is presented in Figure 2.11. Recently, 
researchers have demonstrated several advantageous bioeffects of the propagation of 
ultrasound fields through tissues using focused, non-focused, low-amplitude, and high-
amplitude ultrasound fields at frequencies ranging from 100 kHz to 9 MHz. Some therapeutic 
scenarios resulting from such bioeffects are as follows:  
• Prompt and topical heating of the tissue for ablation of small masses (Kennedy, 2005; 
Leslie et al., 2007; ter Haar et al., 2007). 
• Transcutaneous ablations of small renal masses using nonthermal mechanical effects 
of ultrasound fields (Roberts et al., 2006). 
• Enhancement of thrombolysis using pulsed ultrasound fields. Thrombolysis is a 
therapy for resolving blood clots in blood vessels (Datta et al., 2006; Everbach et al., 
2000; Trübestein et al., 1976). 
• Stopping bleeding from damaged blood vessels at the depth of parenchymal tissues 
using HIFU (Vaezy et al., 2007). This method is called acoustic haemostasis. A 
parenchyma is the lump of functional parts of a structure in the body such as a tumour.    
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• Enhancement of TDD and controlling the release time of drugs, known as 
Sonodynamic therapy (Jeffers et al., 1991; Kinoshita et al., 2006). In this method, 
medications that are cytotoxic in the presence of ultrasound waves are used for TDD 
in cancer therapy. When the cytotoxic drugs arrive at the cancer cells, the ultrasound 
beam is focused on the target site and activates the cytotoxic drugs to kill the cancer 
cells. These drugs are not toxic when they are not exposed to the ultrasound field. 
Hence, any adverse side-effects are reduced, and the drug delivery efficiency is 
enhanced. The underlying mechanism of Sonodynamic therapy is still not fully 
understood; however, some researchers have demonstrated that the associated 
luminescence, thermal, and chemical processes, as well as acoustic cavitation, might 
be involved (McHale et al., 2016; Rosenthal et al., 2004).  
The use of transcutaneous ultrasound for therapeutic purposes (the above-mentioned 
therapeutic scenarios) has been shown to be a promising active targeting approach when 
used in the blood circulation system. However, transcutaneous ultrasound cannot be 
utilised for therapeutic purposes in the respiratory system. This is because the lungs and 
airways are filled with gas, by which the ultrasound is scattered and reflected. Hence, it 
is not possible to focus an ultrasound beam at a target site in the respiratory airways (Pitt 
et al., 2004).  
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Figure 2.11: Schematic illustration of the HIFU principle. An HIFU transducer is used to 
generate ultrasound signals outside the body to concentrate on a target site deep within the 
tissue. The heating induced by HIFU leads the nanoparticles to kill the cells in the target 
region, adopted from An investigation into the use of cavitation for the optimisation of high 
intensity focused ultrasound (HIFU) treatments by James Ross McLaughlan, licenced under 
CC BY-SA 4.0. 
On the other hand, a low-frequency acoustic field has recently been demonstrated to 
be advantageous in nasal drug delivery, especially for drug delivery to the MS. Previous 
studies have reported that low frequency ADD to the MS can enhance drug deposition in the 
MS significantly (El-Merhie et al., 2016; Farnoud et al., 2020; Leclerc et al., 2015; 
Moghadam et al., 2018; Möller, Münzing, et al., 2010; Möller et al., 2014; Navarro et al., 
2019; Xi et al., 2017). In this method, the medications are produced in the form of aerosols, 
which are injected into the NC through the nostril, then an external acoustic field is applied 
to the nostril, affecting the aerosol’s transport and deposition pattern.  
Over the last few years, adding acoustics to a nebuliser (i.e., ibrENT PARI Pharma 
GmbH) has demonstrated a higher drug deposition in the sinuses when compared with a 
nebuliser without acoustics (Möller, Schuschnig, et al., 2010). Given that the sinuses are non-
ventilated areas, the oscillating airflow generated by the acoustic field increases the gas 
exchange between the sinuses and the NC (Suman, 2013).  
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Using an in-vivo study, Möller et al. (2011) investigated the efficacy of drug delivery 
to the sinuses of five healthy human volunteers using a nebuliser coupled with an acoustic 
field (ADD). The median aerodynamic diameter (MAD) of the particles generated by the 
nebuliser was 3 μm, administered to the nostril at a rate of 300 µL/min for 20 s. Utilising 
dynamic gamma camera imaging, they reported that 2.8% of the administered aerosols 
deposited in all sinuses, 27% were trapped by the exit filter representing the exhaled aerosols, 
60.2% deposited in the NC, and 10% of the administered aerosols were deposited in the lungs 
(Möller et al., 2011). On the other hand, 100% of the aerosol administered to the NC via spray 
pumps, which generated particles with MAD of 50 µm, was deposited in the NC, while no 
particles were deposited in the lungs and the MS. Therefore, a combination of a nebuliser 
with an acoustic wave is an efficient and promising method for drug delivery to the MS.  
Although the drug delivery to the MS is increased through the application of ADD, the 
efficiency of the drug delivery is still insufficient for successful treatment of CRS (Leclerc et 
al., 2015). To enhance the efficiency of ADD for drug delivery to the MS, it is crucial to 
develop an understanding of the mechanism underlying this technique, which is the main aim 
of the current study. A comprehensive literature review on ADD is presented in the following 
sections.   
 Acoustic drug delivery to maxillary sinuses 
Several experimental and a limited number of numerical studies have focused on acoustic 
drug delivery to the sinuses, which are presented in detail in the following sections.  
2.3.1 Experimental studies in ADD 
The history of ADD for drug delivery to the sinuses goes back to 1959, when Guillerm et al. 
(1959) showed the feasibility of aerosol penetration into the non-ventilated sinus-like cavity 
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by superimposing a sound wave at a frequency of 100 Hz to a jet nebuliser (Durand et al., 
2001). They used a blown glass as a model of the sinus and also conducted an in-vivo study 
on a canine’s FS (Durand et al., 2001). Later, several studies further confirmed the benefits 
of a sound wave for aerosol penetration to the sinuses, as presented below.  
 Durand et al. (2001) investigated the penetration of aerosols into the MS using two 
plastinated models of the NC and the sinuses of two adult males. To check the accuracy of 
the model, they compared the CT images of the plastinated models with those of adult males. 
For the nebulisation process, they utilised the ATOMISOR NL11S® “sonic nebulizer” to 
nebulise 5 mL of technetium 99-labelled sterile water. The nebuliser produced small particles 
with MAD of 4.7 µm and they superimposed a 100 Hz sound wave onto the nebulised aerosols 
entering the nostril. Using scintigraphy, they measured the aerosol deposition in the sinuses 
qualitatively and reported a 1.3-fold increase in the penetration of aerosols into the MS under 
the effect of the 100 Hz sound wave when compared with non-acoustic drug delivery (non-
ADD) (see Figure 2.12).  
(a) (b)  
 
Figure 2.12: Scintigraphic image of the top view of the plastinated nose-sinus model (a) with 
acoustics; (b) without acoustics, reprinted from Durand et al. (2001), with permission from 
Mary Ann Liebert, Inc. , publishers; a minor modification has been applied to the original 
figure in the labelling and the line colour to improve the quality of the images. A: top of the 
ears, B: middle of the MS. 
MS MS 
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To determine the impact of acoustic waves on the air exchange rate between the NC 
and MS, Weitzberg et al. (2002) investigated the amount of nitric oxide (NO) in exhaled air 
during “humming”. The respiratory system releases nitric oxide (NO) in exhaled air, which 
is largely produced by the paranasal sinuses (Lundberg et al., 1995). Using a clinical study, 
Weitzberg et al. (2002) showed that the humming action significantly increases the NO level 
exhaled from the nose. To be more specific, they measured the NO level of ten healthy adult 
males after a single-exhalation using a chemiluminescence system (NIOX, Aerocrine AB, 
Stockholm, Sweden). The subjects were asked to exhale for 5 seconds with or without 
humming (nasally) or phonation (orally). The subjects wore a nasal mask for the nasal 
exhalation and a mouthpiece for the oral exhalation measurements. The exhalation flow rate 
was adjusted at 0.2 L/s by connecting a dynamic flow restrictor to the nasal mask and 
mouthpiece. Weitzberg et al. (2002) reported that the NO level during nasal humming was 
increased 15-fold when compared with a quiet exhalation (2818±671 nL/minute vs. 189±30 
nL/minute); however, the level of NO in the exhaled air under the effect of the oral phonation 
was not different from that of quiet exhalation (103±43 vs. 104±48 nL/minute). The results 
of their study showed qualitatively that the gas exchange between the NC and the sinuses 
increases when an acoustic wave (such as humming) is implemented to the nose during 
exhalation, which was confirmed by Maniscalco et al. (2003).  
Using a measurement method similar to that of Weitzberg et al. (2002), in a clinical 
and an in-vitro study, Maniscalco et al. (2003) demonstrated that the increase in the 
concentration of exhaled NO is primarily sensitive to the frequency of both the humming and 
the diameter of the maxillary ostium. They applied three different humming frequencies of 
120, 200, and 450 Hz and they found that a frequency of 200 Hz results in the greatest NO 
exchange for 295 nL/min. They also reported an increase in the NO exchange by increasing 
the ostium diameter, in which 100% NO exchange for an ostium diameter of 4 mm was 
Chapter 2. Literature review 
47 
observed. They used a two-compartment model, including a syringe and a cylinder 
resembling the sinus and NC, respectively, which is shown in Figure 2.13. In a later work by  
Maniscalco et al. (2006), a 2- to 4-fold increase in sinus deposition was reported using 
acoustic airflows produced by human nasal humming at a frequency of 200 Hz, compared 
with non-ADD.  
To demonstrated the effect of ADD on all paranasal sinuses, Möller et al. (2008) 
examined the effect of pulsating airflow on the gas exchange between the NC and all 
paranasal sinuses in a nasal cast, produced using Polyoxymethylene (see Figure 2.14 (a)). The 
sinuses and ostia were made using cylindrical glass vials. They reported that the gas exchange 
between the NC and all sinuses with pulsation was increased 6-fold when compared with gas 
flow without pulsation. The result was then quantitively confirmed in a clinical study on 
healthy volunteers conducted by Möller, Münzing, et al. (2010).  
 
Figure 2.13: Schematic diagram of the simplified nose-sinus model. The syringe tip 
resembles the sinus and the plastic cylinder resembles the NC, reproduced from Maniscalco 
et al. (2003), with permission from the European Respiratory Society. 
In a study by Möller et al. (2008), a dynamic 81mKr-gas imaging technique was used 
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Figure 2.14 (a)). The nasal replica was ventilated with 81mKr-gas through a jet nebuliser (PARI 
PRONEB Ultra II Compressor Nebulizer System) and a gamma camera (DIACAM, Siemens, 
Erlangen, Germany) was placed in front of the nasal replica to record serial images of the gas 
flow. The experiments were conducted with and without pulsation (pressure wave) for 30 
seconds. A pressure wave at a frequency of 45 Hz with an amplitude of 25 mbar was generated 
through a pressure wave generator, which was driven by the motor of the compressor 
nebuliser (Möller et al., 2008). They demonstrated that pulsation (frequency of 45 Hz and 
amplitude of 25 mbar) could increase the gas exchange in all sinuses more than 20-fold (see 
Figure 2.14 (b-c)).  
Möller et al. (2008) also investigated the effect of pulsation on aerosol delivery to the 
sinuses using the same nose-sinus replica, nebuliser, and experimental setup as was used for 
the gas exchange measurement. This time, they used air instead of 81mKr-gas as the gas supply 
of the nebuliser but used a solution composed of “99mTc-DTPA mixed 1:1 with 10 mg/mL 
disodium chromoglycate (DSCG) isotonic solution” for the nebulisation process. Using the 
gamma camera imaging technique, 99mTc-activity was detected during the experiments (2 
minutes’ running time). To investigate the effect of the geometric parameter on the sinuses, 
they examined the effect of the ostium diameter (1mm, 2mm, 3mm, and 5 mm) and sinus 
volume (5 mL, 10 mL, and 20 mL) on the aerosol deposition in the sinuses. They showed that 
the aerosol deposition in the sinuses relative to the total nebulised aerosol with pulsation 
(frequency of 45 Hz and amplitude of 25 mbar) could be decreased by increasing the ostium 
diameter for a sinus volume of 5 mL. However, this behaviour did not occur in larger sinuses 
with volumes of 10 mL and 20 mL, where the particle deposition in the sinus was at its 
maximum with an ostium diameter of 2 mm. Such behaviour of aerosol deposition in the 
sinuses due to the ostium and sinus geometry variation may imply a resonance effect between 
the geometry of the sinus, ostium and NC.  







Figure 2.14: (a) The nasal replica with the bottles resembling the sinuses; (b) the frontal 
view of the gamma camera image of Kr-gas ventilation of the nasal cast without an acoustic 
wave; and (c) with an acoustic wave. FR: right frontal sinus; FL: left frontal sinus; MR: right 
maxillary sinus; ML: left maxillary sinus, reprinted from Möller et al. (2008), with 
permission from Rhinology; modification has been applied to the labelling. 
 The effect of a 100 Hz acoustic wave, superimposed on the airflow carrying the 
nebulised aerosol, on the aerosol deposition in the MS using a human plastinated nasal cast 
was investigated by Durand et al. (2011). They reported a 3-fold increase in the deposition of 
gentamicin in the MS under the effect of the acoustic wave (frequency of 100 Hz and sound 
pressure level of 107 dB) when compared with non-ADD (Durand et al., 2011). They used 
gentamicin as the drug tracer, which was nebulised by a jet nebuliser injected into the nose 
through the nostril. Each experiment was tested across 10 minutes and then the gentamicin 
deposited in the MS was collected by flushing the MS through a physiological serum, using 
a syringe. The collected gentamicin from each sinus was quantified using a fluorescence 
polarization immunoassay with a TDxFLx® analyzer (Durand et al., 2011).  
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 Using a clinical trial, Möller et al. (2013) explored the effect of a nasal spray pump 
and an acoustic nebuliser (with an acoustic frequency of 25 Hz, the amplitude was not stated 
in the publication) on the deposition of aerosols (99mTc-DTPA) in the SS and the MS using a 
gamma camera imaging technique. They demonstrated 100% of the aerosol generated by a 
spray pump deposited in the NC, with insignificant aerosol deposition in the sinuses and lungs 
in healthy volunteers. However, using the acoustic nebuliser, about 55.3% of the nebulised 
aerosols deposited in the NC and around 6% deposited in the SS and MS in healthy subjects 
(Möller et al., 2013). In CRS patients, the aerosol deposition in the NC and SS, and MS before 
surgery were 54% and 2.7% of all nebulised aerosols, and after the surgery become 42.9% 
and 3.8% of all nebulised aerosols (see Figure 2.15).  
 
Figure 2.15: Aerosol deposition fraction in total nose (TN % output) and in maxillary sinuses 
(Sinuses % TN) before and after FESS in healthy volunteers and CRS patients. **: p <0.01 
compared to healthy; +: p<0.05 ++: p < 0.01 lateral versus anterior imaging, reprinted from 
Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using 
pulsating aerosols by Möller et al. (2013), licenced under CC BY 4.0; a part of the original 
figure has been removed. 
 The effect of particle size, inhalation pattern (non-nasal breathing and normal nasal 
breathing), and a 100 Hz acoustic wave (the amplitude was not stated in the publication) on 
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sinus model using a transparent, water-resistant, nonporous resin, manufactured using a 
stereolithography technique. In each experimental test, they used 4 mL of gentamicin 
antibiotic as the marker to generate aerosol, using a jet nebuliser for 10 minutes. They 
reported that using the ADD (at a frequency of 100 Hz), the non-nasal breathing condition 
increased the aerosol deposition in the MS by 2- to 3-fold when compared with a normal 
breathing condition (Leclerc et al., 2014). Under the effect of a 100 Hz acoustic wave, Leclerc 
et al. (2014) demonstrated a weak deposition of 9.9 μm particles but a significant deposition 
of 2.8 μm particles (up by 2- to 3-fold) in the MS. This difference may be due to the 
orthokinetic motion of the particles in an acoustic field. When an acoustic wave is applied to 
an aerosol, the particles oscillate at the frequency of the acoustic wave but with a different 
phase and amplitude. The oscillating particle velocity is given by (Marshall et al., 2014): 
𝑢p = p𝐴u sin(2𝜋𝑓𝑡 − 𝜙p),  (2-1) 
where 𝐴u is the maximum particle velocity amplitude, p is the particle entrainment 
coefficient, and 𝜙p is the phase factor. The p is the ratio of the amplitude of particle velocity 
to the amplitude of the fluid velocity. The phase factor and the particle entrainment coefficient 




,     (2-2) 
𝜙p = tan
−1(𝑆𝑡ac) , (2-3) 





 , (2-4) 
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where 𝑓, 𝜌p, 𝑑p, and 𝜇 are the frequency of the acoustic wave, density of the particle, diameter 
of the particle, and the dynamic viscosity of the fluid. Accordingly, an increase in particle 
diameter, 𝑑p, increases the acoustic Stokes number, which decreases the particle entrainment 
coefficient (Equation (2-2)); subsequently, the amplitude of the particle velocity (Equation 
(2-1)) decreases. Therefore, for a larger particle diameter, fewer particles can penetrate into 
the MS.  
For a long time, acoustic frequencies of 50 Hz and 100 Hz were used in the ADD for 
drug delivery to sinuses. Historically, these acoustic frequency values were discovered 
accidentally when researchers found dust deposition in the sinuses of workers who worked 
with electrical rotating machines, generating sinusoidal waves at frequencies of 50 Hz and 
100 Hz (Navarro et al., 2019). However, in several recent studies, it was hypothesised that 
the underlying rationale of increased aerosol deposition in the sinuses is based on the principle 
of the Helmholtz resonator (Möller et al., 2014).  
A Helmholtz resonator is an acoustical device, which is composed of a cavity attached 
to a narrow straight tube (known as the neck). When a Helmholtz resonator is in the presence 
of an external acoustic field, the air plug inside the neck fluctuates at a frequency equal to 
that of the acoustic field. Using a mechanical analogy, the flow behaviour in a Helmholtz 
resonator can be described as a mass-spring system (Ghanadi, 2015). The mass of air plug in 
the neck (𝑚 = 𝜌𝐿𝑛𝑆0) and the compressibility of the air (with stiffness of 𝐾 = 𝜌𝑐
2𝑆0
2 𝑉𝑐⁄ ) in 
the cavity are assumed as the mass and spring of the mass-spring system, respectively. The 
term 𝜌 is the air density, 𝐿𝑛 is the length of the neck, 𝑐 is the sound speed, 𝑆0 is the cross-
section area of the neck, and 𝑉𝑐 is the cavity (Hemon et al., 2004). Using a lumped element 
analysis, the displacement of the air plug in the neck (Meissner, 2002) is given by:  








+ 𝐾𝜎 = 𝐹𝑎𝑐𝑡 (2-5) 
where 𝑡, 𝑚, 𝜎, 𝑅, and 𝐹𝑎𝑐𝑡 are the time, mass of air plug in the neck, displacement of the air 
plug in the neck, damping constant, and the force acting on the air plug in the neck, 
respectively. The airflow in the neck and cavity acts as a mass-spring-damper, where the 
system is damped with a damping constant of 𝑅 due to the energy loss by the radiation and 












+ 𝑀𝑎) , (2-6) 
where 𝑘, 𝛿, 𝑐, and 𝑀𝑎 are the wavenumber, thickness of the boundary layer, speed of the 
sound, and the Mach number of the flow. Assuming a harmonic motion of air in the Helmholtz 
resonator, the displacement of the air plug in the neck is given by: 
𝜎(𝑓) =
𝐹𝑎𝑐𝑡(𝑓)
−4𝑚𝜋2𝑓2 + 2𝑖𝑓𝜋𝑅 + 𝐾
 , (2-7) 
where 𝑓 is the applied acoustic frequency and 𝑖 = √−1 is the imaginary number (Ghanadi, 
2015). Therefore, the amplitude of the air plug oscillation in the neck changes according to 
the variation of the frequency of the external acoustic field. The amplitude of the air plug 
oscillation reaches its maximum at a specific frequency called the “resonance frequency” 
(Leclerc et al., 2015; von Helmholtz et al., 1875). To be more specific, when 𝑓 approaches 
the resonance frequency of the system, 𝑓𝑟 = 𝑓𝑛√1 − 2 (where 𝑓𝑛 = √𝐾 4𝑚𝜋2⁄  is the natural 
frequency and  is the damping ratio), the denominator in Equation (2-7) approaches zero, 
which implies that the amplitude of the displacement of the air plug in the neck becomes very 
large (Ghanadi, 2015). For a Helmholtz resonator with a spherical cavity and a cylindrical 
neck, the resonance frequency is estimated by (Leclerc et al., 2015): 









where c is the sound speed, S0 = 𝜋𝐷𝑛
2 4⁄  is the cross-section area of the neck (where 𝐷𝑛 is 
the diameter of the neck), Vc is the volume of the cavity, and L is the length of the neck. More 
accurate expressions, depending on the shape of the cavity and neck, are derived and reported 
by Alster (1972) and Howard et al. (2000). 
Exploiting this analogy, a nose-sinus combination is similar to a Helmholtz resonator, 
where the sinus and ostium behave like the cavity and neck of the Helmholtz resonator. 
Hence, drawing on the principle of the Helmholtz resonator, if an external acoustic field is 
applied to the nostril at a frequency equal to the resonance frequency of the nose-sinus 
combination, the air exchange between the NC and the sinus should be maximised. The gas 
exchange between the NC and sinuses is the main factor affecting the transport of particles 




Figure 2.16: (a) Schematic of a Helmholtz resonator; (b) schematic of a cross-section view 
of an NC-MS combination, reproduced from Pourmehran et al. (2021) with permission from 
Elsevier. The neck and cavity of the Helmholtz resonator resemble the ostium and MS. 
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  Considering the Helmholtz resonator principle, limited studies have investigated the 
effect of an acoustic wave superimposed on nebulisation during drug delivery to the sinuses. 
Leclerc et al. (2015) investigated the effect of two acoustic frequencies (45 Hz and 200 Hz) 
superimposed on nebulised aerosols, on the aerosol deposition in the MS using a nasal replica 
manufactured using a stereolithography technique and the experimental setup described in 
Leclerc et al. (2014). Using the CT images of the nasal replica, Leclerc et al. (2014) measured 
the volume of the left and right MS as 14 cm3 and 10 cm3, respectively. They also estimated 
the geometric features of the broad and short ostium of the left MS (diameter of 4–5 mm and 
length of 4–5 mm, respectively) and the long and narrow ostium of the right MS (diameter of 
3–4 mm and length of 7–8 mm, respectively) (Leclerc et al., 2015). Referring to the classic 
Helmholtz resonator equation (Equation (2-8)) the resonance frequency of the left and right 
MS were estimated to be 300-400 Hz and 150-200 Hz, respectively. Two different types of 
jet nebulisers, driven by a compressor, were used for nebulisation. In that study (Leclerc et 
al., 2015), one nebuliser (DTF Medical, Saint-Etienne, France) generated aerosols with the 
superposition of an acoustic wave at 200 Hz (termed high frequency), while in the other 
nebuliser (Pari GmbH, Starnberg, Germany) the acoustic frequency was 45 Hz (termed low 
frequency). Leclerc et al. (2015) reported that in comparison with non-acoustic nebulisation, 
the aerosol depositions in the left and right MS were increased by 4-fold and at least 2-fold, 
respectively, under the effect of 200 Hz acoustic wave. When 45 Hz (the amplitude was not 
stated in the publication) was applied, the aerosol depositions in the left and right MS were 
increased by 2-fold and 4-fold, respectively, when compared with the non-acoustic condition 
(Leclerc et al., 2015). They reported that, according to the Helmholtz resonator equation, a 
broad and short ostium resulted in a higher resonance frequency than a long and narrow 
ostium; hence, the aerosol deposition in the left MS, with a broad and short ostium, under the 
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effect of high frequency was more than that of the right MS, with a long and narrow ostium 
(Leclerc et al., 2015).  
In summary, the efficacy of the ADD using a fixed acoustic frequency (i.e., 45 Hz, 
100 Hz, and 200 Hz) superimposed on the aerosols’ flow entering the nostril has been 
investigated in several previous studies. Given that the Helmholtz resonator equation was 
derived for a spherical cavity attached to a cylindrical neck, the resonance frequency of the 
realistic nose-sinus combination estimated in the previous studies does not have acceptable 
accuracy. Hence, it was not guaranteed that the air plug in the ostium was activating 
efficiently under the effect of the fixed acoustic frequency obtained by the Helmholtz 
resonator equation. Accordingly, the highest efficiency of drug delivery could not be 
achieved.  
 The use of an acoustic frequency sweep, instead of a fixed frequency, for an optimised 
ADD technique was proposed by El-Merhie et al. (2016). It was proposed that by 
superimposing a frequency sweep at a specific range of frequency on the airflow (including 
the aerosol) entering the nostril, there must be an input frequency that falls in the proximity 
of the resonance frequency of the NC-MS combination. El-Merhie et al. (2016), in an in-vitro 
study, investigated the effect of the acoustic frequency sweep on aerosol deposition in the 
MS. They used 2.5% sodium fluoride (NaF) as the drug tracer and employed a jet nebuliser 
to generate droplets (particles) with a MAD of 2.75µm (El-Merhie et al., 2016). Three 
frequency spans were superimposed on the inlet airflow (carrying aerosols) ranging from 45-
500 Hz, 45-800 Hz, and 100-500 Hz, with three sweep cycles of duration 0.3 s, 3 s, and 30 s. 
A realistic model of the NC with all paranasal sinuses was manufactured using 3D printing 
technology. El-Merhie et al. (2016) demonstrated that the acoustic sweep frequency can 
increase the aerosol deposition by 2-fold in the right MS and by 2.5-fold in the left MS when 
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compared with a fixed input frequency of 300 Hz, (see Figure 2.17 (a)). They also reported 
that the shorter the sweep cycle duration, the greater the NaF deposition in the MS, which is 
in contrast with the findings of a recent study by Moghadam et al. (2018). 
 Using an experimental setup and procedure similar to that of El-Merhie et al. (2016) 
but with a different nose geometry, Moghadam et al. (2018) investigated the effect of an 
extended range of acoustic frequency sweeps of 100-500 Hz and 100-850 Hz, as well as a 
sweep cycle duration of 0.1 s, 0.3 s, 1 s, 1.5 s, and 2 s on the aerosol (NaF) deposition in the 
MS. They demonstrated that, by expanding the frequency span from 100-500 Hz to 100-850 
Hz, the aerosol deposition increased by 3-fold in the left MS but had no significant effect on 
the right MS (Moghadam et al., 2018). The increase in aerosol deposition in the left MS might 
be due to the fact that the resonance frequency of the left MS falls in a frequency range 
between 500-800 Hz. In respect to the sweep cycle duration, Moghadam et al. (2018) showed 
that the aerosol deposition in the MS has a nonlinear relationship with the sweep cycle 
duration, where the maximum aerosol deposition in the MS occurs at a sweep cycle duration 
of 1 s (see Figure 2.17 (b)) .   
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Figure 2.17: (a) Effect of the acoustic sweep cycle duration on NaF deposition in the MS 
reported in El-Merhie et al. (2016).**: p<0.01), ***: p<0.001, reprinted from El-Merhie et 
al. (2016), Copyright (2016), with permission from Springer Nature ; (b) effect of the sweep 
cycle duration (with an amplitude of 120 dB) on NaF deposition in the MS reported by 
Moghadam et al. (2018), control: without acoustic, reprinted from Moghadam et al. (2018), 
with permission from Elsevier.   
Although the acoustic frequency sweep technique can slightly increase the aerosol 
deposition in the MS, more time is required for injecting the nebulised drug into the nose to 
cover an extended range of frequency. Therefore, the total dosage of the drug injected into 
the nose in the form of aerosols is increased due to an increased injection duration. 
Accordingly, the risk of adverse side effects on the respiratory system is increased. 
2.3.2 Numerical studies in ADD 
Despite several experimental studies, there are limited numerical studies investigating the 
effect of acoustics/pulsation on aerosol deposition in the NC and MS. In the literature, 
computational fluid dynamics (CFD) modelling was employed to simulate the ADD in drug 
delivery to the maxillary sinus. Two different discretisation and solution schemes were used 
to establish the CFD models: a finite elements method (FEM) through COMSOL software, 
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In a recent study, using a modified Helmholtz resonator equation, Xi et al. (2017) estimated 
the resonance frequency of a two-bottle model resembling the nose-sinus combination. The 
modified Helmholtz resonator equation is similar to Equation (2-8) but the term 𝐿𝑛 should be 
replaced by Leq, the equivalent length of the neck, which can be obtained by Leq=Ln+0.6D𝑛 
(Xi et al., 2017). They also employed numerical modelling to predict the resonance frequency 
of the model through the finite element method (FEM) using COMSOL Multiphysics 
software. In that study, Xi et al. (2017) showed a good agreement between the value of the 
resonance frequency of the two-bottle model (neck diameter=7 µm, neck length=10 µm, 
small bottle (sinus) volume: 250 mL) obtained by the modified Helmholtz resonator equation 
(169 Hz) and that obtained by FEM (168 Hz). They also predicted the resonance frequency 
of a realistic NC-MS model using both the equation and FEM, in which the FEM 
underpredicted the resonance frequency when compared with the modified Helmholtz 
resonator equation.  
The resonance frequency of the realistic NC-MS model, with an ostium diameter and 
length of 3 mm and sinus volume of 10.314 mL, was predicted by the modified Helmholtz 
equation and FEM at 652 Hz and 545 Hz, respectively (Xi et al., 2017). The discrepancy 
between the results of the Helmholtz equation and FEM might be due to the 
oversimplification of the realistic nose-sinus model. Hence, further studies are required to 
investigate the effect of geometric features on the NC and the MS in terms of prediction of 
the resonance frequency. In the two-bottle model, Xi et al. (2017) showed that the highest 
aerosol (MAD of 3µm) deposition in the small bottle (as the MS) occurred at an input 
frequency equal to the resonance frequency of the NC-MS combination (see Figure 2.18).  
The airflow features in the NC and MS were not discussed in that study. 
 






Figure 2.18: Numerical simulation of acoustic aerosol delivery at different input acoustic 
frequencies, carried out using COMSOL software, in a two-bottle model resembling the 
combination of the NC and the MS. (a) The aerosol transport pattern after 60 s at frequencies 
of 45Hz, 169Hz, and 300 Hz; (b) the effect of various acoustic frequencies, 45Hz, 169Hz, 
200 Hz, 300 Hz, and 500 Hz on the aerosol deposition fraction in the small bottle, reprinted 
from Xi et al. (2017), with permission from Elsevier. 
 Using CFD modelling with the OpenFOAM software package, Farnoud et al. (2017) 
investigated the effect of a pulsating airflow on the deposition of particles in the nasal 
passages, excluding all the paranasal sinuses. They implemented a pulsating airflow to the 
inlet boundary (nostril) using the following velocity profile: 
𝑈 = 𝑈0|sin(2𝜋𝑓
∗𝑡)| (2-9) 
where ω∗= ω 2⁄  and ω=45 Hz, 𝑈0 is the maximum airflow velocity (1.48 m/s), and 𝑡 is time. 
They injected 10,000 mono-dispersed inert particles (with a diameter of 2.4 µm) into the 
nostril over the first time-step at 10
-5
 s.  
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 Farnoud et al. (2017) reported that the deposition of particles in the NC under the 
effect of a pulsating airflow increased by 1.5-fold when compared with a uniform inlet 
airflow. They found that the uniform inlet airflow led to the deposition of particles in the nasal 
valve, nasopharynx, and septum; however, the pulsating airflow increased the ventilation and 
particle deposition in the olfactory regions, as well as the SM and MM. They proposed that 
an increased deposition in the MM can lead to increased particle delivery and deposition in 
the MS. 
In a recent numerical study, Farnoud et al. (2020) examined the effect of a clockwise 
inclination of 45
°
 and  90° of the nose on particle deposition in paranasal sinuses of a realistic 
nose-sinus model, under the effect of an oscillating airflow (45 Hz) entering the nostril. They 
used the following velocity profile as the velocity inlet boundary condition (Farnoud et al., 
2020): 
𝑈 = 𝑈0(1 + |sin(2𝜋𝜔
∗𝑡)|). (2-10) 
 Farnoud et al. (2020) demonstrated that the oscillating airflow increased the overall 
particle deposition in the sinuses by 1.5-fold and 2.5-fold for the cases with a nosepiece 
inclination of 90
°
 and  45°, respectively, when compared with a uniform airflow (non-
oscillating). It should be noted that in the numerical studies conducted by Farnoud et al. 
(2017) and Farnoud et al. (2020), the pulsating/oscillating airflow was not considered to be 
an acoustic wave because they assumed the air to be an incompressible fluid and also did not 
apply a non-reflecting boundary condition to the inlet and outlet. Hence, the ADD was not 
simulated accurately, given the reflection of an acoustic wave affects the oscillation of the air 
plug inside the ostium. 
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When an acoustic wave is emitted, it travels toward the boundaries and reflects when 
it hits a reflective boundary, such as a solid wall. The reflection of the acoustic wave affects 
the pressure at the boundary due to interference between the reflected and incident pressure 
waves. However, when an acoustic wave travels towards a non-reflecting boundary, it does 
not reflect and passes through the boundary. In practice, the inlet (nostril) and outlet 
(nasopharynx) in an NC-MS combination are almost non-reflecting boundaries. However, 
they represent a minor impedance change and there will be minor reflections, which should 
be considered in any numerical modelling. When a reflecting boundary condition is applied 
to the inlet and outlet in a CFD model, these boundaries are treated as a solid wall. Therefore, 
the acoustic pressure at the inlet and outlet boundaries reaches higher/lower values compared 
with a realistic boundary condition. Consequently, the acoustic pressure within the entire NC-
MS is changed, which affects the oscillation of the air plug in the ostium. In the current study, 
a high-fidelity CFD model considering the non-reflecting inlet/outlet boundary conditions 
using a compressible airflow was developed to predict the resonance frequency of an NC-MS 
combination as well as to simulate ADD for drug delivery to the MS, which are later presented 
in Chapter 3 and Chapter 4, respectively. 
Although several previous studies investigated the feasibility of ADD in enhancing 
drug deposition in MS, the underlying mechanism of ADD is still controversial. A 
fundamental study on understanding the important parameters in the prediction of the 
resonance frequency of the NC and MS combination is also missing in the literature. 
Moreover, the underlying mechanism of particle deposition and transport patterns in the NC, 
ostium, and MS due to the application of an external acoustic field is still not well-understood.  
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2.3.3 Limitations in nasal drug delivery 
The complex structure of the NC leads to some limitations in drug delivery to the NC and 
MS. The initial flow-limiting part of the NC is the nasal valve, which has a narrow triangular 
shape located near the nostril opening (Cole, 2003). The nasal valve changes the direction 
and velocity of the airflow during inhalation (Cole, 1992; Fodil et al., 2005). During quiet 
breathing, the air velocity at the nasal valve comes close to 18 m/s (gale force) and approaches 
32 m/s during sniffing (Cole, 1992). During quiet breathing (15 L/min), the flow regimen 
throughout the NC is mostly laminar; however, downstream of the nasal valve, it becomes 
locally-turbulent when the flow rate increases to 25 L/min (Cole, 1992; Fodil et al., 2005).  
During inhalation, the nasal valve is narrowed progressively when the inhaled flow 
rate increases, which takes place due to the Bernoulli effect acting on the orifice-like structure 
of the nasal valve (Cole, 1993). During exhalation, the nasal valve helps the pharynx, trachea, 
and lower airways to stay open by preserving a positive pressure at the expiratory airways 
due to its narrow structure (Hairfield et al., 1987). The braking behaviour of the nasal valve 
also provides the alveoli with more time for the gas exchange. The narrowed structure of the 
nasal valve and its braking behaviour can be seen as advantageous factors for patients with 
obstructive sleep apnoea disorder (Djupesland et al., 2001). However, in terms of nasal drug 
delivery, the triangular shape of the nasal valve and its small dimensions represent critical 
hurdles to achieving efficient drug delivery, especially when it becomes narrowed during 
inhalation. In addition to the anatomical limitations due to the small dimensions of the nasal 
valve, the vulnerability of the mucosa in the nasal valve and the vestibule region represents 
another limitation to nasal drug delivery. The concentrated local-deposition of the drug on 
the wall of the septum, as well as the possible direct touch of the spray nasal tip during aerosol 
injection, may cause damage and irritation to the mucosa, potentially leading to perforation, 
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crusting, and bleeding of the nose (Waddell et al., 2003). However, in the context of the 
potential for nasal drug delivery, the vulnerability of the nasal mucosa is usually neglected, 
particularly in the evaluation of the results from CFD and in-vitro studies using a cast or 3D 
printing technology.  
 Airflow behaviour and particle motion in the nose  
Understanding the airflow behaviour in the NC and MS is crucial for improving drug delivery 
efficiency. Several numerical and experimental studies have investigated the airflow features 
in the NC and MS. The main goal of these studies is to evaluate the characteristics of the flow 
pattern in the NC and consequently assess the efficiency of particle deposition. Generally, the 
particle transport/deposition behaviour in a fluid flow is quantified by the dimensionless 
Stokes number (St), which is the ratio of the particles’ momentum response time to the flow-






where 𝑈 and 𝐿 are the characteristic velocity and characteristic length, normally taken as the 
mean flow velocity and hydraulic diameter of the inlet, respectively. The Stokes number 
implies an imperative criterion for understanding the particle transport behaviour in the fluid 
flow.  It indicates whether the particles are in kinetic equilibrium with the fluid phase (Tian 
et al., 2005). In other words, 𝑆𝑡 presents a measure of the effect of the inertial impact of the 
particles within the fluid flow. Nevertheless, the application of the 𝑆𝑡 depends highly on the 
characteristic length of the domain of interest, which alters between different geometries of 
the NC. To overcome this limitation of the 𝑆𝑡, the inertial parameter (IP) is widely used for 
the assessment of particle deposition in the NC and respiratory airways because the 
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characteristic length and the characteristic velocity associated with the 𝑆𝑡 is normalised out 
by using a constant flow rate. The inertial parameter is given by (Inthavong et al., 2011): 
IP = Q dae
2
 (2-12) 





where dae is the aerodynamic diameter is defined as “the diameter of the spherical particle 
with a density of 1000 kg/m3 that has the same settling velocity as the particle under study” 
(Yang et al., 2012). The de  and X are the equivalent volume diameter and the shape factor of 
the particle, respectively (Yang et al., 2012). For a spherical particle, the de equals to the 
particle diameter and X is unity (Yang et al., 2012). The inertial parameter is a convenient 
parameter that is normally used for comparing the effects of particle diameters and airflow 
rates on the deposition efficiency. However, the use of a constant flow rate is a limitation of 
the inertial parameter given that it does not take into account the complicated shape of the 
geometry of the NC. Despite this limitation, the inertial parameter is normally used for the 
demonstration of deposition efficiency of particles, particularly where the determination of 
characteristic length is limited due to the geometry variation.   
2.4.1 Experimental studies  
Since the 1950s, a handful of in-vivo and in-vitro studies were established to develop an 
understanding of the airflow in the NC and the sinuses. The deposition of monodisperse 
polystyrene particles was measured by Hounam et al. (1971), with diameters from 1 to 7 µm 
for airflow rates ranging from 5 to 40 L/min. They conducted the experiments on three healthy 
subjects for 20 seconds. They found a direct relationship between the pressure drop along the 
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NC and particle deposition in the NC. Using laser Doppler anemometry, Girardin et al. (1983) 
investigated the airflow pattern and aerosol deposition in the NC using a cadaver model. They 
showed that the velocity of the airflow in the inferior region of the NC is greater than the air 
flow velocity in the superior region of the NC.  
 The aerosol deposition pattern in the NC was investigated experimentally by Suman 
et al. (1999), where the particles were administered to the nostril using a nebuliser and spray 
pump, separately. They demonstrated that the particles can be transported beyond the nasal 
valve and anterior region of the NC when a nebuliser is used for administration of the drug 
particles; however, using the nasal spray pump, the penetration of particles to the posterior 
region is negligible. They showed that the ratio of particle deposition in the posterior region 
to the particle deposition in the anterior region is 0.211 and 0.073 when the nebuliser and the 
nasal spray pump are used, respectively.  The low penetration of the particles to the posterior 
region of the NC originates from the inertial impaction (Yu et al., 1998). The inertial 
impaction takes place when the direction of the flow changes abruptly, wherein the particles 
are pushed to deviate their streamline while the particles’ inertia pushes them to move on 
their initial trajectories (Darquenne, 2020). Using particle image velocimetry (PIV), Kelly et 
al. (2000) examined the deposition pattern of pollutants in the NC by applying a solution of 
water and glycerol to the nostril at a flow rate of 7.5 L/min. They found that the highest 
airflow velocity occurs in the nasal valve and inferior region of the airways of the NC.  Kelly 
et al. (2000) demonstrated that a very low airflow rate was observed in the olfactory and 
superior region, which implies a negligible deposition of pollutants in the olfactory region. 
Using an MRI-based reconstructed model of NC and nasal spray pumps, Cheng et al. 
(2001) investigated the deposition pattern of particles in different regions of the NC. They 
reported that a large number of the particles deposited in the anterior region and the turbinates; 
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however, a small fraction of the particles could reach the nasopharynx. Using high-speed 
photography and laser diffraction technology, they measured the particle deposition on the 
inner wall of the nasal replica and reported that the particle deposition pattern varies with the 
size of the particles and the spray angle, in which a higher particle size and spray angle 
increase the particle deposition in the anterior region of the NC. Using mathematical 
modelling, they demonstrated that the diffusion mechanism is dominant in particle deposition 
in the NC for particles smaller than 0.5 µm; however, the inertial impaction is the dominant 
mechanism of deposition for particles greater than 0.5 µm.  
To account for the effect of the geometry of the NC on airflow and deposition patterns, 
Kim et al. (2004) used a silicon-made nasal replica of two healthy persons to investigate the 
airflow pattern in the NC by applying an airflow rate of 7.5 L/min to the nostril. They found 
that the number of flow recirculation zones in the NC varies with the shape of the NC 
geometry. Chung et al. (2008) reported that the differences in the airflow patterns in various 
NC models stem from the variation of the geometry of the inferior, middle, and superior 
turbinates. Doorly et al. (2008) examined the flow pattern in the NC using PIV measurements 
and a CFD simulation. They found a recirculation zone at the end of the nasal valve in both 
the experiments and the CFD simulation. This recirculation zone was created because the 
section area of the end point of the nasal valve expands suddenly. Doorly et al. (2008) showed 
that a jet flow and a sheer layer between the jet flow and the recirculation zone is seen 
immediately after the nasal valve. 
The effect of particle size on the deposition of the particles in the sinuses after FESS 
was assessed by Hilton et al. (2008). They reported that the deposition of particles in the NC 
with a particle diameter smaller than 5 µm is lower than the deposition of particles with a 
diameter greater than 5 µm. Yuan Liu et al. (2009) reconstructed a standardised NC model 
(known as the Carleton-Civic model) based on CT images of 30 different healthy persons. 
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Using this model, Yuan Liu et al. (2010) examined the particle deposition patterns of particles 
with diameters of 1.71 µm to 9.14 µm under the effect of airflow rates of 30 to 90 L/min. 
They demonstrated that inertia was the dominant mechanism for particle deposition in their 
study. Using computational and experimental studies, Rennie et al. (2011) investigated the 
air exchange between the NC and MS using 81mKr gas as a working fluid. They demonstrated 
that the gas exchange between the NC and MS could increase 50-fold by adding an additional 
ostium (see Figure 2.19 (a-c)). Moreover, they reported a direct relationship between the gas 
exchange and the ostium diameter.  
(a)  
 
(b)  (c)  
  
Figure 2.19: (a) Schematic diagram of an experimental setup used in the study by Rennie et 
al. (2011). Raw g-camera images for (b) single ostium and (c) double-ostium configurations, 
for a 10 mL sinus and an inlet flow rate 5 L/min, reproduced from Rennie et al. (2011), with 
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2.4.2 Numerical studies 
Advances in tomography imaging techniques have resulted in a large number of 
numerical studies using image-based geometries to develop a better understating of the 
airflow behaviour in the NC and MS. Accordingly, several studies have employed CFD to 
model the airflow in an NC, mostly without considering the MS. 
The earliest numerical study investigating the flow structure in an NC dates back to 1995 
when Keyhani et al. (1995) simulated the laminar flow patterns in a realistic geometry of the 
NC at quiet breathing flow rates using a CFD model (steady-state and laminar flow) through 
the finite element software package FIDAP (Fluid Dynamics International). They 
demonstrated that about 30% of the inhaled volumetric flow passed through the floor of the 
inferior turbinate and nearly 10% passed through the superior meatus (olfactory region). 
Using FIDAP, Subramaniam et al. (1998) investigated the effect of inlet flow rates of 15 
L/min and 26 L/min on the flow structure in an anatomically accurate NC model, 
reconstructed from MRI images. They demonstrated a recirculation and swirling flow occurs 
in the vestibule and nasopharynx (see Figure 2.20). Subramaniam et al. (1998) also showed 
that the flow in the NC was laminar for both flow rates of 15 L/min and 26 L/min, which is 
in agreement with the results of a study by (Hahn et al., 1993), while it is in contrast with 
(Swift et al., 1977) who demonstrated the flow in the NC is turbulent for a flow rate of 25 
L/min.  
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Figure 2.20: Illustration of streamlines in the vestibule, main passage, and nasopharynx for 
a steady flow, adapted from Subramaniam et al. (1998), with permission from Taylor & 
Francis. 
 The studies in the literature have demonstrated that the anatomy of the NC influences 
the flow structure in the NC. Zhao et al. (2004) investigated the effect of various shapes of 
the nasal valve and olfactory airway on the sense of smell and the flow structure in the NC. 
They found that the flow patterns in the olfactory region vary in different anatomies of the 
nasal cavity and olfactory airways, which can describe the sensitivity of each person to the 
odorant. They also demonstrated that the majority of the volumetric inlet flow passes through 
the inferior meatus. Hörschler et al. (2006) simulated the laminar flow (Re=400-500) in an 
NC with and without turbinates to investigate the sensitivity of the inhalation/exhalation flow 
pattern to the anatomy of the NC using commercial software, FLUENT/UNS 4.2 and 
experiments. They found that the effect of the sensitivity of the flow pattern to the NC 
geometry (with and without turbinates) during the inhalation period is much more than that 
during the exhalation phase. Using a large eddy simulation (LES) turbulent model, Lee et al. 
(2010) investigated the flow behaviour in a realistic geometry of an NC, reconstructed by CT 
images, using an unsteady-state CFD model. They demonstrated that the highest wall shear 
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and exhalation phases. They also reported that a secondary flow was observed in the 
nasopharynx, and the flow circulation zone occurred in the olfactory airway. Hood et al. 
(2009) computationally modelled the air exchange in two different simplified models of the 
human MS (see Figure 2.21). They examined the effect of ostium size and the addition of an 
accessory ostium on the air exchange between the MS and NC (see Figure 2.21 (b)). They 
also simulated mucociliary transport and found no effect on the gas exchange between the 
MS and the NC. Hood et al. (2009) demonstrated that the dominant transport mechanism for 
the small ostium (diameter ≤ 2 mm) was diffusion; however, convection was the dominant 
transport mechanism for the large ostium (diameter > 2 mm). They also observed an increase 
in MS ventilation by adding one more accessory ostium, which is in agreement with the study 
by Zhu et al. (2012).  
 (a)  (b)  
  
  
Figure 2.21: (a) x-Velocity contours and sinus streamlines for (a) a single ostium; and (b) the 
addition of an accessory ostium, reprinted from Hood et al. (2009), with permission from the 
American Physiological Society. 
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Gabory et al. (2017) conducted a numerical simulation of a CT image-based 
reconstructed model of a nasal passage, together with the sinuses, using consecutive nasal 
respiratory cycles. They considered the airflow and assessed the flow velocity, wall shear 
stress, pressure, and particle residence time using a low Reynolds number k-ω turbulence 
model in two consecutive respiratory cycles within the nasal passage. They found that the 
pressure within the sinus cavities depends on the distance to the NC airstream. For instance, 
the pressure in the MS, ES, and SS was lower than that in the FS for expiration, in comparison 
with inspiration (see Figure 2.22). 
The anatomy of the NC changes after nasal surgery. Several numerical studies have 
demonstrated the effectiveness of the surgery on the flow structure and particle deposition 
pattern in the NC and MS. Frank et al. (2013) used the realistic geometries of NC before and 
after nasal surgery, to investigate the deposition of particles in the NC using CFD modelling. 
They employed a Eulerian-Lagrangian particle tracking scheme using ANSYS® Fluent to 
simulate the trajectories of particles injected into the nostril simulating sprays with particle 
sizes ranging from 10 µm to 110 µm in aerodynamic diameter. They demonstrated that the 
transport of particles to the unventilated regions (before the surgery) was increased after the 
removal of the obstructions in the NC. They also showed that the particle deposition in the 
(a) (b) 
  
Figure 2.22: Pressure contours for the maximum flow rate for; (a) inspiration and; (b) 
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anterior region and posterior region decreased by 13% and increased by 118%, respectively 
(see Figure 2.23).  
(a) (b) 
 
Figure 2.23: Particle deposition patterns for (a) pre-surgery; and (b) post-surgery geometries 
of NC, reprinted from Frank et al. (2013) with permission from Elsevier.  
The effect of nasal surgery on airflow behaviour and particle deposition in the NC 
was investigated by Moghadas et al. (2011) using CFD modelling. They demonstrated that 
flow behaviour and particle deposition depends highly on the anatomy of the main passage 
of the NC. They found that the particle deposition in the main passage of an NC with a septal 
deviation was higher than that of a healthy subject. They also reported that any obstruction in 
the NC decreased the airflow rate and caused problems with breathing; however, a normal 
breathing condition was observed after the NC surgery.  
In addition to the nasal surgery, where the obstruction on the NC is removed, sinus 
surgery is carried out when the maxillary ostium is obstructed. This type of surgery takes 
place for the treatment of CRS. Abouali et al. (2012) investigated the penetration of particles 
to the MS before and after functional endoscopic sinus surgery (FESS). They used a realistic 
geometry of the nose-sinus combination of a healthy subject and removed the uncinate 
process to simulate the FESS (marked in red in Figure 2.24 (a)). They used a Eulerian-
Lagrangian particle tracking scheme and considered one-way coupling between the particle 
and flow phases for predicting the particles’ transport/deposition patterns in the NC and MS 
110 
Particle diameter [µm] 
10 
Pre-surgery                                                                  Post-surgery 
Obstruction 
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using ANSYS® Fluent. They explored the fact that no ventilation occurred in the MS before 
the FESS; however, the airflow could enter the MS after FESS (see Figure 2.24 (b-c)). They 
demonstrated that the deposition of particles in the MS in a post-FESS subject increased10-
fold when compared with a pre-FESS subject.  
  
 
Figure 2.24: (a) An illustration of the nasal cavity and paranasal sinuses; the red part 
represents the removed area in the surgery; the streamlines of airflow: (b) before; and (c) 
after the operation for Q = 4 L/min, reprinted from Abouali et al. (2012), with permission 
from Elsevier. 
Using the Eulerian-Lagrangian method, Shanley et al. (2008) investigated 
numerically the effect of particle diameter on particle deposition in the NC using a steady and 
laminar inlet flow. They used a realistic geometry of NC reconstructed from MRI images. 
They injected monodispersed particles with a diameter in the range of 1 µm and 10 µm. They 
showed that an increase in the diameter of the particles increases the overall deposition of 
particles in the NC. They also found that the deposition of particles in the nasal valve and 
anterior region increases with an increase in the inlet flow rate and particle size. The effect of 
the weight of the particles on particle deposition in the NC was investigated by Inthavong et 
al. (2010) using a CFD model. They used a realistic geometry of an NC, reconstructed by CT 
images of a human NC, to simulate the airflow behaviour at a flow rate of 7.5 L/min, as well 
as to predict the transport/deposition of particles with different densities and diameters. They 
demonstrated the size of the particle affects the particle inertia more than its density. An 
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increase in the particle inertia increases the deposition fraction. They also reported that the 
dominant mechanism of the deposition of nanoparticles is diffusion. Using a CFD model, Shi 
et al. (2007) examined the effect of particle diameters ranging from 1 µm to 50 µm on the 
particle deposition patterns in the NC for inlet flow rates of 7.5 to 20 L/min. They used a 
realistic geometry of an NC reconstructed by MRI scans to develop a CFD model employing 
a Lagrangian particle tracking scheme via the commercial CFX software package. They 
demonstrated that the small particles (e.g., 2 µm) could reach the posterior region of the NC 
and then enter the pharynx. Moreover, they investigated the effect of the roughness of the NC 
wall on the deposition particles and reported that particle deposition increases when the 
roughness of the surface is increased. Schroeter et al. (2011) investigated the effect of surface 
roughness on the deposition of particles in the NC by modifying the smoothness of the wall 
of a realistic geometry of an NC in the Mimics software package. They employed ANSYS® 
Fluent to simulate the particle deposition patterns in the NC using a Lagrangian particle 
tracking scheme and one-way coupling between the particles and the fluid phase. They 
reported that even a slight variation in the smoothness of the surface of the NC has a 
significant effect on the deposition of the particles in the NC, which implies that this 
information should be taken into account when the results of CFD modelling are compared 
with the experimental data using a 3D printed or cast nasal replica. The effect of different 
factors of a spray on the particle deposition in the NC was studied by Inthavong et al. (2006) 
using CFD modelling. Monodispersed microparticles were injected into the nostril and the 
deposition patterns under different insertion angles of a nasal spray were examined. The 
insertion angle is the angle between the nasal spray and the horizontal plane (Inthavong et al., 
2006). They demonstrated that the maximum particle deposition occurred when the diameter 
of the particles is in the range of 10 µm to 15 µm and the insertion angle is 100°; however, 
the minimum deposition occurred when the insertion angle was 70°.  
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As reviewed above, several studies have investigated airflow features and particle 
depositions in the NC and sinuses in various scenarios, including different nose-sinus models, 
different particle sizes, different airflow rates, etc. Nevertheless, the effect of variation of the 
inlet airflow precondition such as inlet swirling and turbulent flow, as well as the particles’ 
release patterns on the airflow features and particle deposition in the NC and sinuses, has not 
yet been studied. 
 Concluding Remarks and perspectives 
This chapter reviewed the broad research areas associated with this thesis, in particular, an 
overview of TDD systems for the treatment of CRS, their advantages and related challenges, 
and the main factors that affect their performance in drug delivery to the NC and sinuses. 
The NC is an important organ of the human body with crucial functionalities such as 
warming and humidification of inhaled air, filtering inhaled air to clean it of foreign 
particulates and accommodate the olfactory region for sensing smells. The sinuses are also 
responsible for critical functionalities such as lightening the skull, resonating speech sounds 
and producing lysozyme, which protects the nasal mucus against bacterial infections. Some 
diseases, such as viral infections and CRS, highly affect the functionalities of the NC and 
sinuses. CRS has a prevalence of 4.9% to 10.9% worldwide. CRS patients endure excessive 
mucus secretion, swollen mucosa, and obstructed airways due to infections in the sinuses. 
Hence, it is important to develop an efficient treatment for this chronic disease. Efficient 
medicine for the treatment of CRS is available through phage therapy; however, an efficient 
method of delivery of the medication (bacteriophage) is yet to be developed. TDD systems 
are potential candidates for delivering the drug to the sinuses.  
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Various existing methods of TDD were reviewed in this chapter: MDT, ECDD, and 
acoustically-driven therapy. MDT, as a method of active drug targeting, enhances drug 
delivery efficiency using an increase in the temperature of a target point to release the drugs 
(hyperthermia) or by guiding the particles to a target site (magnetically-guided drug delivery). 
The former approach, hyperthermia, should take place in a fluid medium (i.e., via blood in 
the human body), which cannot be used for drug delivery in human airways such as the NC 
or sinuses.  MDT and ECDD can be used for drug delivery in a gas medium, such as human 
airways, and demonstrate a significant increase in drug delivery to the olfactory and OMC 
regions, respectively. However, due to the complexity of the NC anatomy and the poor 
accessibility of the sinuses, the implementation of these methods for drug delivery to the 
sinuses is likely to be more complicated, for which no previous study has been conducted.  
Acoustically-driven therapy is divided into two categories: ultrasonic-enhanced drug 
delivery and low-frequency ADD. Based on the literature, the use of ultrasonic-enhanced 
drug delivery for therapeutic purposes is a promising active targeting approach when used in 
the circulation system. However, it cannot be utilised for therapeutic purposes in the 
respiratory system. This is because the lung and airway tissues are filled with gas, whereby 
the ultrasound is scattered and reflected. Hence, it is not possible to focus an ultrasound beam 
at a target site in the NC and sinuses. On the other hand, low-frequency acoustic fields have 
recently been demonstrated to be advantageous in nasal drug delivery, especially for drug 
delivery to the MS.  
The feasibility of ADD has been demonstrated in several in-vitro and in-vivo studies. 
The main components of ADD are the nebulisation of the medication and the superposition 
of an acoustic wave on the aerosols entering the nostril. Several studies have examined the 
effect of fixed frequencies of 45 Hz and 100 Hz on the efficacy of ADD in drug delivery to 
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the MS, which demonstrated an increase in the drug deposition in the MS of at most 3-fold; 
however, in some cases, a negligible increase was reported. Due to the similarity of the NC-
MC combination and a Helmholtz resonator, and to explain the inconsistency of the observed 
results, researchers have recently hypothesised that the highest drug delivery to the MS takes 
place at the resonance frequency of the NC-MS combination. Accordingly, they exploited the 
equation of a Helmholtz resonator to estimate the resonance frequency of the NC-MS and 
applied this to the nostril for the assessment of ADD, after which a 5-fold increase in drug 
delivery to the MS was reported, when compared with non-ADD approaches.  
The classic equation of a Helmholtz resonator estimates the resonance frequency of a 
spherical cavity attached to a cylindrical neck, which differs significantly from the complex 
geometry of an NC-MS. Therefore, it is critical to develop a model to estimate the accurate 
resonance frequency of the NC-MS combination and assess it for the variations in geometrical 
parameters, which will be discussed in Chapter 3. To improve ADD efficiency, developing 
an understanding of the flow features in the NC-MS combination under the effect of an 
external acoustic wave is necessary, and will be investigated in Chapter 4 using CFD 
modelling. The effect of the application of an accurate resonance frequency in the ADD 
technique for the assessment of the drug deposition in a realistic model of NC-MS should be 
investigated using in-vitro experiments to verify the hypothesis that the highest ADD 
efficiency occurs at the resonance frequency, and this is considered in Chapter 5. In addition 
to the acoustic component of the ADD technique, the characteristics of the drug nebulisation 
and inlet airflow are crucial in drug delivery efficacy. The effect of various inlet airflow rates 
on drug delivery to the NC and MS were examined in several studies, where no significant 
increase in the efficiency of drug delivery to the NC and MS were reported. However, Ari et 
al. (2015) experimentally showed that different nasal mask configurations affect the 
performance of drug delivery to the lungs. This implies that the inlet airflow preconditioning, 
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and particle distribution pattern at the inlet, can have an impact on aerosol deposition and 
transport in different regions of the NC. Accordingly, the effect of different inlet flow 
preconditionings, such as turbulent and swirling flows, as well as the effect of the nozzle 
diameter, will be presented in Chapter 6. The thesis is concluded in Chapter 7, which also 
provides recommendations for future work. 
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In this chapter, a computational fluid dynamics (CFD) model, a finite element analysis (FEA) 
model, and an analytical equation of the classic Helmholtz resonator were used to predict the 
resonance frequency of the NC-MS combination. A simplified model of NC-MS, with 
dimensions close to a realistic model of NC-MS, was used to conduct a broad range of 
parametric studies. The results of these numerical models were compared with the results of 
in-house experiments to assess the accuracy of the models. Using the most accurate model 
(i.e., CFD), the effect of geometric parameters such as the ostium length, ostium diameter, 
NC width, MS volume, and MS shape on the resonance frequency was investigated. Then, 
the geometric parameters with the highest effect on the resonance frequency of the NC-MS 
were determined. Aero-acoustic analysis was also carried out to develop the relationship 
between the damping ratio of the air plug oscillation in the ostium and the drug delivery 
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efficiency, and the resonance frequency. Finally, the effect of the middle meatus on the 
estimation of the resonance frequency of a realistic model of NC-MS was investigated using 
the CFD model. Accordingly, a correction to the equation of the Helmholtz resonator was 
developed, which accounts for the effect of the middle meatus for estimation of the resonance 
frequency of the realistic NC-MS model. Overall, the models developed, and the discussions 
made in this chapter, address the first objective of this work, that is, “to develop a well-
resolved numerical model to investigate the effect of different geometrical parameters on the 
resonance frequency of the NC-MS combination”.  
3.1 Published articles 
This chapter consists of a published journal article and a conference paper. In the journal 
article, the effect of geometrical parameters on the resonance frequency of an NC-MS 
combination was investigated. In the conference paper, the effect of the middle meatus on the 
prediction of the resonance frequency of the NC-MS model was examined.  
Pourmehran, O., Arjomandi, M., Cazzolato, B., Ghanadi, F., & Tian, Z. (2020). The impact 
of geometrical parameters on acoustically driven drug delivery to maxillary sinuses. 
Biomechanics and Modeling in Mechanobiology, 19(2), 557-575. 
Pourmehran, O., Cazzolato, B., Tian, Z., & Arjomandi, M. (2020). Acoustic behaviour of 
the human maxillary sinus: The importance of the middle meatus and the ostium on resonance 
frequency behaviour. Presented in 18th International Conference of Numerical Analysis and 
Applied Mathematics, Rhodes, Greece. Accepted to be published in AIP conference 
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Acoustic Behaviour of the Human Maxillary Sinus: The 
Importance of the Middle Meatus and the Ostium on 
Resonance Frequency Behaviour 
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Abstract. This study aims to investigate the resonance frequency of the human maxillary sinus for the application of 
acoustically-driven drug delivery. An improved model of the classic Helmholtz resonator formula has been developed to 
predict the resonance frequency of a nasal cavity and maxillary sinus combination, using computational fluid dynamics 
(CFD). To be more specific, a 3-D CFD model of the left side of a healthy human nose, composed of a nasal cavity 
connected to the maxillary sinus through an ostium, has been developed to undertake direct computational acoustics for 
predicting the resonance frequency. The simulations of the acoustic airflow in the nasal cavity, ostium, and maxillary sinus 
were carried out by solving the continuity and Navier-Stokes equations. A series of experiments were conducted for 
validation of CFD modelling using the resonance frequency of the nasal cavity and maxillary sinus combination as a 
criterion. The results showed that the classic Helmholtz resonator formula overpredicted the resonance frequency of the 
realistic nasal cavity and maxillary combination by 50% compared to measured experimental data. However, the results of 
the CFD simulation demonstrated a good agreement with the experimental data, showing a difference of 10%. Further, it 
is shown that by accounting for the fluid mass within both the maxillary sinus and the middle meatus the resonance 
frequency of the nasal cavity and maxillary sinus combination can be accurately predicted.  
INTRODUCTION 
Rhinosinusitis, known as a sinus infection, is one of the most widely-recognized ailments related to rhinology, 
which affects up to 15% of the global population 1. The maxillary sinus (MS) is the most voluminous of the all 
paranasal sinuses and, due to its location, it is prone to a broader range of diseases, such as viral infection, bacterial 
colonization, and anatomical obstruction. The MS is located in a secluded place in the nasal cavity, which limits the 
drug delivery to this area 2. Most drugs administered via the nostril, using conventional nebulizers, fail to reach the 
MS efficiently due to the specific geometry of the nasal cavity (NC) and MS combination 1. However, the acoustically-
driven drug delivery (ADD) technique, first proposed by Guillerm, Badre, Flottes, Riu and Rey 3, has gained 
considerable attention from many researchers due to its higher efficiency than the conventional nebulization drug 
delivery technique 4-8. In this technique, an acoustic field is superimposed onto the nebulized drug particles (aerosols), 
which have been clinically used as a medicinal treatment to enhance the penetration of the drug particles into the MS, 
for several decades. 
For a long time, a sinusoidal sound signal with a frequency of 50 Hz and 100 Hz was used by researchers and 
clinicians as the principle of the acoustically-driven nebulization process 9. However, many recent studies have 
focused on the calculation of other frequencies to improve the efficiency of ADD to MS, exploiting the Helmholtz 
resonator principle and an external sound signal applied at the nostril 8, 10-12.  A Helmholtz resonator is a device 
composed of a cavity connected to a small tube (neck) 13. In an NC-MS combination, the MS is assumed to be the 
cavity, and the ostium is considered to be the neck of a Helmholtz resonator. According to the theory, the air plug 
inside the neck oscillates along the length of the neck when an external sound signal is applied 13. A frequency equal 
to the resonance frequency of the Helmholtz resonator device should be applied as an external sound at the nostril to 
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 19 with three coefficients was used. The walls were set up to be adiabatic and acoustically reflective. 
For the inlet and outlet, pressure-inlet and pressure-outlet boundary conditions, both with zero-gauge-pressure, were 
defined. A zero-pressure and zero-velocity were used as the initial condition. It must be noted that the inlet and outlet 
must be acoustically non-reflective for the planned acoustic simulation. Therefore, a general non-reflecting boundary 
condition (NRBC) was applied to the outlet and Transparent Flow Forcing boundary condition was applied to the 
inlet, which simulates the NRBC, as well as superimposing the acoustic wave to the inlet zero-gauge-pressure. An 
acoustic sweep in a range of frequencies identical to those produced by white bandlimited noise signal in the 
experiments (from 150 Hz to 800 Hz), was used as the Transparent Flow Forcing via a User Defined Function (UDF) 
given by, 
2
0 1 0( ) sin( ( ) 2 ),sp t A f t t f f T where p(t), A, f0, and f1 are the pressure as a function of time, the incident 
pressure amplitude, starting frequency, and final frequency, respectively. Also, Ts is the time it takes to sweep from f0 
to f1. A non-iterative time-advancement (NITA) algorithm using a PISO pressure-velocity coupling scheme was used 
in this simulation. Second-order spatial discretization, Third-Order MUSCL, and QUICK methods were used for the 
pressure, density, and momentum and energy equations, respectively. Moreover, the second-order implicit method 
was performed for the transient formulation. A total of 1.28 million polyhedral elements with two boundary layers 
were generated for the flow simulation for a duration of t = 0.2 s, using a time-step size of . The use of 
polyhedral-elements in this study is due to their advantages, including better convergence, shorter computational time 
and high WSS accuracy 20. An overview of the mesh generated for the realistic NC-MS model is illustrated in Fig. 1. 
 
   
 
(a) (b) (c) 
FIGURE 1. (a) frontal view of the polyhedral mesh generated for a 3-D NC-MS model, (b) zoomed view of the ostium (c) 2-D 
view of the polyhedral mesh on the interface between the ostium and the nasal cavity on the Z-Y plane. 
RESULTS AND DISCUSSION 
A series of experimental tests were conducted for the validation of the CFD simulation, focused on the resonance 
frequency of the realistic NC-MS combination. Figure 2 (a) shows the transfer function estimate between the input 
and response points obtained for two 3-D printed and one CFD NC-MC models. As can be seen in this Fig., the 
resonance frequency of the realistic NC-MS model created with low-resolution printing (Explow-res) is fr = 410 Hz, 
which is 18 Hz more than that obtained from a model created with high-resolution printing (Exphigh-res). One can infer 
from Fig. 2 (a) and Equation (1) that the discrepancy between the resonance frequencies obtained through Explow-res 
and Exphigh-res stems from the high sensitivity of the resonance frequency to the ostium diameter and length. 
Accordingly, the data collected by Exphigh-res is used for the evaluation of the results obtained using CFD and the 
classic Helmholtz resonator formula (Theory). Figure 2 (b) illustrates the deviation of the resonance frequency 
calculated using CFD and Theory from the experimental data, which are quantified by ECFD and ETheory, respectively. 
This Fig. reveals that the CFD simulation predicted the resonance frequency of the realistic NC-MS combination with 
an error of ECFD = 10%, which is more accurate than that obtained by Equation (1) with ETheory = 49%. Thus, the results 
demonstrated a good agreement between the experimental and CFD modelling. Figure 3 (a) shows the root mean 
squared error (RMSE) of static pressure, which quantifies the amplitude of the pressure fluctuations on different planar 
surfaces along the nasal cavity. According to this Fig., the RMSE static pressure on an X-Y plane coincided with the 
ostium centerline, demonstrates that the maximum pressure fluctuation occurs inside the MS, which implies a 
maximum transfer function between the inlet and MS, showing a similar behaviour of the MS and ostium to a 
Helmholtz resonator. Figure 3 (b) presents the RMSE X-Velocity on different planar surfaces, which confirms the 
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achieve the maximum amplitude of the air plug oscillation. The frequency can be calculated by the classic Helmholtz 
resonator formula, as follows 12: 











where fr, c, VMS, and S0, are the resonance frequency, the sound speed, the volume of the MS, and the area of the ostium 
cross-section, respectively. Leff in Equation (1) is the effective length of the ostium, which is defined by Leff = Los + 0.6 
DH,os 12, where Los and DH,os are the length and hydraulic diameter of the ostium, respectively.  The term 0.6 DH,os 
represents an end-correction. Using this principle, several researchers have investigated the efficacy of ADD, 
considering different variables such as geometrical and acoustic parameters, particle sizes, and breathing patterns 4, 5, 
7, 10, 14, 15. Xi, Si, Peters, Nevorski, Wen and Lehman 12 investigated the particle deposition fraction on the MS wall 
using the ADD technique through both finite element analysis (FEA) and experiments. They reported that the 
resonance frequency of the NC-MC model in their study was fr = 652Hz; however, the maximum deposition efficiency 
on the MS wall occurred at a different inlet frequency of fr = 545Hz. Pourmehran, Arjomandi, Cazzolato, Ghanadi and 
Tian 16 investigated the effect of geometrical parameters on the resonance frequency of an idealized NC-MS 
combination using CFD, FEA, the Helmholtz resonator formula, and experimentation. The findings of their study 
revealed that the classic Helmholtz resonator formula overestimates the resonance frequency of the idealized NC-MS 
combination by more than 20% compared to the experimental data. Thus, it is essential to understand how accurately 
the Helmholtz resonator formula predicts the resonance frequency of a realistic NC-MS combination. This study aims 
to investigate the fluid features of the acoustic airflow in a realistic NC-MS combination at a fundamental level, as 
well as undertaking an acoustic analysis to predict the resonance frequency of the model.  
METHODOLOGY 
A numerical model of a real NC-MS combination was developed based on computer tomography images provided 
by Inthavong, Wen, Tian and Tu 17 and Kumar, Jain, Douglas and Tawhai 18. This geometry is composed of the left 
side of the nasal cavity attached to the ostium and MS with DH,os Los VMS . The frontal, 
sphenoid, and ethmoid sinuses are excluded from the geometry. For validation purposes, the resonance frequency of 
the NC-MS combination was used. The resonance frequency of the realistic NC-MS model was calculated using the 
Helmholtz resonator theory (Equation (1)), experiments, and CFD simulation.  
Experimental Design 
The realistic model of the NC-MS combination was manufactured using 3-D printing techniques at the University 
of Adelaide. Two different materials were used for printing the models to evaluate the sensitivity of the accuracy of 
3-D printed models. The plastic material resulted in a resolution of 0.2 mm (low-resolution), and the resin-based 
material created a model with a resolution of 0.09 mm (high-resolution). Using a similar experimental test rig and the 
procedure described in Pourmehran, Arjomandi, Cazzolato, Ghanadi and Tian 16, the resonance frequency of the 3-D 
printed NC-MS models were measured. To do so, a white bandlimited noise signal from 150 Hz to 800 Hz, was 
applied to the nostril using a loudspeaker. The transfer function between the input and response pressure signals was 
estimated in the frequency domain using a MATLAB code. A magnitude-squared coherence function (Coh) was used 
to verify the degree of linearity between the input and response signals. The Coh is a function of frequency and has a 
value between zero and unity, which exceeded 0.9 for the most part in this study, showing a high level of coherence 
and demonstrating an acceptable level of accuracy. The TF estimate and coherence function was obtained using a 
Hanning window with 1024 FFT points and a 75% overlap for a total of 17 averagings.  To ensure that the results are 
predictable and repeatable, the experiments were conducted five times for each NC-MS 3-D printed model. 
CFD Simulation 
The airflow features in the real NC-MS combination were simulated using ANSYS® FLUENT. To resolve the 
flow features in the presence of an acoustic field, a pressure-based solver was used for solving the compressible 
transient nonlinear Navier-Stokes equations. To simulate the conditions of the experiment, the fluid medium in this 
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oscillate in the presence of an external acoustic field, but also a portion of the air plug in the middle meatus fluctuates 




FIGURE 2. (a) TF estimate obtained by experiments and CFD, (b) comparison of fr obtained by different methods 
According to the correction mentioned above, the effective length, Leff, in Equation (1) is assumed to be Leff = Los 
+ os DH,os + LMM + MM DH,os, where LMM  is the length of the middle meatus (MM) as identified in Fig. 3 (b). The 
length of MM in this study is LMM = 7 mm. Also, os and MM are the neck length correction factor related to the ostium 
and the MM. The ostium end is assumed to be flanged, in which the end-correction factor is os =
 21. The end-correction for the MM is deduced from the resonance frequency obtained experimentally through 
substituting the known parameters in Equation (1), which gives MM = 0.387. Therefore, the corrected effective length 
of the neck in Equation (1) becomes Leff = Los +0.425 DH,os + LMM + 0.387 DH,os. Using this correction, Equation (1) 
gives an accurate resonance frequency of fr = 392 Hz. However, this correction is only valid for the specific, realistic 
geometry used in this study. A series of realistic NC-MS models should be analyzed experimentally and numerically 
to generalise the correction of the classic Helmholtz resonator formula.  
CONCLUSION 
In this study, the resonance frequency of a realistic human NC-MS model was investigated using experiments, 
CFD, and the Helmholtz resonator formula for the application of acoustically-driven drug delivery to the MS. The 
results showed that CFD was more accurate than the classic Helmholtz resonator formula. However, a correction was 
made to the neck effective length in the classic Helmholtz resonator formula to improve the resonance frequency 
prediction. Using that correction, the Helmholtz resonator formula could predict the resonance frequency of a specific, 
realistic NC-MS combination more accurately than the classic one. Nevertheless, for a generalization of the correction, 
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In the previous chapter (Chapter 3), the resonance frequency of the combination of the nasal 
cavity (NC) and maxillary sinus (MS) has been predicted using various numerical models, 
and the computational fluid dynamics (CFD) model has demonstrated an acceptable accuracy. 
To investigate the effect of the resonance frequency, obtained using the CFD model described 
in Chapter 3, as well as to understand the underlying mechanism of acoustic drug delivery 
(ADD) to the maxillary sinus (MS) on the transport and deposition patterns of particles 
(drugs) in an NC-MS combination, a CFD model was developed. A Eulerian-Lagrangian 
particle tracking scheme was used to understand the aerosol transport pattern and deposition 
of aerosols in the MS under the effect of an acoustic wave with different aero-acoustic 
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characteristics. A parametric study was conducted to investigate the effect of aero-acoustic 
parameters such as input frequency (including the resonance and off-resonance frequency), 
amplitude, and inlet airflow rate on the flow features within the NC, ostium and MS. Using 
the parametric study, the optimised value of the acoustic wave was determined to achieve the 
highest drug delivery efficiency. The effect of the acoustic radiation force on ADD was 
discussed through assessment of the acoustic Stokes number. The effect of particle density 
and diameter on the ADD efficiency were also investigated, considering their effects on the 
acoustic Stokes number. The models developed in this chapter address the second objective 
of this study that is “to develop an understanding of airflow behaviour in a simplified NC-MS 
combination in the presence of an external acoustic field in order to investigate the effect of 
aero-acoustic parameters on the efficiency of ADD”. 
 Published articles 
This chapter consists of a published journal article and a conference paper. In the journal 
article, the effect of aero-acoustic parameters on ADD efficiency, and in the conference 
article, the effect of particle diameter and density on ADD efficiency, are presented. 
Pourmehran, O., Cazzolato, B., Tian, Z., & Arjomandi, M. (2020). Acoustically-driven drug 
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diameter and density on acoustic drug delivery to maxillary sinus – A sensitivity study”. 22nd 
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Abstract
Acoustic drug delivery to human maxillary sinus is a novel 
technique in the field of targeted drug delivery. This paper 
investigates the effect of drug particles
on the efficiency of drug delivery to maxillary sinus through the 
direct computational aero-acoustics. A computational fluid 
dynamic model (CFD) using the discrete phase model has been
developed and employed to simulate the transport pattern of the 
drug particles. For sensitivity study, a simplified model of nose-
sinus comprising a nasal cavity, ostium and maxillary sinus has 
been utilised. It has been concluded that, in an acoustic field,
decreasing the particle mass increases the particle entrainment 
coefficient due to the enhancement of the amplitude 
(entrainment coefficient) of the particle motion. The results also 
decreases the acoustics stokes number, which negatively affects 
the drug delivery efficiency.
Keywords
Acoustic drug delivery; Helmholtz resonator; Maxillary sinus; 
Computational Fluid Dynamics (CFD)
Introduction 
Sinusitis is one of the most common diseases associated with 
rhinology, which affects up to 15% of the population 
throughout the world [1]. Since the nasal cavity (NC) is exposed 
to the infections carried by the inhaled aerosols, the maxillary 
sinus (MS) is highly prone to infection. The only opening to the 
MS is a slit-like channel of 3-9mm in diameter called ostium. 
The narrowness of ostium prevents easy access to the MS 
resulting in a challenge for efficient drug delivery to MS. Most 
drugs administered through the nostril by a conventional 
nebulisation system, fail to reach the MS efficiently [2] because 
the MS is located in a non-ventilated area due to the complexity 
of human nose geometry. Acoustically-driven drug delivery
(ADD) technique offers an alternative solution for increasing
the drug delivery efficiency because the pressure-induced flow 
generated by the acoustic field enhances the air exchange 
between the NC and MS. The underlying mechanism of the 
ADD is based on the Helmholtz resonator theory, in which the 
MS and ostium represent the cavity and neck of a Helmholtz 
resonator. Based on the Helmholtz resonator principle, in the 
presence of an external acoustic field, the air plug inside the 
ostium vibrates at the frequency of the applied acoustic field. 
The vibration of the air in the ostium causes a pressure 
difference between the NC and MS, which contributes to the
transport of the drug particles from NC to MS. Hence, the 
highest drug delivery efficiency is achieved when the air plug 
in the ostium vibrates with the largest amplitude, which occurs 
at the resonance frequency of the NC-MS combination. 
The ADD technique was firstly proposed by Guillerm et al. [3]
in 1959 and later in several studies the feasibility of the ADD 
was investigated using experimental and modelling works.
experimental and numerical studies [4, 5]. For a long time, a 
sinusoidal sound signal with a frequency of 50 Hz and 100 Hz 
was used by researchers and clinicians as the principle of the 
acoustically-driven nebulization process [6]. As an example,
Weitzberg and Lundberg [7] in an experimental study showed 
that a humming exhalation could enhance the exchange of air 
between the NC and MS by 15-fold in comparison with quiet
exhalation. Later on, Maniscalco et al. [8] demonstrated that the 
concentration of exhaled NO is significantly sensitive to the 
frequency of both the humming and the diameter of the 
maxillary ostium. Durand et al. [9] investigated the effect of an 
acoustic signal of 100 Hz on the efficiency of drug delivery to 
MS, experimentally. They reported that an increase of drug 
deposition on the sinus wall was achieved by a factor of 1.6 to 
3 in comparison with non-acoustic drug delivery. Leclerc et al. 
[4] investigated the impact of airborne particle size on the
efficiency of ADD to MS using an input acoustic frequency of
100 Hz, experimentally. They found that the fraction of
particles deposited on the maxillary sinus wall increases when
submicron drug particles are used. They reported a 20-fold
increase in drug delivery efficiency by use of the particle size
of 550 nm in comparison with the particle size of 9.9 µm[4]. In
more recent studies, the researchers have utilized the resonance
frequency of NC-MS as the inlet frequency exploiting the
Helmholtz resonator frequency equation instead of the fixed
frequencies of 50 Hz and 100 Hz. Moghadam et al. [5] used a
sweep frequency for enhancing drug delivery efficiency. Xi et
al. [10] used the Helmholtz resonator frequency equation and
examined the effect of inlet frequency on the drug delivery
efficiency. They reported that the maximum efficiency of drug
delivery was achieved at the resonance frequency of NC-MS
and its harmonics. In a recent study, Pourmehran et al. [1]
proposed a novel experimental and numerical methods to
estimate the resonance frequency of the NC-MS combination.
They demonstrated that the Helmholtz resonator formula
overestimates the resonance frequency of NC-MS combination
by 20%-40%. In a later study [11], they employed this method
for the estimation of resonance frequency and showed that the
maximum efficiency of drug delivery to MS is achieved at the
resonance frequency of NC-MS combination but not with the
use of Helmholtz resonator formula. They also briefly discussed
the orthokinetic motion of particles and the effect of particle
diameter on ADD efficiency theoretically, however, with no
case-specific results. In this study, a more accurate technique
for the estimation of resonance frequency proposed as
described in Pourmehran et al. [1], was applied and the effects
of particle diameter and density on the particle Stokes number,
entrainment coefficient, and the efficiency of ADD to MS are
investigated in more details considering different case studies.
Numerical Modeling
In the present study, direct computational aero-acoustics were 
employed to simulate acoustically-driven drug delivery to 
maxillary sinuses. To enable a systematic study [12], a
simplified NC-MS geometry (Figure 1) was used given that the 
resonance frequency of the NC-MS combination is not sensitive 
to the NC and MS shapes [1]. The three-dimensional (3D) 
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as the governing equations of Newtonian and compressible 
acoustically-driven flow in an unsteady state. The fluid was dry 
air, and the ideal gas law was employed to calculate the density 
of  
to resolve the air viscosity.  
 
Figure 1. The cross-section of the simplified NC-MS geometry as 
an analogy of the realistic one-side NC-MS. Reprinted from 
European Journal of Pharmaceutical Sciences, 151, O. Pourmehran 
et al, Acoustically-driven drug delivery to maxillary sinuses: Aero-
acoustic analysis, 105398, Copyright (2020), with permission from 
Elsevier 
To simulate the particle trajectories, a discrete phase model 
(DPM) exploiting the Lagrangian particle tracking approach 
was used. Based on the Lagrangian approach, the trajectories of 
the particles are tracked through the integration of the force 
balance equation on each particle. In the presence of an 
acoustically-driven airflow, the total force which acts on an 
inert small particle is a combination of several different forces 
such as Basset, thermophoretic, Saffman, Brownian, pressure-
gradient, virtual mass, Magnus, Faxen, gradient and drag 
forces. All forces except the gradient and drag forces are 
neglected in this study. A comprehensive discussion on this 
topic can be found in [11]. 
Considering the gradient and drag forces, the equation of force 
balance for a spherical particle, which used in the present study, 
is given by [11] 
 (1) 
where , , , and  are the gravity acceleration, fluid flow 
velocity, particle velocity, particle density, respectively.  is 
the particle relaxation time defined by: 
 (2) 
where  is the diameter of particle and  is the drag 
coefficient, which is calculated through the equation of drag 
coefficient derived by Morsi and Alexander [13]. The drag 
coefficient equation is correlated to particle Reynolds number,  
given by .  
ANSYS® Fluent was used to model the ADD to the MS in a 
simplified NC-MS combination. Given that the volume fraction 
of the particle phase falls in an order of magnitude of less than 
-6 ( ), and due to the low particle Reynolds number 
( ), a one-way coupling of the particle-fluid phases was 
used for particle tracking through DPM. A pressure-based 
solver with SIMPLEC scheme was used for solving the Navier-
Stokes equations through an iterative time-advancement (ITA) 
algorithm. Second-order, third-order MUSCL spatial 
discretization methods were used for the pressure and density, 
respectively. Also, QUICK spatial discretization was used for 
the momentum and energy equations. A pressure-inlet 
boundary condition was applied to the inlet through a user-
defined function (UDF) to simulate the sinusoidal acoustic 
wave given by  
 (3) 
where  is the inlet pressure, t is the time, is the initial 
pressure,  is the amplitude of the pressure wave, and  is the 
inlet frequency. A pressure-outlet boundary condition was 
applied to the outlet. To prevent reflection of the sound waves, 
a non-reflecting condition was also applied to the outlet 
boundary. A no-slip boundary condition was also defined on the 
walls.  
Validation Study 
The numerical simulation of this study has been validated 
against experimental data conducted by the authors at the 
University of Adelaide. A simplified NC-MS model was 
constructed using a Zortrax 3D printer device, with a resolution 
of 0.2 mm. Using an identical experimental setup and the 
procedure explained in Ref. [1] the resonance frequency of the 
NC-MS model was obtained. For this purpose, a load speaker 
was used to generate and apply a white noise signal, covering a 
range of frequencies from 150 Hz to 800 Hz, to the inlet. A 
MATLAB code was employed to estimate the transfer function 
(TF) between the inlet and response pressure waves. To 
quantify the degree of linearity between two microphones at the 
inlet and at the response points, a magnitude-squared coherence 
function (Coh) was utilised. Both the TF and Coh were 
estimated through a Hanning window with  FFT points and 
a 75% overlap for a total of 14 averages. The Coh falls in the 
range of [0,1], in which the zero value of Coh shows a non-
coherence condition and a unity value of Coh indicated the 
highest level of coherence between the inlet and response 
signals.  
 
Figure 2. Comparison of the transfer function estimate obtained by 
CFD and experiment (Exp) 
In the frequency range utilised in this study, the Coh exceeded 
0.9, which indicates a high level of coherence showing an 
acceptable accuracy level. The experimental tests were repeated 
five times to ensure the predictability and repeatability of the 
results. The TF estimate and Coh function were also obtained 
via numerical modelling and the results were compared with the 
experimental data as shown in Figure 2. As can be seen in this 
figure, the numerical modelling is in good agreement with the 
experiment, showing a difference of 5.2%, which is due to the 
discretization and truncation errors of the numerical modelling. 
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by numerical modelling is , which is used as the 
inlet frequency in this study.  
Results and Discussion 
Small Particle Behaviour in an Acoustic Field 
In general, small particles in an aerosol oscillate if an acoustic 
field is applied to the aerosol. The particles oscillate with a 
frequency identical to the frequency of the applied acoustic 
field but at a different phase and amplitude [14]. Hence, the 
velocity of a particle can be expressed by 
 
where  is the velocity of the particle,  is the particle 
entrainment coefficient,  is the maximum amplitude of the 
velocity of the particle, and  is phase factor. The particle 
entrainment coefficient, , is the ratio of the amplitude of the 
velocity of the particle to the amplitude of the velocity of 
airflow, which are given by [14]  and 
, where  is the particle time scale given 
by . Herein, the acoustic Stokes number is 
defined by , in which the amplitude of the 
velocity and phase of the particle approaches the airflow 
velocity amplitude and phase in the limit of  [15].  
 
Figure 3. The effect of particle diameter and density on acoustic 
Stokes number at the resonance frequency ( ) 
Figure 3 shows the effects of particle diameter and density on 
acoustic Stokes number at the frequency of . The 
dynamic viscosity and temperature assumed to be constant. 
From this figure, it is obvious that both the particle diameter 
and density have a direct relationship with the acoustic Stokes 
number. It can be seen from Figure 3 that the effect of particle 
diameter on the acoustic Stokes number depends on the particle 
density. For an illustration, for  particles with a density of 
, an increase in particle diameter from 2µm to 
12µm, , increases the acoustic Stokes number from 0.006 to 
0.203, however, for particles with a density of 
, the acoustic Stokes number increases from 0.017 
to 0.610.  
Effect of particle diameter and density on ADD 
To evaluate the effect of particle mass on the efficiency of ADD 
to MS, the airflow exchange between the NC and MS was 
quantified using a particle tracking scheme for different particle 
diameter and density. Given that the one-way fluid-particle 
coupling was used for the formulation of the particle tracking, 
the transport of particles to the MS is a representative of the 
exchange of the airflow between the NC and MS. To do so, a 
total of 5000 inert monodisperse particles were released in the 
NC zone.  The particles were released in the domain after 20 
periods to ensure that the pressure oscillation is stable. Then, 
the dynamic behaviour of the particles was simulated for an 
additional 100 periods. A total of 11 case studies including six 
different diameters of the particle (e.g. dp= 2 µm, 4µm, 6 µm, 8 
µm, 10 µm, and 12 µm) and five different densities of the 
particle (e.g.  to  with an 
interval of 500) were considered to investigate their effects on 
drug delivery efficiency. An inlet frequency of  with 
an amplitude of  Pa was applied to the inlet boundary 
for all cases. 
 
Figure 4. The effect of particle diameter and density on drug 
delivery efficiency (DDE). The black line shows the effect of 
particles diameter on DDE for a particle density of 
 and the blue line represents the effect of particle 
density on DDE for a particle diameter of dp= 4 µm. 
In this study, the drug delivery efficiency (DDE) is defined as a 
percentage of the number of particles delivered to the MS to the 
total distributed particles in the NC. Figure 4 shows the effect 
of particle diameter and density on DDE. As can be seen in this 
figure, both the diameter and density of the particles have an 
inverse relationship with DDE. It can be concluded that, the 
lighter the particles are distributed, the higher the DDE is 
achieved. The decreasing trend of the DDE shown in Figure 4 
stems from the effect of particle diameter and density on the 
acoustic Stokes number. As it was discussed in the previous 
section, the acoustic Stokes number increases by an increase in 
the particle diameter and density. On the other hand, an increase 
in the acoustic Stokes number results in a decrease in particle 
entrainment coefficient showing a decrease in the amplitude of 
the particle oscillation. In other words, these particles travel a 
shorter distance along the ostium in every period, which results 
in a lower DDE. 
In addition to the delivery of the particles to the MS, the 
deposition of the particles on the walls was also studies. In this 
regard, the term deposition fraction (DF) was used, which 
represents the percentage of the number of particles deposited 
on a wall to the number of particles distributed in the NC 
initially. Figure 5 (a) represents the effect of particle diameter 
on the DF at the entire NC-M walls and the NC, ostium, and 
MS walls. Although the DDE decreases with an increase in 
particle diameter (Figure 4), the total DF increases (Figure 5 
(a)) because the surface area of the bigger particles is larger than 
the small particles, hence the bigger particles are more likely to 
be deposited onto walls. Figure 5 (b) demonstrates that 
changing the particle density does not affect overal DF. This 
figure also shows that increasing particle density increases the 
DF on NC wall but decreases DF on ostium wall because fewer 
particles are delivered to the MS through ostium. Figure 6 


























it is obvious that most of the particle deposition occurs at the 
edges of the ostium connected to the NC and MS. 
 
 
Figure 5. (a) The effect of particle diameter on the deposition 
fraction (DF) for particles with a density of  ; (b) 
the effect of particle density on DF for particles with a diameter of 
dp= 4 µm. 
 
 
Figure 6. A snapshot of the particle transport and deposition pattern 
when dp= 4 µm, ,and at 120th 
periods. The blue dots show the particles deposited on the 
walls, and red dots  
Conclusion 
In this study, the effect of particle diameter and density of the 
efficiency of ADD to the MS was investigated using a CFD 
model of a simplified NC-MS combination. The model was 
validated against the experimental data. The results show that, 
at the resonance frequency of the NC-MS, the acoustic Stokes 
number decreases, and the drug delivery efficiency increases 
with decreasing the particle diameter and density. Also, the 
overall DF on NC-MS walls increases with increasing the 
particle diameter, however, the variation of the particle density 
does not have a considerable effect on overall DF.  
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In this chapter, using the experimental and computational fluid dynamics (CFD) model, 
described in Chapter 3, to predict the resonance frequency of the combination of the nasal 
cavity (NC) and maxillary sinus (MS), as well as considering the important aero-acoustic 
parameters identified in Chapter 4, the feasibility of acoustic drug delivery (ADD) to a 
maxillary sinus (MS) were investigated. To do so, an experiment was designed to examine 
the effect of the aero-acoustic parameters, the input acoustic frequency, amplitude, and 
particle flowrate on the deposition of aerosols in the MS. A 3D printed model of a realistic 
nose-sinus geometry was used in the experiments. Sodium fluoride (NaF) 2.5 wt% was used 
as a drug tracer and was nebulised using a mesh nebuliser. A loudspeaker was used to generate 
the required acoustic waves. In addition to the experimental configuration, a computational 
fluid dynamics (CFD) model was developed to predict the particle transport and deposition 
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in a nose-sinus model, identical to that used in the experiments, under the effect of an input 
acoustic signal driven at the resonance frequency of the nose-sinus combination. The models 
developed and the discussions made in this chapter and the related results address the third 
objective of this work, namely, “to fabricate a well-designed experimental setup using a 3D 
printed model of a realistic NC-MS model to examine the efficacy of ADD in drug delivery to 
the MS”.  
The chapter consists of a journal article accepted for publication. 
Pourmehran, O., Arjomandi, M., Cazzolato1, B., Tian, Z., Vreugde, S., Javadiyan, S., 
Psaltis, A., & Wormald, PJ. (2021), “Acoustic drug delivery to maxillary sinuses”.  
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Acoustic drug delivery to the maxillary sinus 
Oveis Pourmehran1, Maziar Arjomandi1, Benjamin Cazzolato1, Zhao Tian1, Sarah 
Vreugde2, Shari Javadiyan2, Alkis J Psaltis2, Peter-John Wormald2 
1School of Mechanical Engineering, The University of Adelaide, Adelaide, SA, Australia 
2Department of Surgery - Otolaryngology Head and Neck Surgery, The University of Adelaide, 
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 Abstract 
Acoustic drug delivery (ADD) is an innovative method for drug delivery to the nose and 
paranasal sinuses and can be used to treat chronic rhinosinusitis (CRS). The underlying 
mechanism of ADD is based on the oscillatory exchange of air between the nasal cavity (NC) 
and the maxillary sinus (MS) through the ostium, which assists with the transfer of the drug 
particles from the NC to the sinuses. This study aims to examine the efficacy of ADD for 
drug delivery to the MS using an acoustic wave applied to nebulised aerosols entering the 
nostril. Here, the effect of acoustic frequency, amplitude, and nebulisation flowrate on the 
efficiency of ADD to the MS is investigated experimentally. A computational fluid dynamics 
model was also developed to understand the deposition and transport patterns of the aerosols. 
The results showed that superimposing an acoustic frequency of 328 Hz, which is the 
resonance frequency of the selected 3D printed model of the NC-MS combination, on the 
nebulised aerosols could improve the efficiency of the drug delivery to the MS by 75-fold 
compared with non-acoustic drug delivery case (p<0.0001). The experimental data also shows 
that an increase in the amplitude of excitation, increases the concentration of aerosol 
                                                 
1 Corresponding author. Present address: School of Mechanical Engineering, the University of Adelaide, 
North Terrace, Adelaide, SA, 5005, Australia. 
Email address: oveis.pourmehran@adelaide.edu.au (Oveis Pourmehran) 
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deposition in the MS significantly; however, it reaches to a plateau at a sound pressure level 
of 120 dB re 20 µPa.  
 Introduction 
Chronic rhinosinusitis (CRS) has a prevalence ranging from 4.9% to 10.9% worldwide 
(Bhattacharyya, 2012; Cho et al., 2010; Liu et al., 2018; Pilan et al., 2012). Among the various 
paranasal sinuses, the maxillary sinuses (MS) are the most voluminous. They are connected 
to the nasal cavity (NC) through a very narrow channel called the ostium. In addition to nasal 
rinsing with buffered saline solutions, topical therapy with anti-inflammatory drugs forms the 
mainstay of treatment and various delivery methods are used, including, aerosol-based 
delivery such as metered-dose pump sprays, and nebulisation (Moffa et al., 2019).  
Metered-dose pump sprays produce particles (droplets) with a median aerodynamic 
diameter (MAD) of 50-100 µm. Metered-dose pump sprays work based on instilling fine 
particles into the nostril through activating a hand-operated pump mechanism 
(a) (b)  
  
 
Figure 5.1: A schematic of the paranasal sinuses: (a) sagittal view; (b) section B-B’ 
representing the maxillary sinuses (MS), ostium, middle meatus (MM), and nasal cavity (NC). 
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(Alagusundaram et al., 2010). The positioning of a metered-dose pump spray and the 
actuation force influence the dose and particle size of the formulation (Basu et al., 2020). 
Whilst, the spray pump has been demonstrated to be an efficient method for the delivery of 
corticosteroids for the treatment of seasonal allergic rhinitis, the majority of the particles 
produced by sprays are deposited on the nasal valve and cannot reach the posterior regions of 
NC and poorly-ventilated areas, such as sinuses (Berger et al., 2007; Möller et al., 2014). 
Therefore, spraying the drug is not an effective method for sinus drug delivery (Suman et al., 
1999). 
Nebulisers, which are mainly used as a post-surgical treatment, produce finer particles 
than nasal sprays, in a range of 1-30 µm, which can transport drugs beyond the nasal valve, 
to reach the ostium and sinuses, (Hilton et al., 2008; Wofford et al., 2015). Although the 
nebulised drug particles can reach the middle meatus (MM), a very small proportion of the 
drugs during the nebulisation process enters the MS through the ostium (Wofford et al., 2015). 
One end of the ostium is connected the MM region of the NC (under the middle turbinate) 
and the other end of the ostium is connected to the MS. The diameter of the unoperated and 
operated ostia typically are <5 mm and 10-20 mm, respectively (Cankurtaran et al., 2007; 
Moghadam et al., 2018; Sharma et al., 2014; Tarhan et al., 2005). Due to the small size of the 
ostium and barely-accessible location of the MS, it is challenging to deliver the nebulised 
particles effectively into the MS (Hyo et al., 1989; Möller et al., 2014) (see Figure 5.1). 
In the last few years, adding acoustics to a nebuliser demonstrated higher drug 
deposition in the sinuses when compared with a conventional nebuliser without acoustics 
(Möller et al., 2010). The use of acoustics in nebulised drug delivery to the MS was first 
proposed by Kauf (1968), known as acoustic drug delivery (ADD). Given that the sinuses are 
non-ventilated areas, the oscillating airflow resulting from the acoustic field produces a 
Chapter 5. Acoustic drug delivery to the maxillary sinus: In-vitro study 
154 
pressure gradient between the NC and MS leading to increase the gas exchange between the 
sinuses and the NC (Suman, 2013).  
The efficacy of ADD to the MS has been reported in the literature (Durand et al., 
2011; Leclerc et al., 2014; Maniscalco et al., 2013; Maniscalco et al., 2006). In an 
experimental study Weitzberg et al. (2002) measured the nitric oxide (NO) egressed from the 
nostril under the effect of humming exhalation. They showed that humming exhalation 
increased the concentration of exhaled NO up to 15-fold when compared with quiet 
exhalation, which was confirmed by Maniscalco et al. (2003). Weitzberg et al. (2002) also 
found that the concentration of exhaled NO varies at different frequencies of humming. The 
respiratory system releases nitric oxide (NO) in exhaled air, which is largely produced by the 
paranasal sinuses (Lundberg et al., 1995). Hence, an increase in the exhaled NO under the 
effect of humming exhalation (acoustic wave) is a representative of an increase in air-
exchange between the NC and MS, which can result in enhancing the drug delivery to the 
MS. Maniscalco et al. (2006) reported that the superposition of acoustic signals with 
frequencies of 45 Hz, 120 HZ, and 200 Hz (sound pressure level was not reported in their 
study) on nebulised aerosols entering the nostril enhanced drug deposition on the MS wall by 
3-fold, 3.5-fold, and 4.4-fold, respectively. Using an in-vitro study, Durand et al. (2011) 
showed that a 100 Hz acoustic wave with a sound pressure level of 107 dB re 20µ (measured 
at the outlet) applied to the nostril could increase aerosol deposition in the MS 3-fold. Leclerc 
et al. (2014) also showed that the deposition of aerosols with MAD of 2.8 μm in the MS was 
increased 2- to 3-fold under the effect of a 100 Hz acoustic wave (the sound pressure level 
was not reported in that study) when compared with the non-acoustic condition. 
In a recent study by Hosseini et al. (2019) the effect of the anatomy of the nasal airway 
on drug delivery to the NC was investigated using the 3D printed models of nasal airways of 
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2-, 5- and 50-year old human subjects. They used a pulsating airflow with a frequency of 44.5 
Hz and amplitude of 24 mbar superimposed to the aerosol stream entering the nostril. They 
reported that the drug delivery to the MS in the adult subject under application of pulsating 
airflow was increased 4-fold when compared with uniform airflow (non-pulsating). They 
demonstrated that the anterior deposition in toddler/child NC is greater than that of adults, 
which leads to 3-11% decrease in MS deposition and 25% decrease in lung deposition 
showing the effect of age on MS drug delivery. Hosseini et al. (2019) also showed that the 
paranasal delivery increases significantly when a bidirectional breathing administration 
technique is used under pulsating airflow. Using the breathing administration technique under 
the effect of 45 Hz pulsating nebulisation, Farnoud et al. (2020) investigated the effect of 
inclination of nosepiece with respect to the horizontal axis. They showed that the pulsating 
airflow increased the overall particle deposition in the sinuses by 1.5-fold and 2.5-fold for the 
cases with a nosepiece inclination of 90
°
 and  45°, respectively, when compared with a 
uniform airflow (non-pulsating) demonstrating the effect of aerosol injection pattern at the 
nostril. Using a mask, double-head nozzle, and single-head nozzle at the nostril, (Dong et al., 
2020) investigated the effect of different aerosol injection pattern on drug delivery to the MS 
under the effect of pulsating airflow superimposed to the aerosol stream (the frequency and 
amplitude of pulsation were not reported in the publication). They found that the method of 
drug administration influence on the efficiency of drug delivery to the sinuses and reported 
that using a single-head nozzle the deposition of drug in the MS increased by 2-fold when 
compared with double-size nozzle. They also showed that no MS deposition occurred when 
a face mask was used.  
Initially, acoustic frequencies of 50 Hz and 100 Hz were superimposed onto 
nebulisation in ADD for sinus drug delivery (Navarro et al., 2019). Historically, these 
acoustic frequencies were discovered accidentally when researchers found dust deposition in 
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the sinuses of workers who worked with electrical rotating machines generating sinusoidal 
waves at frequencies of 50 Hz and 100 Hz (Navarro et al., 2019). However, this phenomenon 
has been questioned by recent studies, in which it was hypothesised that the underlying 
rationale of increased aerosol deposition in the sinuses is based on the principle of the 
Helmholtz resonator (Leclerc et al., 2014; Möller et al., 2014). 
 
Figure 5.2: (a) Schematic of a Helmholtz resonator; (b) schematic of a cross-section view of 
an NC-MS combination, reproduced from Xi et al. (2017) with permission from Elsevier. 
The neck and cavity of the Helmholtz resonator resemble the ostium and MS. VMS: Volume 
of the cavity (MS), Los: Length of the neck (ostium), Dos: Diameter of the neck (ostium) 
A Helmholtz resonator is an acoustical device, which is composed of a sphere cavity 
attached to a narrow tube (known as the neck) (von Helmholtz et al., 1875). When a 
Helmholtz resonator is in the presence of an external acoustic field, the air plug inside the 
neck oscillates at a frequency equal to that of the external acoustic field. The amplitude of the 
air plug oscillation in the neck changes according to the variation of the frequency of the 
external acoustic field, and it becomes maximum at a specific frequency called “resonance 
frequency” (Von Helmholtz & Ellis, 1875). At the resonance frequency of a Helmholtz 
resonator, maximum gas exchange between the cavity and the surrounding media occurs 
(Möller et al., 2014; Pourmehran, Cazzolato, et al., 2020b). For a Helmholtz resonator with a 
spherical cavity and a cylindrical neck (see Figure 5.2), the resonance frequency can be 
estimated by (Xi et al., 2017) 




Cavity ~ MS 
Oscillating air plug 















where c is the sound speed, S0 is the cross-section area of the neck (𝑆0 = 𝜋Dos
2 4⁄ ), VMS is the 
volume of the cavity, and Leq is the equivalent length of the neck, which can be obtained by 
Leq=Los+0.6Dos. Los is the length of the neck and Dos is the diameter of the neck. More 
accurate expressions, depending on the shape of the cavity and neck, can be derived (Alster, 
1972; Howard et al., 2000). A nose-sinus complex is similar to a Helmholtz resonator, where 
the sinus and ostium behave like the cavity and neck of the Helmholtz resonator, respectively. 
Hence, drawing on the principle of the Helmholtz resonator, if an external acoustic field is 
applied to the nostril at a frequency equal to the resonance frequency of the nose-sinus 
combination, the air exchange between the NC and the sinus should be maximised. The gas 
exchange between the NC and sinuses is the basic requirement for the transport of aerosols 
from the NC to the sinuses. 
In the ADD technique, the larger the oscillation amplitude of the air plug in the ostium, 
the greater the number of particles that are delivered to the MS (Pourmehran, Cazzolato, et 
al., 2020b). Hence, it is imperative to apply an acoustic field with a frequency equal to the 
resonance frequency of the NC-MS, in which the amplitude of the air plug inside the ostium 
is maximal. Limited studies have used the classic Helmholtz resonator equation to predict the 
resonance frequency of the NC-MS to be applied to the nostril for the application of ADD in 
drug delivery to the MS (Leclerc et al., 2015; Xi et al., 2017).  
 Leclerc et al. (2015) used the classic equation of Helmholtz resonator (where Leq=Los) 
to estimate the resonance frequency of a realistic NC-MS model. They reported that at the 
resonance frequency of the NC-MS combination, the aerosol deposition in the MS increased 
4-fold. Xi et al. (2017) investigated the deposition of aerosols with MAD of 3 µm in the MS 
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using Finite Element Method and experimental tests. Exploiting Equation (5-1), Xi et al. 
(2017) estimated the resonance frequency of a realistic NC-MS model and reported an 
increase of 6- to10-fold in aerosol deposition in the MS when compared to a case without 
acoustics. Pourmehran, Cazzolato, et al. (2020b) showed that the Helmholtz resonator 
equation overpredicts the resonance frequency of NC-MS by more than 30%, when compared 
with the experimental data. This discrepancy is due to the fact that the Helmholtz resonator 
equation was derived for a spherical cavity attached to a cylindrical neck, which is much 
different from a realistic NC-MS combination. Accordingly, the resonance frequency of the 
realistic nose-sinus complex estimated in the previous studies might be inaccurate. Hence, for 
previous studies it was not guaranteed that the air plug in the ostium was activating efficiently 
under the effect of the fixed acoustic frequency obtained by the Helmholtz resonator equation. 
So, the highest efficiency of drug delivery could not be achieved.  
In addition to the frequency of the inlet acoustic wave, aero-acoustic parameters, such 
as the inlet acoustic amplitude and breathing pattern (airflow rate), are vital components that 
play an important role in the ADD technique. Moreover, the size of the nebulised particles 
affects the efficiency of ADD. using an in-vitro study, demonstrated a weak deposition of 9.9 
μm particles but a significant deposition of 2.8 μm particles in the MS under the effect of a 
100 Hz acoustic wave. Recently, Pourmehran, Arjomandi, Cazzolato, and Tian (2020) 
examined the effect of particle diameter and density on the efficiency of ADD in a simplified 
NC-MS model using computational fluid-particle dynamics. Considering the acoustic Stokes 
number and particle entrainment coefficient, they demonstrated an increase in particle 
diameter and density decreases the efficiency of ADD to the MS which is in the line with the 
findings of Xi et al. (2017). Although the use of small nebulised particles (i.e. 2.8 μm) results 
in higher ADD efficiency, when the particle diameters are lower than 10 microns, the particles 
are easily transported to the lung, which is not the intended region for drug delivery to the 
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MS (Kulkarni et al., 2012). Finally, the effect of the nebulisation flowrate (the particle 
flowrate) coupled with a constant airflow rate has not yet been investigated in the literature. 
In this study, using nebulised aerosols with a median diameter of 12 μm, the effect of input 
acoustic frequency, amplitude, and particle flowrate on the efficiency of ADD to the MS is 
investigated. A realistic geometry of one-side of an NC-MS combination was used as a nasal 
replica.  
 Materials and Methods 
5.3.1  Nasal replica 
An NC-MS combination was manufactured with epoxy-based resin (Zortrax Resin BASIC) 
using a Zortrax Inkspire 3D printer with an accuracy of 0.05mm on the horizontal (X-Y) plane 
and 0.025mm along the vertical (Z) axis (along printing layer) at the University of Adelaide. 
The X-Y plane was perpendicular to the inlet of the nostril. The MS was extracted from a 
realistic NC-MS STL file (for a healthy person) adapted from Kumar et al. (2016) and the NC 
was extracted from a CAD model of human (healthy 25-year-old Asian male) upper airway 
adapted from Inthavong et al. (2008). To better understand the potential of the MS behaving 
as a Helmholtz resonator we decided to estimate the resonance frequency of the NC-MS and 
to investigate the ADD efficiency for drug delivery to the MS isolated from other sinuses and 
hence, all the sinuses except the MS were excluded from the model (Figure 5.3). The volume 
of the sinus was approximately 15 mL and the length and diameter of the ostium were 
approximately Los = 5.5 mm and Dos = 4.2 mm, respectively. To access the inside of the MS 
as well as to allow installation of a microphone for acoustic measurement, the NC-MS model 
was fabricated in three separate parts, P1, P2 and P3, as depicted in Figure 5.3 (b). For 
measuring the resonance frequency, the P3 was replaced by a microphone to detect the sound 
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at the response point. A tube with an inner diameter of 8 mm and a length of 9 cm was also 
attached to the nasopharynx (the nasopharynx has already been extended 1 cm in the original 
model) to stabilise the outlet flow for preventing the possible reverse flow from the outlet 
boundary into the NC-MS model induced by the surrounding airflow inside the fume hood 
where the experiments were conducted.  
 
Figure 5.3 (a) Reconstructed model of a realistic nose-sinus geometry; the MS was extracted 
from a realistic NC-MS STL file adapted from Kumar et al. (2016) and the NC was extracted 
from a CAD model of human upper airways adapted from Inthavong et al. (2008); (b) the 
dissembled 3D model of NC-MS representing different parts of 3D printed model; (c) 
assembled model of NC-MS used in experiments; (d) inside view of the NC-MS model. P1: 
part 1 comprising the NC, ostium, nostril, nasopharynx, and a portion of MS. P2: part 2 
which is a part of MS. P3: part 3 which blocks the holes of the MS wall (on P2). P3 is 
replaced with microphone for measuring the resonance frequency. P1-MS: the inner surface 
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5.3.2  Experimental setup 
Two different in-house experimental setups were used in this (in-vitro) study. The first 
experimental setup was used to estimate the resonance frequency of the NC-MS combination. 
In these experiments, an acoustic actuator (a loudspeaker) was used to generate a white 
broadband noise and applied to the nostril. Two 1 4⁄
′′
 microphones (Bruel and Kjaer®, Type 
4958), Mic 1 and Mic 2, were installed on the NC-MS model: Mic 1 was installed at the 
nostril which is termed as the input point and  Mic 2 was installed at the lateral wall of the 
MS termed as the response point by replacing with part P3 (see Figure 5.3 (a, b) and Figure 
5.4 (b)). The sound pressures at the input and response points were measured using the 
microphones and a Bruel and Kjaer Photon® signal analyser was used to estimate the transfer 
function (TF) and coherence. 
The second experimental setup was designed and used for the investigation of the drug 
delivery process and the impact of the variation in nebulisation parameters. A loudspeaker 
was connected to the nasal tip through a transparent flexible tube. The nasal tip was designed 
using Autodesk Inventor software and then manufactured by a Zortrax M200 printer (with an 
accuracy of 0.2mm for the X-Y plane and 0.09mm along the Z-axis). The nasal tip consists 
of two inlets and one outlet openings (see Figure 5.5 (c)). One of the inlets of the tip was 
connected to an acoustic signal generator (via the tube) and the other inlet was attached to the 
nebuliser head. The outlet of the tip was connected to the nostril on the 3D printed model. A 
vibrating mesh nebulizer manufactured by TEKCELEO® was used to inject the liquid 
droplets into the NC-MS combination through the nostril. In this study, a droplet generated 
by the nebuliser is termed as particle. The median diameter of the nebulized particles was 12 
µm, which is compliant with US Food and Drug Administration (FDA Guidance for industry 
2002; Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products - 
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Chemistry, Manufacturing, and Controls Documentation) to reduce the penetration of 





Figure 5.4. (a) 3D view and schematic diagram of the nasal tip used in the first experiments 
for the estimation of the resonance frequency of the NC-MS combination. The dimensions 
are presented in mm; (b) schematic of the first experimental setup used for measuring the 
resonance frequency of the NC-MS model. Mic pre-amp: Microphone preamplifier 
As recommended in the literature (Moghadam et al., 2018) and international standards 
(European standard procedure, NF EN 13544-1), 2.5 wt% sodium fluoride (NaF) was used as 
the drug tracer test solution. For each experimental test, 4 mL of 2.5 wt% NaF was nebulised 
and injected into the NC-MS combination through the nostril. Once the nebulization 
experiment was complete, the inlet and outlet of the NC-MS model were sealed and 
maintained stationary for 20 min to allow the suspended particles to deposit on the inner wall 
of the MS. To measure the deposition of nebulised droplets (i.e., NaF solution) in the MS, the 
inner surface of MS was washed with distilled water to collect the deposited F− ions. Then 
the concentration of F− ions was measured by an Ion-Selective Electrode (ISE) meter, using 
a fluoride electrode (BANTE Instrument) with an accuracy of 0.001 ppm. Given that the ion-
White noise 
Mic1 (input point) 
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selective electrodes measure the activity of the analyte, to stable the measurement the ionic 
strength of the solution should be enhanced to a relatively high level, which was achieved by 
TISAB-2 buffer. TISAB-2 was prepared by adding 2.7 ml of Acetic acid (98‐99%), 17.6 g of 
Sodium Acetate (anhydrous), and 8 g of Sodium chloride to 200 ml of DI water, then the 
mixture was transferred to a 250 ml flask and filled with distilled water and shaken well. The 
following protocol was used to measure the deposition of NaF: To be able to wash the inside 
of the MS with distilled water and collect the deposited NaF solution, part P2 was detached 
from part P1 (see Figure 5.3 (d)). To wash the inner wall of P1 (i.e., P1-MS), a silicon pin 
was used to seal the ostium opening hermetically to prevent leakage of the liquid through the 
ostium. A volume of 2.5 mL of distilled water was used for washing the surface P1-MS, and 
2 mL of distilled water was utilised for washing the inner wall of surface P2-MS. The washing 
process was carried out using a pipette. Eventually, the total amount of liquid was collected, 
and then 0.5 mL of TISAB-2 (total ionic strength adjustment buffer) was added to it (i.e., 
onetime buffer addition). A blank sample was taken before starting the experiments for each 
parameter (such as acoustic frequency, amplitude, and nebulisation flow rate). After the 
completion of each experiment, and to prepare the test section for the next experiment, the 
3D printed model of the NC-MS combination was washed out with distilled water to clean 
out any Fluoride contamination from the inner walls then the model was dried with hot air.  
After the completion of each experiment and to prepare the test section for the next 
experiment, the 3D printed model of the NC-MS combination was washed out with distilled 
water to clean out any Fluoride contamination from the inner walls then the model was dried 
with hot air.  
 
 






Figure 5.5.  (a) Schematic diagram of the second experimental setup; (b) an overview of the 
second experimental setup used for ADD conducted in a fume hood; (c) 3D view and 
schematic diagram of nasal tip excluding the microphone holder, which was used for 
measuring the acoustic pressure in the first experimental setup for estimating the resonance 
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As tabulated in Table 5.1, a total of 18 different case studies were considered to 
investigate the effect of input acoustic frequency (10 cases), acoustic amplitude (4 cases), and 
particle flow rate (4 cases) on the efficiency of ADD for the MS. The ADD efficacy in this 
paper is quantified by measuring the concentration of the Fluoride ions deposited on the MS 
wall and comparing them with that obtained via non-acoustic drug delivery (non-ADD). For 
all the parameters, the experiments were repeated four times to ensure the results were 
reliable. The results were presented as the “mean value ± standard deviation”.  
Table 5.1. Details of the case studies for the experimental tests 
Cases Input Frequency 
[Hz] 
Input SPL 
[re 20 µPa] 
particle flow rate 
[mL/min] 
1-10 100, 200, 250, 300, 328, 
356, 403, 450, 537, 585 
126 0.267 
11-14 328 113.4, 116.9, 120.6, 126 0.267 
15-18 328 126 0.059, 0.098, 0.138, 
0.267 
5.3.3 Numerical modelling 
In addition to the experiments, computational fluid dynamics (CFD) modelling was used to 
investigate the particle deposition and transportation patterns under an acoustic wave at the 
resonance frequency of the NC-MS combination. ANSYS® FLUENT 2020 R1 was used to 
simulate the particle dynamics in a realistic NC-MS model. The geometry of the realistic NC-
MS model, used in CFD modelling, was identical to that of the experiments; however, to 
reduce the computational cost the nasopharynx was restricted to 1 cm (Inthavong et al., 2008; 
Kumar et al., 2016). Due to the presence of an acoustic field, the fluid medium in this study 
was selected as compressible dry air and the density of the air was calculated using the ideal 
gas law. Sutherland’s third law (Sutherland, 1893) was used for calculating viscosity. The 
compressible transient nonlinear Navier-Stokes equations were solved using a pressure-based 
solver to resolve the airflow field in the presence of an acoustic field. The boundary condition 
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of the walls was set to be acoustically reflective and adiabatic. Zero-gauge pressure was 
selected for the outlet boundary condition, as well as the initial condition. For the prediction 
of resonance frequency of the NC-MS combination, a general non-reflecting boundary 
condition (NRBC) was applied to the inlet and outlet boundaries. To resolve the momentum 
and energy equations, density, and pressure, the QUICK, third-order MUSCL, and second-
order spatial discretization methods were utilised, respectively. Finally, the transient 
formulation was resolved using the second-order implicit method. 
To predict the resonance frequency of the proposed model (without the nasopharynx 
extension) using CFD, an acoustic sweep in a range of frequencies from 150 Hz to 800 Hz 
was applied to the inlet as a pressure-inlet boundary condition given by (Pourmehran, 
Cazzolato, et al., 2020b): 




where p(t) is the time-dependent pressure, and A is the amplitude of the incident pressure. f0, 
f1, and Ts are the starting angular frequency, final angular frequency, and the required time 
for the acoustic wave to sweep from f0 to f1. A total of 1,280,000 polyhedral elements were 
generated using the polyhedral elements with two prism layers near the wall boundaries. The 
polyhedral elements were used for mesh generation because of its advantages, such as a 
shorter run-time, a higher accuracy in determining wall shear stress, and a better convergence 
(Spiegel et al., 2011). Moreover, a time-step of ∆𝑡 = 1μs was used for the simulation of the 
flow and particle phases, which meets the acoustic courant number required for direct 
computational aero-acoustic analysis. Figure 5.6 Shows the mesh generated for the proposed 
realistic NC-MS model. To evaluate the accuracy of the CFD model, the predicted resonance 
frequency of the NC-MS combination, excluding the nasopharynx extension, was compared 
with the resonance frequency obtained through the first experimental setup. 
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A time-independent transfer function estimate (TF estimate) was used to predict the 
resonance frequency of the NC-MS model. The TF estimate models a linear relationship 
between the input (i) and response (j) acoustic waves. The input time-series acoustic wave 
was obtained by recording the pressure fluctuation at the inlet boundary (input point) and the 
response time-series acoustic wave was detected via recording the pressure fluctuation at the 
response point (see Figure 5.3 (a)). The peak value of the TF estimate in the frequency domain 





where 𝑓 is the acoustic frequency at the input point, 𝐺𝑖𝑗 is the cross-power spectral density 
between the input and the response, and 𝐺𝑖𝑖 is the power spectral density of the input acoustic 
wave. The reliability of the pressure fluctuations, recorded at the input and response points, 






where 𝐶𝑖𝑗(𝑓) is the Coh estimate, which quantifies the degree of linearity between the input 
and response acoustic waves and gives a value between 0-1. A zero value of Coh indicates 
that there is no relationship between the input and response acoustic wave; however, a unit 
value of Coh implies that the pressure fluctuation recorded at the input point is perfectly 
coherent with the acoustic wave applied to the inlet boundary and the signals from other 
sources are screened out (Pourmehran, Cazzolato, et al., 2020b).  
For modelling the two-phase flow and to capture the impact of flow on nebulised 
particles, a Lagrangian particle tracking approach, which employs a discrete phase model 
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(DPM), was used for the particle tracking simulation. In this approach, the trajectories of the 
particles can be tracked by integrating the equation of force balance on every particle. In this 
study, the force balance equation, which equates the particle inertia with the forces acting on 
the particle, is composed of gravitational and drag forces (Pourmehran, Cazzolato, et al., 
2020b). The acoustic radiation force has been neglected in this study since its effect on 
particle movement is significant in ultrasonic medium, while the acoustic field used in this 
study is in a low-frequency range (<1000 Hz). The effect of all forces exerting on a particle 
in an acoustic field has been discussed in Pourmehran, Cazzolato, et al. (2020b), which 
provides more details on the significance of forces acting on a moving particle in an acoustic 
field.  
 
Figure 5.6. (a) an overview of the polyhedral mesh generated for the realistic NC-MS model 
used in CFD simulation, (b) a close-up view of the ostium and MS; (c) polyhedral mesh at 
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 Results and discussion  
5.4.1  Acoustic analysis 
The resonance frequency of the NC-MS combination was estimated using the first 
experimental setup. The experimental data indicated that the resonance frequency of the NC-
MS model of this study is f
r
=328 Hz. Figure 5.7 (a) shows the transfer function (TF) and 
coherence (Coh) estimates between the nostril (input) and MS (response). It should be noted 
that the resonance frequency of the MS occurs at the peak value of the TF estimate. As can 
be seen in Figure 5.7 (a), the TF estimates show three peak values. The first peak value at f = 
50 Hz is associated with electrical noise, the second peak value at f
r
 = 328 Hz is the resonance 
frequency of the NC-MS, and the third peak value is due to the resonance of the NC 
(Pourmehran, Arjomandi, Cazzolato, Ghanadi, et al., 2020). Figure 5.7 (b) represents the 
pressure amplitude (dB re 20 µPa) measured at the nostril and MS. As can be seen in this 
figure, the difference between the sound pressure level (SPL) at the nostril and the MS is 
maximised at f = 328 Hz, which confirms that the resonance frequency of the NC-MS 
combination occurs at the second peak value of the TF estimate. The resonance frequency of 
the NC-MS combination was also estimated using the Helmholtz resonator equation 
(Equation (5-1)). Considering the MS volume of 15 mL ostium length of Los = 5.5 mm, and 
ostium diameter of Dos = 4.2 mm, the resonance frequency of the NS-MC combination was 
estimated as f
r
=585 Hz. The difference in the resonance frequency estimated by Equation 
(5-1) and the experimental data originates from the difference between the geometry of the 
realistic NC-MS combination and a Helmholtz resonator. The middle meatus affects the 
resonance frequency of the NC-MS combination while Equation (5-1) does not account for 
the presence of middle meatus (Pourmehran, Cazzolato, et al., 2020a).  
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 (a) (b) 
  
Figure 5.7. a) Transfer function and coherence estimates between the sound pressure at the 
nostril and the MS; b) Sound pressure level (SPL) between the input and response points 
versus frequency. The anatomical location of the input and response points are represented 
in Figure 5.3 (a). 
In the first series of experiments, the aerosol deposition on the MS wall was measured 
under the effect of an acoustic signal, characterised by a fixed frequency applied at the inlet 
to the nostril (see Figure 5.5 (c)). For each experimental test, the input acoustic signal was 
characterised by a specific frequency applied at the inlet to the nostril to agitate the nebulised 
aerosol (NaF) entering the nostril; then the concentration of NaF deposited on the MS wall 
was measured at high accuracy. In terms of the input frequency, in addition to the resonance 
frequency of the NC-MS combination estimated in the first experimental setup, (328 Hz), and 
Helmholtz resonator equation, (585 Hz), four frequencies (100 Hz, 200 Hz, 250 Hz, 300 Hz) 
that are lower than the resonance frequency and four frequencies (356 Hz, 403 Hz, 450 Hz, 
537 Hz) that are higher than the resonance frequency were selected for application to the 
nostril as additional case studies.  The first four frequencies were selected to cover a broad 
range of TF estimate at frequencies lower than the resonance frequency. The second four 
frequencies (356-537Hz) were chosen to match the amplitude of the transfer function to the 
first four frequencies. The rationale behind the selection of those two groups of off-resonance 
frequencies is to realise the relationship between the TF estimate and ADD efficiency in 
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addition to understanding the effect of acoustic frequency on the efficiency of ADD. In total, 
10 different sinusoidal acoustic signals, with a fixed sound pressure level of almost 126 dB 
re 20µPa, were applied to the nostril and then the SPL at the input and response points were 
measured.  
Figure 5.8 shows the effect of the input frequency on the SPL at the response point 
for a fixed input SPL. The SPL in the MS increases when the inlet frequency reaches the 
resonance frequency. At the resonance frequency, the maximum SPL in the MS occurs, which 
implies that the pressure fluctuation in the MS is at its maximum at the resonance frequency 
of the NC-MS combination. Given that the MS is connected to the ostium, the oscillation of 
the air in the MS is directly interconnected to the oscillation of air plug in the ostium. 
Accordingly, the amplitude of the oscillation of the air plug in the ostium becomes maximal 
at the resonance frequency in which the highest air exchange between the NC and MS takes 
place through the ostium. So, it is expected to achieve the highest efficiency of the ADD at 
the resonance frequency of the NC-MS combination, which is investigated in the following 
section. 
 
Figure 5.8. The effect of input acoustic frequency on the sound pressure level (SPL) in the 
MS (response) and at the nostril (input) 
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The resonance frequency of the proposed NC-MS model used for CFD simulation 
was obtained fr=352 Hz as illustrated in Figure 5.9 (a). According to this figure, the results of 
CFD showed good agreement with the resonance frequency calculated in the experiments 
(fr=392 Hz), with a discrepancy of 10%. Figure 5.9 (b) presents the magnitude-squared 
coherence estimate between the input and response points for both the experimental and CFD 
results. This figure shows that the value of Coh is close to unity for CFD modelling 
demonstrating the reliability of the pressure field obtained in CFD modelling. Herein, to 
reduce the computational cost (by reducing the number of mesh) the nasopharynx was 
extended only 1 cm rather than 10 cm. However, for drug delivery modelling, the 
nasopharynx was extended 10 cm to prevent the reverse flow. 
(a) (b) 
 
Figure 5.9. a) Transfer function estimate; and (b) coherence estimate between the input and 
response points obtained by computational fluid dynamics (CFD) and experimental test 
(Exp). To reduce the computational cost the nasopharynx was extended only 1 cm rather 
than 10 cm 
5.4.2 Effect of acoustic frequency on ADD efficacy 
Figure 5.10 shows the effect of input frequency on the concentration of aerosol (NaF) 
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compared with non-ADD. As can be observed in Figure 5.10, the highest deposition of NaF 
on the MS wall occurs when the input acoustic frequency is characterised by 328 Hz (the 
resonance frequency estimated experimentally). The deposition of NaF on the MS wall is 
high at the frequencies of 250 Hz, 300 Hz, and 356 Hz, and is low at the frequency of 450 
Hz, compared with the non-ADD case. However, the effect of superposition of the acoustic 
wave at the frequencies of 100 Hz, 200 Hz, 403 Hz, 537 Hz, and 585 Hz (the resonance 
frequency obtained by the Helmholtz resonator equation) is negligible compared with the 
absence of a superimposed acoustic wave. When the statistical significance test was applied 
to the deposition results, it was found that ADD with an input frequency of 328 Hz and 
amplitude of 126 dB re 20µPa increased the concentration of NaF deposited on the MS wall 
75-fold compared with non-acoustic nebulisation.  
 
Figure 5.10. The effect of input frequency on aerosol deposition in the MS when the input 
acoustic amplitude is 126 dB, and the particle flowrate is Qp =0.267 mL/min. Control 
experiments correspond to the non-ADD case with particle flowrate of 0.267 mL/min. ns 
(not significant) p > 0.4, *p < 0.03, **p = 0.0089, and ****p < 0.0001 by one-way ANOVA 
with Tukey post hoc test. The right vertical axis represents the ration of the NaF 
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It might be expected that the deposition of NaF on the MS wall is enhanced when the 
SPL in the MS increases, and does not change when the SPL in the MS is constant at different 
frequencies. However, by comparing Figure 5.8 and Figure 5.10, it was found that this 
expectation was not true for all input frequencies. It was only true for cases with input 
frequencies of 300 Hz and 356 Hz, with an amplitude of 126 dB re 20µPa, in which the SPL 
in the MS was obtained at 138.4 dB re 20µPa and 138.2 dB re 20µPa, respectively. These 
two SPL values are almost equal since the accuracy of the microphones was 0.2 dB re 20µPa. 
When these two frequencies, 300 Hz and 356 Hz, were superimposed on the nebulised 
aerosols entering the nostril, the concentration of NaF collected from the MS wall was 
obtained as 4.9 ppm and 4.4 ppm, which are statistically equal when compared with non-
ADD (≈ 0.1 ppm).  
For the cases with input frequencies of 250 Hz and 403 Hz, with an amplitude of 126 
dB, the concentration of deposited NaF are significantly different (4.5 ppm and 1.1 ppm, 
respectively), although the corresponding SPL in the MS are almost equal for both cases 
(131.5 dB re 20µPa and 130.7 dB re 20µPa, respectively). The difference in the deposition of 





where 𝛿, 𝑣, and 𝑓 are the particle displacement in an acoustic field, particle velocity, and the 
acoustic frequency, respectively. If two acoustic signals with different frequencies have the 
same SPL, then they should have the same particle velocity (at least this is the case for free 
field sound propagation). Therefore, according to Equation (5-5) the particle displacement at 
250 Hz will be 1.6-fold as much as 403 Hz for the same particle velocity. Moreover, during 
the experimental tests for the cases with input frequencies of 200 Hz and 403 Hz, some 
particles were thrown into the tube that connects the speaker to the nasal tip. This observation 
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reveals that a portion of the nebulised particles were deposited on the nasal tip, which resulted 
in a decrease in the number of particles passing through the NC and ostium opening. This 
might imply that the nasal tip was at resonance at the frequencies of 200 Hz and its harmonics, 
which resulted in aerosol deposition on the inner wall of nasal tip. Hence, the deposition of 
the NaF under the effect of the acoustic frequencies of 200 Hz and 403 Hz decreased 
significantly compared with 450 Hz and 250 Hz (see Figure 5.10), even though their 
corresponding SPLs in the MS were identical (see Figure 5.8).  
5.4.3  Effect of acoustic amplitude on ADD efficacy 
The amplitude of the acoustic wave, superimposed on the nebulised particles, has a direct 
relationship with the amplitude of the sound pressure in the MS, which controls the amplitude 
of the oscillation of the air plug in the ostium. Figure 5.11 (a) shows the SPL at the nostril 
versus the SPL in the MS, at a fixed frequency of 328 Hz (resonance frequency). From this 
figure, it is obvious that the SPL in the MS increases with a linear trend when the input SPL 
increases. Figure 5.11 (b) presents the effect of input SPL on the concentration of NaF 
deposited in the MS. It is clear from this figure that increasing the input SPL enhances the 
deposition of NaF in the MS. It is clear from this Figure that increasing the input SPL 
enhances the deposition of NaF in the MS. Figure 5.11 (b) shows that increasing the input 
acoustic amplitude increases the aerosol deposition in the MS. However, increasing the 
amplitude from 120dB upwards did not have a significant effect on the aerosol deposition, 
which might imply that at certain acoustic amplitude a saturation point for the aerosol 
deposition is reached. This figure also reveals that at the input SPL of 113.4 dB re 20µPa and 
lower, the deposition of NaF in the MS is not significant when compared with non-ADD 
(input SPL=0). 
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Figure 5.11. (a) SPL at the nostril versus SPL in the MS at a frequency of 328 Hz; (b) effect 
of the input acoustic amplitude on the aerosol deposition in MS when the input frequency is 
328 Hz and particle flowrat is 0.267 mL/min. Control experiments correspond to the non-
ADD case with particle flowrate of 0.267 mL/min. ns > 0.4, *p < 0.05, **p < 0.001, and 
****p < 0.0001 by one-way ANOVA with Tukey post hoc test. 
5.4.4  Effect of particle flowrate on ADD efficacy 
In this study, a mesh nebuliser was used to nebulise the 2.5%wt NaF. Unlike the 
compressor nebuliser, the mesh nebuliser does not blow out the nebulised particles using 
compressed air but instead throws the nebulised particles through a vibrating meshed surface. 
The frequency of the vibration of the meshed surface indicates the nebulisation flowrate (Qp), 
which increases with an increase in the vibration frequency. In this study, the nebulisation 
flowrate refers to the flowrate of nebulised particles entering the nostril, so we call it the 
particle flowrate. By using an Arduino board connected to the nebuliser controller, four 
different particle flowrates, including Qp=0.059 mL/min, Qp=0.098 mL/min, Qp=0.138 
mL/min, and Qp=0.267 mL/min were used. To measure the flowrate of the particles entering 
the nostril, the nebuliser tank was filled with 100 mL of 2.5%wt NaF and the time required 
for nebulisation of it was recorded for different frequencies of the vibration of the meshed 
surface of the nebuliser. A large number of nebulised particles deposited in the nebuliser head, 
which were collected in a reservoir as the waste and then the volume of it was measure by a 
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pipette. In all experiments, the waste of the nebulisation of 100 mL of NaF was 96±0.2 mL 
demonstrating that almost 4 mL of nebulised particles could enter the nostril. Hence, the 
particle flowrate could be simply estimated by dividing the time required for the nebulisation 
of 100 mL of 2.5%wt NaF by 4 (mL).  
Figure 5.12 shows the effect of the particle flowrate on the deposition of NaF on the 
MS wall under the effect of an acoustic frequency of 328 Hz and SPL of 126 dB re 20µPa, 
superimposed on the inlet nebulised particles. All the experiments were conducted for a 
condition that 4 mL of nebulised particles enter the nostril. The control case in Figure 5.12 
corresponds to the NaF deposition with the highest nebulisation flowrate (Qp=0.267). It is 
obvious from this figure that the concentration of NaF deposited on the MS wall with a 
particle flowrate of 0.059 mL/min is about twice that of the control case (a particle flowrate 
of 0.267 mL/min). However, the time required for 4 mL of the drug tracer to enter the nostril 
under the effect of a particle flowrate of 0.059 mL/min is 4.5 times longer than that of 0.267 
mL/min (68 minutes versus 15 minutes). On the other hand, there is no significant difference 
between the deposition of NaF under the effect of particle flowrates of 0.098 mL/min and 
0.138 mL/min when compared with the control case. Their corresponding nebulisation times 
are 2.7 times and 2 times longer than that of the control case, respectively. Therefore, a 
particle flowrate of 0.267 mL/min can be regarded as an optimised value for ADD to the MS. 
It should be noted that, the results are valid for the NC-MS model used in this study. A series 
of different realistic nose models should be analysed experimentally to generalise the particle 
flowrate. 
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Figure 5.12. The effect of particle flowrate on aerosol deposition. Control experiments 
correspond to the particle flowrate of 0.267 mL/min. ns > 0.24, ****P < 0.0001 by one-way 
ANOVA with Tukey post hoc test. 4 mL of 2.5% wt NaF was nebulised for all cases. 
5.4.5 Droplet formation around the ostium in the MS 
In some of the experiments with acoustic inputs, some droplets were observed in the MS but 
around the edge of the interface of the of the ostium and MS (see Table 5.2). The droplets 
were observed when the P2 part of the MS was detached from P1, whilst undertaking the 
washing process. The size of droplets varied in different cases and no droplets were observed 
for most cases by naked eyes. Figure 5.13 shows the formation of droplets around the ostium 
edge for a case with an input acoustic frequency of 328 Hz (resonance frequency), input SPL 
of 126 dB, and particle flowrate of 0.267 mL/min, in which the concentration of the NaF 
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Droplet size observed around the MS 
opening 
100 124 0.267 Not visible 
200 126 0.267 Not visible 
250 126 0.267 Small 
300 126 0.267 Small 
328 126 0.267 Large 
356 126 0.267 Small 
403 126 0.267 Not visible 
450 126 0.267 Not visible 
537 126 0.267 Not visible 
585 125 0.267 Not visible 
328 113.4 0.267 Not visible 
328 116.9 0.267 Not visible 
328 120.6 0.267 Average 
328 126 0.138 Average 
328 126 0.098 Large 
328 126 0.059 Large 
The reason for the formation of droplets is due to the high area concentration of 
particles on the trailing edge of the ostium. At the interface of the ostium and MS, the air 
velocity reduces (Pourmehran, Cazzolato, et al., 2020b) and hence the particles leave the flow 
and land on the surface. This means we need to make sure that the flow is fast enough to carry 
the particles into the MS. This also implies that the smaller the particles, the longer they 
remain in the flow and be carried into the MS. To understand more about the details of ADD 
to the MS, as well as the formation of droplets in the MS, a CFD model was developed. In 
the CFD modelling, particles were distributed randomly in the NC around the ostiomeatal 
complex (OMC), under the effect of an inlet frequency of 352 Hz (the resonance frequency 
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Figure 5.13. (a) A photo of droplets (large-size) deposited around the ostium edge in the MS 
after applying acoustic drug delivery before washing the MS wall for an input acoustic 
frequency of f=328 Hz, the amplitude of 126 dB re 20µPa, and particle flowrate of Qp = 0.267 






Large droplet size Average droplet size 
Small droplet size Non visible 
(a) 
(b) 
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Figure 5.14 (a) shows the distribution of the particles (black colour) before applying the 
acoustic wave. Figure 5.14 (b-c) represents the particle transportation and deposition pattern 
after 70 cycles. It is clear from these figures that many particles (approximately 9% of 
initially-distributed particles) were transported from the NC to the MS after 0.2 s. From Figure 
5.14 (b-c) it can be seen that some particles were deposited on the MS wall around the ostium 
edge (red dots). It can be inferred that the deposition of liquid particles on the ostium wall 
(blue dots in Figure 5.14 (c)) and on the corner of ostium and MS (red dots Figure 5.14 (c)) 
increases over time and eventually generate droplets in these areas, which are similar to 
droplets that were observed in the experiments (Figure 5.13). According to the results of the 
CFD modelling, not only do some particles deposit (form the droplets) around the ostium 
edge, but many particles are also delivered into the MS, which will eventually deposit on its 
wall.  
According to Figure 5.14, the reason for the absence of particles in the anterior and posterior 
regions of the NC, which is in contrast with Siu et al. (2019), is that the particles were initially 
released in the middle part of the NC with zero velocity to reduce the computational cost. The 
focus of CFD modelling in this study was to visualise the effect of the acoustic wave on 
particle movements in the NC-MS combination as well as to investigate the particle 
deposition in the ostium and MS; hence the mean flow rate was ignored (zero inlet airflow 
velocity was assumed) and particles were distributed in the NC with zero velocity and then 
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(c)   
 
Figure 5.14. (a) CFD simulation of particles distribution in the NC before applying input 
acoustic wave; (b) Top view and (c) frontal view of particles deposition and transport pattern 
in NC-MS model after 70 cycles under the effect of input frequency of f = 352 Hz, amplitude 
of 126 dB re 20µPa. The black dots show the particles suspended in the computational 
domain, the red, blue, and green dots show the particles deposited on the MS, ostium, and 
NC walls, respectively. The blue and red dots are scaled up to better visualised the deposited 
particle in 70 cycles. The deposition of particles in the NC (green dot) has been ignored to 
display in Figure 5.14 (c) to focus on the deposition of particles in the ostium and MS. 
MS Ostium 
Nostril 
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 Conclusion 
The main goal of the current study was to determine the vital components that play an 
important role in ADD for the MS. The effect of different parameters, including the input 
acoustic frequency, amplitude, and particle flowrate on the deposition of aerosols in the MS, 
using the ADD technique, was investigated. The exact resonance frequency of the NC-MS 
model was measured experimentally. An experimental setup was used to conduct the drug 
delivery simulation and a CFD model was also developed to simulate particle tracking in a 
realistic model of NC-MS. 2.5 wt% NaF was used as a drug tracer, nebulised with a mesh 
nebuliser. One of the more significant findings to emerge from this study is that applying an 
acoustic wave to the nostril at the resonance frequency of the NC-MS combination can 
significantly increase the deposition of aerosols in the MS. For the NC-MS model used in this 
study, superimposing an input frequency of 328 Hz and amplitude of 126 dB re 20µPa on 
nebulised aerosol (12 µm) entering the nostril with a particle flowrate of 0.267 mL/min 
increased the concentration of NaF deposited in the MS 75-fold. The experimental data 
showed that increasing the input acoustic amplitude increased the aerosol deposition in the 
MS. However, increasing the amplitude from 120 dB re 20µPa upwards did not have a 
significant effect on the aerosol deposition, which might imply that at certain acoustic 
amplitude a saturation point for the aerosol deposition is reached. This study also found that 
although decreasing the flowrate of particles entering the nostril increases the aerosol 
deposition in the MS, the time-duration of nebulisation of a fixed volume of drug solution 
increases significantly, making treatment tedious. Hence, it is important to find an optimised 
particle flowrate, which was found to be 0.267 mL/min for this study.  
The findings in this study are subject to the following limitations: the experiments used a one-
sided nose-sinus model excluding the frontal, ethmoid, and sphenoid sinuses; neglected 
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mucociliary transport; and incorporated the use of NaF as the drug tracer. In CFD modelling, 
the humidity of the air was neglected, one-way coupling of fluid and particle was used, and 
randomly distributed particles were seeded in the NC after 20 acoustic cycles, which is a 
simplification of the particle flowrate during actual ADD. Nevertheless, neglecting the 
particle initial velocity could circumvent the complexity of the aerodynamics in the NC and 
focus on the influences from the acoustic waves.  
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In the previous section, it was found that using a well-designed acoustic wave, the drug 
deposition in the MS increased by >45-fold. It was shown that the particle deposition in the 
MS changes with the mass flow rate of particles entering the nostril, even though an optimal 
acoustic wave was used. This implies that the efficiency of acoustic drug delivery (ADD) not 
only depends on the aero-acoustic parameters but also depends on the concentration of 
particles passing the middle meatus (MM). Hence, an increase in the concentration of 
particles passing the MM can increase the ADD efficiency. In this chapter, the effect of flow 
parameters such as turbulence and swirl and the diameter of the nozzle for injecting particles 
on the performance of drug delivery to the maxillary sinus (MS) is studied. The MS is 
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perpendicularly connected to the NC through the ostium, which is connected to the main route 
of the nasal cavity. The aerosolised drug delivery to the olfactory region is limited due to the 
convoluted anatomy of the NC in the MS, where the airflow rate and particle transport are 
negligible. Previous studies have shown that the ventilation in the MM is much lower than 
the ventilation of the main nasal passage and inferior meatus, which contributes to low drug 
delivery to the MS. Ari et al. (2015) showed experimentally that different inhalation mask 
shapes affect the performance of drug delivery to the lung. It can be implied that the inlet 
airflow parameters and distribution of the particles at the nostril can influence the deposition 
and transport of the particles in different regions of the NC. In this chapter, the effect of inlet 
flow parameters such as turbulent and swirling flows, as well as the effect of the nozzle 
diameter, on the airflow behaviour and drug (particle) delivery to the MS were investigated. 
CFD models using a hybrid RANS-LES model and laminar solver were developed and cross-
validated with the available experimental data. A Eulerian-Lagrangian approach was used for 
the prediction of particle trajectories. The models developed and the discussions made in this 
chapter address the fourth objective of this work: “to develop a computational fluid dynamics 
(CFD) model to investigate the effect of the inlet flow parameters and the nozzle diameter on 
the particle transport/deposition in a realistic NC-MS combination”. 
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Effect of the inlet flow profile and nozzle diameter on drug 
delivery to the maxillary sinus 
Oveis Pourmehran1, Benjamin Cazzolato1, Zhao Tian1, Maziar Arjomandi1 
School of Mechanical Engineering, The University of Adelaide, Adelaide, SA, Australia 
 Abstract 
In this paper, the effect of inlet flow turbulence and swirling, and nozzle diameter on flow 
features and particle transport/deposition patterns in a realistic combination of the nasal cavity 
(NC) and maxillary sinus (MS) were examined. A computational fluid dynamics (CFD) 
model was developed in ANSYS® Fluent using a hybrid Reynolds averaged Navier–Stokes–
large eddy simulation (RANS-LES) algorithm. For the validation of the CFD model, the 
pressure distribution in the NC was compared against the available experimental data in the 
literature. An Eulerian-Lagrangian approach was employed for the prediction of the particle 
trajectories using a discrete phase model. Different inlet flow conditions were investigated, 
with turbulence intensities of 0.15 and 0.3, and swirl numbers of 0.6 and 0.9 applied to the 
inlet flow at a flow rate of 7 L/min. Monodispersed particles with a diameter of 5 µm were 
released into the nostril for various nozzle diameters. The results demonstrate that the nasal 
valve plays a key role in nasal resistance, which damps the turbulence and swirl intensities of 
the inlet flow. Moreover, it was found that the effect of turbulence at the inlet of the NC on 
drug delivery to the MS is negligible. It was also demonstrated that increasing the flow swirl 
at the inlet improves the total particle deposition due to the generation of the centrifugal force, 
                                                 
1 Corresponding author. Present address: School of Mechanical Engineering, the University of Adelaide, 
North Terrace, Adelaide, SA, 5005, Australia. 
Email address: oveis.pourmehran@adelaide.edu.au (Oveis Pourmehran) 
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which acts on the particles in the nostril and vestibule. The results also suggest that the drug 
delivery efficiency to the MS can be increased by using a swirling flow with a moderate swirl 
number of 0.6. It was found that decreasing the nozzle diameter can increase drug delivery to 
the proximity of the ostium in the middle meatus, which subsequently increases the drug 
delivery to the MS. 
Keywords: Computational fluid dynamics; Drug delivery; Maxillary sinus; RANS-LES 
Nomenclature 
𝐶d drag coefficient [-] 𝑆n swirl number [-] 
𝐶f fullness coefficient (𝐷N 𝐷in⁄ ) [-] 𝜏𝑖𝑗,LES Reynolds stress tensor 
𝐶p concentration of particles [%] 𝜏𝑖𝑗,RANS subgrid-scale stress tensor  
dae equivalent aerodynamic diameter [m] 𝜏p particle relaxation time [s] 
dp particle diameter [m] TIin inlet turbulence intensity [-] 
𝐷in diameter of inlet (nostril) [m] TImax max turbulence intensity [-] 
𝐷N nozzle diameter [m] 𝑈 mean fluid velocity [m/s] 
∆ maximum length of hexahedral cell [m] 𝑢 fluid velocity [m/s] 
i local deposition efficiency per unit of 
area [%/m] 
𝑢𝑎 axial velocity[m/s] 
T total deposition efficiency [%] 𝑢p particle velocity [m/s] 
𝑓 frequency of breathing [Hz] 𝑢t tangential velocity [m/s] 
𝐹C centrifugal force [N] W Womersley number [-] 
𝐹g gravitational force [N] y
+ normalised wall distance [-] 
𝐹D drag force [N]   
𝑓𝑠 shielding function   
𝑔 gravitational acceleration [m/s2] Abbreviations 
IP inertial parameter [µm2 cm2/s]   
k turbulent kinetic energy [m2/s2] ADD acoustic drug delivery 
𝐿 characteristic length [m] CAD computer-aided design 
𝑚p particle mass [kg] CFD computational fluid dynamics 
𝜇 dynamic viscosity of fluid [kg/m.s] LES large eddy simulation 
Np
 dep number of deposited particles [-] MM middle meatus 
𝑁p number of particles [-] MS maxillary sinus 
Np
 r number of particles released at the inlet 
[-] 
NC nasal cavity 
𝑁p
∗ particles’ retention criterion [s] RANS Reynolds-Averaged Navier–
Stokes 
𝜌𝑓 density of fluid [kg/m
3]   
𝜌p density of particle [kg/m
3] SBES Stress-Blended Eddy 
Simulation ω specific dissipation rate [1/s] 
𝑅 radius of inlet (nostril) [m] SST 
STL 
Shear Stress Transport 
stereolithography 𝑆m source term 
𝑆𝑡 Stokes number [-] WALE Wall-Adapting Local Eddy-
Viscosity 
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 Introduction 
The nasal cavity is an important organ in the human body with critical functions such as 
humidification and heating the inhaled air, and filtration of the pollutants from the inhaled air 
(Drettner et al., 1977; Keck et al., 2000). The surface of the nasal cavity is mostly lined with 
mucosa. The mucosa is highly vascularized, such that the amount of the blood flow to the 
surface of the NC is higher than that of the blood flow to the brain (Mygind et al., 1978). The 
mucosal surface of the NC, which is highly vascularized, provides an attractive route for the 
treatment of sinus-related diseases, such as chronic rhinosinusitis (CRS)(Bell et al., 2012; 
Rissler et al., 2012; Wichers et al., 2006).  
The human NC is constructed by convoluted airways. The maxillary sinus (MS) is 
located on the lateral side of the NC, where it is difficult to access (see Figure 6.1 (b)). The 
only opening that can accommodate the delivery of medication to the MS is the ostium which 
is located in the middle meatus (MM). The locations of MS contribute to some of the 
challenges for achieving efficient drug delivery to those regions because most inhaled 
medications either deposit in the anterior region or pass through the inferior meatus and the 
main passage of the NC, which are far from the target site, the middle meatus and the MS 
(see Figure 6.1 (b)) (Bahadur et al., 2012; Xi et al., 2015).  
For drug delivery to the MS, two components should be considered: the delivery of 
the drug to the MM where the ostium is located, and the delivery of the drug particles from 
the MM to the MS (see Figure 6.1 (b)). The latter component has already been investigated 
in previous studies, which showed that nasal sprays and standard nebulisers (either jet or mesh 
nebulisers) are not able to efficiently deliver aerosolised medications into the MS (Berger et 
al., 2007; Hilton et al., 2008; Möller et al., 2014; Wofford et al., 2015). Instead, an active 
drug delivery technique is required to drive the drug particles from the MM to the MS. Studies 
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have shown that the most efficient, non-invasive, and low-cost method is acoustic drug 
delivery (ADD) (Navarro et al., 2019). 
In ADD, an acoustic wave is superimposed to the aerosol entering the NC through the 
nostril. The acoustic wave leads to the oscillation of the airflow in the NC, which causes a 
pressure difference between the NC and MS resulting in enhanced flow exchange between 
the NC and MS (Leclerc et al., 2015). The momentum exchange between the MS and NC is 
the primary requirement for the delivery of the drug particles to the MS through the ostium. 
The performance of ADD for MS highly depends on the aero-acoustic parameters such as 
input frequency and sound pressure level (SPL) (Durand et al., 2011). Several studies have 
investigated the aerosol deposition in the MS using ADD with different input frequencies and 
SPL, which demonstrated a 3- to 4-fold increase in the aerosol deposition in the MS compared 
with conventional nebulisation without acoustics (Durand et al., 2011; Leclerc et al., 2014; 
Maniscalco et al., 2013; Maniscalco et al., 2006). In the recent study by the authors (which 
has not been published at the time of submission of the current paper), using a well-designed 
acoustic wave, the drug deposition in the MS was increased by 45-fold. They showed that the 
particle deposition in the MS changes with the mass flow rate of particles entering the nostril 
even though an optimal acoustic wave was applied to the nostril. This implies that the 
efficiency of ADD not only depends on the aero-acoustic parameters but also depends on the 
concentration of particles passing through the MM. Hence, an increase in the concentration 
of particles passing through the MM can increase the ADD efficiency proportionally, which 
is related to the former component of drug delivery to the MS, as mentioned above.  
Various delivery methods and devices are available for nasal drug delivery such as 
nasal sprays and nebulisers. Nasal sprays produce particles with diameters in the range of 
50m-100m, which almost entirely deposit in the anterior region of the nasal cavity. The 
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main reason for the deposition of most sprayed particles in the nasal valve is related to the 
high velocity and the large size of the particles (Inthavong, Ge, et al., 2011; Kimbell et al., 
2007; Suman et al., 1999). Hence nasal sprays are not capable of delivering the particles to 
the meatuses and posterior regions of the NC, which limits their application for delivery of 
medication to the MS (Shi et al., 2006; Shi et al., 2007; Tong et al., 2016; Xi et al., 2008).  
(a) (b)  
 
 
Figure 6.1: (a) An overview of the NC, representing the vestibule, nasal valve region, the 
respiratory region, olfactory region, middle meatus (MM) and nasopharynx, adapted from  
Shi et al. (2007) with permission from Elsevier; (b) section A-A’ representing the maxillary 
sinuses (MS), ostium, and superior meatus (SM), middle meatus (MM), main passage, (MP), 
inferior meatus (IM), adapted from Xi et al. (2017) with permission from Elsevier. 
Delivery of medications to the NC using nasal sprays was investigated in several 
previous studies. Tong et al. (2016) showed that the orientation of the nozzle of the spray 
plays an important role in NC drug delivery efficiency. Inthavong et al. (2006) used numerical 
modelling to study the effects of different factors on the deposition patterns of particles 
injected from nasal sprays. They reported that the geometry of the NC and the features of the 
nasal spray mainly influence the deposition pattern of the particles. They evaluated the 
influence of the insertion angle, defined as the angle of the nasal spray with the horizontal 
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plane, on the deposition efficiency (DE) of the particles. The results depicted that, for particles 
with diameters of 10 μm to 15 μm, the highest deposition occurred with an insertion angle of 
100o; however, the lowest DE occurred with an insertion angle of 70o (Inthavong et al., 2006). 
The application of nebulisers, however, has been shown to be an efficient method to 
overcome the challenges related to the limitation of delivery of particles to the posterior 
region of the NC and the meatuses (Laube, 2007). Nebulisers produce fine particles in a range 
of 1-30m, which enables particle to reach the posterior region (Hilton et al., 2008; Wofford 
et al., 2015). However, the particle transport in the middle meatus is considerably lower than 
that of the inferior meatus when a nebuliser is used (Zhao et al., 2004). On the other hand, 
different studies showed that particle deposition in respiratory airways is impacted by the 
inhaled flow patterns. Lin et al. (2012) examined the effect of nebuliser types and aerosol 
face masks on the efficiency of drug delivery to the NC. They reported that the design of an 
aerosol mask affects the dose of the inhaled aerosolised drug for different types of nebulisers. 
Using jet and mesh nebulisers, Ari et al. (2015) investigated the impact of airflow rates on 
particle deposition in the lung. They demonstrated that the drug delivery efficiency using a 
mesh nebuliser was higher than that using a jet nebuliser. They also found that the efficiency 
of drug delivery to the lung through the valve mask is higher than that of a standard open 
aerosol mask. Hence, it can be inferred that the inlet airflow features, and aerosol distribution 
applied at the nostril, can have an impact on aerosol deposition and transport in different 
regions of the NC, which is the main motivation of this study. 
In this study, the effects of various inlet flow parameters and the diameter of the nozzle 
(which injects particles) on particle transport and deposition patterns in different parts of the 
NC are investigated. To do so, various turbulent intensities and swirl numbers were applied 
at the nostril and their impact on the flow structure in the NC-MS combination, as well as on 
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the transport/deposition patterns of the particle in the NC-MS combination, was quantified. 
The effect of the nozzle diameter (the diameter of injection of particles at the inlet) on the 
aerosol deposition and transport pattern was also studied using computational fluid dynamics 
(CFD).  
 Methods 
6.3.1  Nasal cavity geometry 
Two different nose geometries were used in this study. The first geometry (G1), which 
excludes the paranasal sinuses, was used for validation of the CFD model. It was necessary 
to use G1 since the experimental data for the validation of the CFD model were available for 
G1 in a recently published article by Van Strien et al. (2021). The second geometry (G2), 
which includes the MS, was used for conducting the parametric studies. The STL 
(stereolithography) file of G1 was adapted from Van Strien et al. (2021). The STL file was 
imported into ANSYS® SpaceClaim to convert the point-cloud to a CAD (computer-aided 
design) format using the Shrink Wrap technique for improving the quality of the model by 
smoothening the surfaces. An external facial feature (Figure 6.2(a)) in the shape of a 
hemisphere (Figure 6.2(b)), was also added to the computational domain to ensure simulation 
of a realistic condition for inhalation through the nostril (Van Strien et al., 2021). After 
ensuring the validity of the CFD model through comparison of the G1 inputs with the 
experimental data, the geometry G2 was used to conduct parametric studies to investigate the 
effect of the inlet flow parameters and nozzle diameter on the flow features and particle 
transport in the NC. To measure the particle deposition in different parts of the NC-MS 
combination, G2 was segmented into 10 zones (see Figure 6.2 (c-d)).  
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Figure 6.2: (a) Sagittal view, and (b) isometric view, of the first geometry (G1) (the STL 
model of the geometry was adapted from Van Strien et al. (2021) with permission; (c) sagittal 
and (d) frontal view of the second geometry (G2). The NC part of G2 was extracted from a 
CAD model of a realistic human respiratory system adapted from Tian et al. (2008), and the 
MS part of G2 was generated based on a realistic nose geometry adapted from (Kumar et al., 
2016). G2 was segmented into 10 zones. Each zone is defined by a colour and a number 
between 1-10.   
6.3.2 Problem definition and case studies 
The main aim of this study is to investigate the effect of inlet flow parameters such as its 
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delivery to the MM-Ostium region. MM-Ostium refers to a region in the MM where the 
ostium connects the MM to the MS as illustrated in Figure 6.3. The reason for considering 
MM-Ostium region is that when an external acoustic field is applied to the nostril in ADD 
technique, not only does the air plug inside the ostium fluctuates, but also a portion of the air 
plug in the middle meatus (i.e., MM-Ostium region). In ADD, the oscillating air plug in the 
ostium captures the particles from the MM-Ostium region and then deliver them to the MS 
after several cycles (Pourmehran, Arjomandi, Cazzolato, Ghanadi, et al., 2020). Hence, an 
increase in the number and residence time of particles in the MM-Ostium region can increase 
the number of particles delivered to the MS and subsequently increase the ADD performance. 
It should be noted that in this study, the term particle refers to the droplet generated by a 
nebuliser.   
 
Figure 6.3: The top view of G2 and the MM-Ostium region marked in cyan 
To take into account both the instantaneous number of particles and their residence 
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where 𝑁p is the instantaneous number of particles in the target region and 𝑡 is the time. 𝑁p
∗ is 
the particles’ retention criterion calculated by the integration of the number of particles in a 
target region with respect to the particle time in a specific time frame. The time commences 
when the particles are released in the inlet.  
Two different types of inlet flow were considered in this study: turbulent (2 cases) and 
laminar (3 cases). For the turbulent cases, two different turbulence intensities of TIin=0.15 
and TIin=0.3 were considered. Turbulence intensity is defined as the ratio of the standard 
deviation of fluctuating flow velocity to the mean flow velocity (Kimura, 2016). The turbulent 
cases were produced by applying artificial turbulence to the laminar inlet flow with Reynolds 
number of (𝑅𝑒 = 1023).  The laminar flow cases include a non-swirling inlet flow (𝑆n=0) 
and two swirling inlet flows (𝑆n=0.6 and 𝑆n=0.9). The term 𝑆n refers to the swirl number, 
which quantifies the swirl intensity of the swirling flow defined as the ratio of the tangential 







where 𝑟, 𝑢t, 𝑢𝑎, and 𝑅 are the radial coordinate, tangential velocity, axial velocity, and the 
radius of the inlet boundary, respectively.  
  The effect of how particles are released in the inlet on the drug delivery to the MM-
Ostium region was also studied by considering 5 different fullness coefficients (𝐶f), defined 
as the ratio of nozzle diameter to the inlet (nostril) diameter given by 
𝑁p
∗ = ∫𝑁p𝑑𝑡 (6-1) 






where 𝐷N is the diameter of the nozzle for injecting the particles at the inlet and 𝐷in is the 
diameter of the inlet boundary. Figure 6.4 illustrates the particle distribution for different 𝐶f 
in the inlet boundary. The particles were injected into the inlet with random position 
distribution.  
𝐶f = 0.3 𝐶f = 0.5 𝐶f = 0.7 
 
  
𝐶f  =0.9 𝐶f =1 
  
Figure 6.4: A snapshot of monodispersed particle distribution in the inlet for different 
fullness coefficient (𝐶f). 𝐷N: nozzle diameter (the diameter of injection of the particles), 
𝐷in: inlet diameter 
6.3.3 Governing equations and boundary conditions 
6.3.3.1  Fluid phase modelling  
ANSYS® Fluent 2020 R1 was used to simulate the airflow and particle transport/deposition 
patterns in a realistic NC-MS model. The working fluid was considered as air, which was 
𝐷N 
𝐷in 
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assumed to be Newtonian and incompressible. To investigate the particle deposition and 
transport pattern, as well as to isolate the outcomes independently from the oscillation 
variables, a constant inhalation airflow was used instead of a periodic inhalation flow. To 
ensure the validity of the use of a constant inhalation flow, the impact of cyclic inhalation on 
the airflow field was evaluated through the Womersley number (W) (Inthavong et al., 2008). 
W is a non-dimensional number indicating the effect of oscillatory flow on the flow behaviour 
in an internal flow, such as airflow in the NC and blood flow in the blood vessels (Loudon et 
al., 1998). The fluid flow behaves similarly to a quasi-steady state when W < 1, but the flow 








where 𝐿 is the characteristic length, which is identified as the distance between the two walls 
of the NC (Inthavong et al., 2008), 𝜌𝑓 is the fluid density, 𝜇 is the dynamic viscosity of the 
fluid, and 𝑓 is the frequency of breathing, which is approximately 15 cycles per minute.  
In this study, the characteristic length varies between 1 mm to 10 mm for the NC, 
which results in 0.065 < W < 0.65. Hence, the assumption of quasi-steady state used in this 
study is valid for airflow modelling. It is worth mentioning that the quasi-steady state does 
not refer to a constant flow field over time but it implies that the instantaneous flow rate is 
characterised by the instantaneous pressure gradient (Loudon et al., 1998). Regarding the 
effect of periodic flow on particle deposition, (Häuβermann et al., 2002) demonstrated that 
the impact of periodic inhalation-exhalation flow on the deposition of particles in the NC is 
similar to the particle deposition pattern under a constant inhalation when the flow rate is 
Q=10 L/min or less (Tian et al., 2008). Given that the flow rate used in the current study is 
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Q=7 L/min, the assumption of a constant inhalation flow rate is valid for the particle 
deposition in the NC-MS model (G2).  
For cases with turbulent inlet flow, Stress-Blended Eddy Simulation (SBES), which 
is a Hybrid RANS-LES (RANS: Reynolds-averaged Navier-Stokes, LES: Large Eddy 
Simulation) turbulence model was used. In the SBES model, LES is used for resolving the 
flow field beyond the near-wall region, while the RANS model is applied to the near-wall 
region, which overcomes the need for very small grids in the near-wall region in LES 
turbulent modelling (Van Strien et al., 2021). The equation of mass conservation in an 
incompressible flow is given by: 
𝜕𝑢𝑖
𝜕𝑥𝑖
= 𝑆m ,  (6-5) 
where ?̅? is the flow velocity and 𝑆m is a source term originating from the mass added to or 
subtracted from the fluid due to different phenomena, such as vaporization of the droplets. In 
this study, 𝑆m is zero. The equation describing the conservation for momentum in an 

















where 𝜌𝑓, ?̅?𝑖, 𝑝, 𝜎𝑖𝑗, and 𝜏𝑖𝑗 are the density of the fluid, vector of the flow velocity, pressure 
field, stress tensor due to molecular viscosity, and the turbulence stress tensor 𝜏𝑖𝑗 =
𝜌𝑓(𝑢𝑖𝑢𝑗̅̅ ̅̅ ̅ − ?̅?𝑖?̅?𝑗), respectively (Fluent Theory Guide, 2020). The overbar on the velocity and 
pressure scalars (?̅?𝑖 and ?̅?) indicates the Reynolds-averaging and spatial-temporal filtering 
operations in the RANS and LES models, respectively (Van Strien et al., 2021). In the SBES 
turbulence model, a blending function is used to blend the turbulence stress tensor, 𝜏𝑖𝑗, 
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between the Reynolds and subgrid-scale stress tensors for the RANS and LES formulations, 
respectively (Fluent Theory Guide, 2020). The blending function is given by:  
𝜏𝑖𝑗 = 𝑓𝑠𝜏𝑖𝑗,RANS + (1 − 𝑓𝑠)𝜏𝑖𝑗,LES (6-7) 
where 𝑓𝑠 is the shielding function with values between zero and unity, 𝜏𝑖𝑗,RANS is the Reynolds 
stress tensor, and 𝜏𝑖𝑗,LES is the subgrid-scale stress tensor.  
To implement the SBES turbulent model in ANSYS® Fluent, the k-ω SST (Shear 
Stress Transport) model was utilised because the SBES model is embedded in the k-ω SST 
model. Also, a WALE (Wall-Adapting local Eddy-Viscosity) model was used for the subgrid-
scale component. A pressure-velocity coupled solver was used for solving the governing 
equations. A bounded second-order implicit scheme was used for the transient formulation, 
the second-order scheme was employed for the discretization of the pressure, and the second-
order bounded schemes were used for the convective terms. The least-squares cell-based 
method was utilised for calculating the gradients.  
6.3.4 Particle phase modelling  
To predict the transport of the particle phase in a fluid, two different approaches can be 
applied: Euler-Euler and Euler-Lagrange approaches. In the Euler-Lagrange approach, the 
fluid phase is modelled as a continuum phase, while the particle phase is treated as a 
discretised phase, which is tracked in the Lagrangian reference frame (Adamczyk et al., 
2014). The Euler-Lagrange approach was used in this study since the physical description and 
the details of the particle transport and deposition patterns can be determined. To predict the 
particle transport and deposition patterns in the NC-MS combination a discrete phase model 
(DPM) was used, where the trajectory of the particle phase can be predicted by integrating 
the force balance on the particle. The force balance equation on a particle is defined by:  





= 𝐹 g + 𝐹 D , (6-8) 
where 𝑚p, 𝑢p, 𝐹 g, and 𝐹 D are the particle mass, velocity, gravitational force, and drag force, 
respectively. Other forces such as the virtual mass, pressure-gradient, Basset, Faxen, 
Saffman’s lift, and Brownian forces were neglected. The virtual mass, Basset, and pressure-
gradient forces are considered when the density of the fluid is much greater than the density 
of the particles (Bassett, 1888; Kolev, 2011; Maul, 2019). In this study, the density of the 
fluid is much smaller than that of particles (𝜌𝑓 = 1.225 kg m
3⁄  vs. 𝜌p=1000 kg m
3⁄ ), hence 
the virtual mass, Basset, and pressure-gradient forces can be neglected. The Faxen force 
comes into play when the size of the domains of the particle and fluid are in the same order; 
while in this study, the size of the particle domain is four orders of magnitude smaller than 
the size of the fluid domain (Chen et al., 2000). Saffman’s lift and Brownian forces are 
considered when the particles are submicron in size (Ounis et al., 1991; Schwarzkopf et al., 
2011), while the monodispersed particles with a diameter of 5 µm used in this study.  
The gravitational, 𝐹 g, and drag, 𝐹 D , forces are given by: 
𝐹 g = 𝑚p
𝑔 (𝜌p − 𝜌𝑓)
𝜌p
 (6-9) 
𝐹 D = 𝑚p
(?⃗? − ?⃗? p)
𝜏r
 (6-10) 
where 𝑔 , 𝜌p, ?⃗? p and ?⃗?  are the gravitational acceleration, density of the particle, velocity of 
the particle, and the velocity of the fluid, respectively. 𝜏p is the particle relaxation time 
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where 𝑑p, 𝜇, 𝐶d, and Rep are the diameter of the particle, the dynamic viscosity of the fluid, 
the drag coefficient, and the particle Reynolds number, respectively. In this study, it is 
assumed that the particles are spherical. For a sphere particle with a smooth surface, the drag 
coefficient can be estimated by Morsi et al. (1972): 







where the terms 𝑎1, 𝑎2, and 𝑎3 are the constant numbers that were estimated empirically over 
different ranges of Rep by Morsi et al. (1972). 
6.3.5  Boundary conditions 
For modelling the airflow in geometry G1, a pressure inlet boundary condition was applied 
to the inlet (the hemisphere dome, see, Figure 6.2 (b)) with zero gauge-pressure (atmospheric 
pressure), and a mass flow outlet boundary condition was implemented to the outlet. A no-
slip condition was applied to the wall. No particle tracking model was used in G1. For 
modelling the airflow in geometry G2, the mass flow inlet boundary condition was applied to 
the inlet and pressure outlet condition that was implemented on the outlet boundary with 
atmospheric pressure. A uniform velocity profile was used at the inlet due to the negligible 
effect of the fully developed inlet flow on the particle deposition in the NC (Tian et al., 2008). 
A no-slip boundary condition was applied to the walls. Regarding the particle phase, the inlet 
and outlet boundaries were set as “Escape”, and a “Trap” boundary condition was applied to 
the wall to stimulate the deposition of the particles. 12000 inert particles were released with 
zero initial velocity in the nostril through the inlet boundary.  
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6.3.6 Validation of CFD model and mesh independence test 
For validation purpose, the pressure at different locations in the NC using the geometry G1 
was used. The pressure values were recorded at different points along the NC wall. The 
location of the points was selected based on the available experimental data and CFD results 
reported in a recent study by Van Strien et al. (2021). Three different flow rates of Q=10 
L/min, Q=15 L/min, and Q=30 L/min were applied to the outlet as a mass flow outlet 
boundary condition. A laminar solver was used for Q=10 L/min (𝑅𝑒in,right =823, 
𝑅𝑒in,left=359) and Q=15 L/min (𝑅𝑒in,right =1234, 𝑅𝑒in,left=585), and the SBES turbulent 
model was employed for Q=30 L/min (𝑅𝑒in,right =2529, 𝑅𝑒in,left=1271).  
Initially, a mesh independence was conducted by comparing the velocity magnitude 
along a line in a cross-section plane in the nasopharynx region (see Line 1, Figure 6.5 (b)). 
Using the mosaic technology (introduced by ANSYS® (2020)), a poly-hexcore meshing 
model was used for generating the meshes. The polyhedral mesh was generated on the surface 
of the NC while the interior was filled with hexahedron meshes. Polyhedral meshes were used 
to connect the interior hexahedrons to the inflation with eight prism layers.  
For Q=30 L/min the flow is turbulent in the NC, hence, to resolve the large eddies 
using the LES component of the hybrid RANS-LES turbulence model (the SBES model) a 
sufficiently fine mesh is required. To meet this requirement, 8 prism layers were generated in 
the near-wall region. The size of the prism layer connected to the wall was 10% of the interior 
hexahedral cell length with a growth rate of 1.2. The normalised wall distance (y+) was less 
than unity on the NC wall, which satisfies the requirement of the k-ω SST model used in this 
study. Four different mesh densities of 1.1 million (Mesh 1), 3.3 million (Mesh 2), 5.1 million 
(Mesh 3), and 8.7 million (Mesh 4) cells at a maximum hexahedral cell length of ∆=0.5 mm, 
∆=0.3 mm, ∆=0.25 mm, and ∆=0.2 mm, respectively, were generated to evaluate the mesh 
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size. Figure 6.5 (d) shows the comparison of the velocity magnitude on Line 1 obtained from 
different mesh configurations. The meshes with ∆=0.2 mm and ∆=0.25 mm (Mesh 1 and 
Mesh 2) yield almost the same distribution of the velocity magnitude. Therefore, the mesh 
model with ∆=0.25 mm was used in this study. 
The size of time-step to resolve the eddies containing energy; hence, the Kolmogorov 
time scale was considered to calculate the time step size using the following equation 





where 𝜏𝑛, 𝜇, 𝜌𝑓, and  are the Kolmogorov time scale, fluid viscosity, fluid density, and 
turbulence kinetic energy per unit mass, respectively. The minimum value for Kolmogorov 
time scale was 𝜏𝑛 = 6 × 10
−3 s. However, a smaller time step size (𝜏𝑛 = 5 × 10
−5) was used 
for the simulations, which can guaranty that the spatial resolution was more than sufficient to 
resolve the turbulent flow field. The same time step size was also used for the particle tracking 
simulation. 
To ensure that the proposed modelling technique is suitable, the flow behaviour in the 
G1 was modelled for different mass flow outlet rates: Q=10 L/min, Q=15 L/min, and Q=30 
L/min. The pressure values at 16 different locations on the NC wall were determined and 
compared with the published data. Figure 6.6 (a) illustrates the location of the points on the 
NC wall including three points on the floor and four points on the lateral walls of both left 
and right sides of the NC as well as two points in the posterior region of the nasopharynx. 
Figure 6.6 (b) represents the pressure values at the pre-defined points at different flow rates. 
It can be observed from this Figure that, the agreement between the results obtained in this 
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study and the results reported in the literature is reasonably good for both the laminar (Q=10 
L/min, Q=15 L/min) and turbulent (Q=30 L/min) flows.  
The validation of the particle tracking model (DPM) was examined by comparing the 
total particle deposition efficiency ( T) in the NC predicted in this study with that reported in 





 r × 100% , (6-14) 
where Np
 dep is the number of particles deposited on the wall and Np
 r is the number of particles 
released in the nostril initially. Generally, the particle transport/deposition behaviour in a fluid 
flow is quantified by the dimensionless Stokes number (St), which is the ratio of the particles’ 






where 𝑈 and 𝐿 are the characteristic velocity and characteristic length, normally taken as the 
mean flow velocity and the hydraulic diameter the inlet (or a planar surface in the 
computational domain), respectively. The Stokes number is for understanding the particle 
transport behaviour in the fluid flow. It indicates whether the particles are in a kinetic 
equilibrium with the fluid phase (Tian et al., 2005). The application of the 𝑆𝑡 depends highly 
on the characteristic length of the domain of interest, which changes throughout the different 
geometries of the NC resulting in a limitation in the calculation of Stokes number in different 
parts of the NC. To overcome this limitation of the 𝑆𝑡, the inertial parameter (IP) was used 
as the criterion for the assessment of the validity of the particle phase model used in this 
study. The IP is widely used for the assessment of particle deposition in the NC and 
respiratory airways because the characteristic length and the characteristic velocity associated 
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with the 𝑆𝑡 is normalised out by using a constant flow rate. The inertial parameter is given by 
(Inthavong, Tu, et al., 2011a): 
IP = Q dae
2
 (6-16) 






where dae is the aerodynamic diameter is defined as “the diameter of the spherical particle 
with a density of 1000 kg/m3 that has the same settling velocity as the particle under study” 
(Yang et al., 2012). The de  and X are the equivalent volume diameter and the shape factor of 
the particle, respectively (Yang et al., 2012). For a spherical particle, the de equals to the 
particle diameter and X is unity (Yang et al., 2012). In this study, the spherical particles are 
assumed with a density of 𝜌p = 1000 kg m
3⁄ , hence the equivalent aerodynamic diameter is 
identical to the particle diameter. The IP is a convenient parameter that is normally used for 
comparing the effect of dp and Q on the deposition efficiency. However, the use of a constant 
flow rate is a limitation of the inertial parameter given that it does not take into account the 
complicated shape of the geometry of the NC. Despite this limitation, the inertial parameter 
is normally used for the demonstration of deposition efficiency of particles, particularly where 
the determination of characteristic length is limited due to the geometry variation.   
The effect of the inertial parameter of the total deposition efficiency in G2 was 
predicted using the CFD model in this study. The results were compared with the 
experimental and numerical data reported in the literature (Cheng et al., 2001; Kelly et al., 
2004; Pattle, 1961; Shang et al., 2015; Shi et al., 2007; Tian et al., 2008). Figure 6.7 shows 
that the trend of the deposition efficiency predicted in this study is similar to that of the 
previous studies, which implies the validity of the particle tracking model of this study. The 
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variation in deposition efficiency between the current and the previous studies is rooted in the 




Figure 6.5: (a) Schematic of NC in G1;  (b) an overview of the plane A-A’ and  Line 1; (c) 
an overview of the meshes on the plane B-B’; (d) zoomed-in view of the mesh on plane B-
B’ representing the prism layers; (e)  mesh independence test based on the velocity 
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Figure 6.6: (a) An overview of different points defined on the wall of the nasal cavity used 
for predicting the pressure values  (the model was generated through the STL file adapted 
from Van Strien et al. (2021) with permission); (b) pressure distribution on the wall of the 
nasal cavity obtained by the current CFD study compared with the experimental data and 
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Figure 6.7: A comparison between the CFD results in the current study for total deposition 
efficiency ( T) as a function of the inertial parameter (IP) and available data in the literature 
(Cheng et al., 2001; Inthavong, Tu, et al., 2011b; Kelly et al., 2004; Pattle, 1961; Shang et 
al., 2015; Shi et al., 2007; Tian et al., 2008) 
 Results and discussion  
6.4.1  Effect of inlet flow parameters on the flow structure in NC 
To investigate the effect of inlet flow parameters on the flow structure, several cross-section 
planes across the NC were created in critical locations as presented in Figure 6.8 (a). Figure 
6.8 (b) shows the comparison of the maximum turbulence intensity (TImax) between the cases 
with TIin=0.15 and TIin=0.3 on planes P1-P9. The instantaneous contours of turbulence 
intensity on planes P1-P7 across the NC are presented in Figure 6.8 (c-d). From Figure 6.8 
(b), it can be seen that the maximum turbulence intensity decreased remarkably on planes P1 
to P4 for both cases. However, from P5-P9 the TImax remains relatively constant. For 
example, in a case with TIin=0.3, the maximum turbulence intensity is reduced to TI=0.045 
in P5. This means that NC operates similar to a settling chamber transforming a turbulent 
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flow to near laminar flow. By comparing the contours of turbulence intensity on plane P6 
between the cases with TIin=0.15 and TIin=0.3, it can be seen that in both cases the turbulence 
intensities in the ostium and the MM-Ostium region are negligible (TI ≅ 0). It can be inferred 
that the implementation of turbulence to the inlet flow has not had a significant effect on the 
airflow behaviour in the MM-Ostium region (see Figure 6.8 (c-d)). 
Figure 6.9 (a-e) presents the instantaneous streamlines and the velocity magnitude 
contours in plane P6 for different inlet flow parameters. As it is shown in Figure 6.9 (a-c), in 
the plane P6 the flow structure after introducing turbulence at the inlet is identical to the 
laminar inlet flow. Based on the streamlines illustrated in Figure 6.9 (d-e), the flow structure 
in the MM-Ostium region under the effect of swirling inlet flows (𝑆n = 0.6 and 𝑆n = 0.9) is 
also essentially identical to those of non-swirling inlet flows. Therefore, it is inferred that due 
to the large volume of the NC and the resistance of the nasal valve the flow stabilises and 
hence the inlet flow preconditioning does not affect the flow features in the MM-Ostium 
region. When a swirling flow is applied to the inlet, the flow structure in the inferior meatus 
(marked IM in Figure 6.9) undergoes some change in the number of vortices (i.e. secondary 
flows) due to the curvature of the anterior region. The anterior region includes the nostril and 
vestibule. Figure 6.9 (a-e) shows that the swirling flow can influence the flow structure in the 
NC but mostly in the inferior meatus where the width of the airway is wider than the middle 
and superior meatuses. 
To better understand the role of the nasal valve as an airway resistance Figure 6.10 
(a-c) illustrates the streamlines on planes P2-P4 for different inlet flow parameters. The 
vestibule is located between P2 and P3, and the nasal valve is located between P3 and P4. It 
is clear from this Figure that there are no significant changes in the flow streamlines in planes 
P2-P4 under the effect of turbulent inlet flows when compared with the laminar non-swirling 
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inlet flow. In contrast, the flow structure in planes P2 and P3 changed significantly under the 
effect of swirling inlet flows. By increasing the swirl intensity of the inlet flow, the number 
of vortices (i.e. secondary flows) on plane P3 is increased, which demonstrates the impact of 
swirling flow on the flow structure in the nostril and vestibule regions. However, the influence 
of all inlet flow parameters on the flow structure in the plane P4 (except the IM region of P4) 
is negligible compared with plane P3. This implies that the constrictive nasal valve region 
significantly changes the flow features and reduces the effect of turbulence and swirling flow 
implemented to the inlet, confirming the airway resistance of the nasal valve. Hence, it might 
be expected that inlet flow preconditioning does not affect the efficiency of drug delivery to 
the MS significantly.  
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Figure 6.8: (a) Illustration of the location of different cross-section planes in the NC-MS 
combination G2); (b) maximum turbulence intensity for different cross-sectional planes; (c) 
instantaneous turbulence intensity (TI) contour demonstrated for different cross-section 
planes (P1-P7) in the NC-MS combination when the inlet turbulence intensity is TIin=0.15; 
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Figure 6.9: Instantaneous flow streamlines and velocity contour on plane P6 under the effect 
of  non-swirling (a) laminar inlet flow; (b) inlet turbulence intensity of TIin = 0.15; (c)  inlet 
turbulence intensity of TIin = 0.3; and swirling flow with (d) inlet swirl number of Sn =
0.6; (e)  inlet swirl number of Sn = 0.9. Artificial turbulence was applied to the inlet for the 
turbulent inlet flows.  
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Figure 6.10:  Instantaneous flow streamlines and velocity contour on (a) plane P2; (b) plane 
P3; and (c) plane P4 under the effect of different inlet flow parameters.  
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6.4.2  Effect of inlet flow parameters on particle transport  
Particle tracking simulation provides a detailed understanding of particle transport and 
deposition. To increase the efficiency of ADD to the MS, the number of particles in the MM-
Ostium region should be increased and also the retention of particles in that region should be 
enhanced. When the ADD technique is applied, the particles are transferred to the MS through 
the oscillation of the air plug in the ostium. To be more specific, by the oscillating air plug 
during every cycle, some of the particles in the MM-Ostium region are trapped after several 
cycles and then transported to the MS (Pourmehran, Arjomandi, Cazzolato, & Tian, 2020). 
Therefore, to increase the number of particles transported to the MS through ADD, the total 
number of particles trapped in the oscillating air plug in several consecutive cycles should be 
increased, which requires longer particle retention in the MM-Ostium. To consider both the 
number of particles and the retention of particles in the MM-Ostium, the particles’ retention 
criterion (𝑁p
∗) was estimated using Equation (6-1). 
Figure 6.11 (a-b) represents the number of particles in the MM-Ostium region, as a 
function of particle time, and the related 𝑁p
∗ under the effect of turbulent and swirling inlet 
flows when 𝐶f = 1 and d𝑝 = 5μm. From Figure 6.11 (b), it can be seen that there are no 
significant differences in 𝑁p
∗ between the cases with turbulent inlet flows and the laminar non-
swirling inlet flow in the MM-Ostium region. This behaviour originates from an identical 
flow behaviour between those cases (see Figure 6.9 and Figure 6.10). 
  According to Figure 6.11 (a-b), the particle retention criterion for a swirling inlet flow 
with 𝑆n = 0.6 is greater than for a non-swirling inlet flow (𝑆n = 0). Therefore, the efficiency 
of drug delivery to the MS (through the MM-Ostium using ADD) is expected to increase 
when a swirling flow (i.e., 𝑆n = 0.6) is applied to the inlet. The differences in the 𝑁p
∗ in the 
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cases with swirling and non-swirling flows might take place due to the variations of the flow 
fields in the nostril and vestibule regions (zones 1 and 2 depicted in Figure 6.2 (e)), which is 
discussed in the following paragraphs.  
Given the cross-sectional area of the nostril zone (zone 1 depicted in Figure 6.2 (e)) 
is almost constant, the Stokes number in this region can be calculated using Equation (6-15), 
which yields 𝑆𝑡 = 0.0115. Figure 6.12 presents the Stokes number on planes P1-P9 for 
different inlet flow parameters. It is clear from this Figure that the Stokes number along the 
NC is much lower than unity, hence the particles almost follow the fluid streamlines. When 
a swirling flow is applied to the inlet, the airflow in the nostril swirls around the centreline of 
the nostril (z-axis), hence, the particles released at the nostril also swirl around the centreline 
of the nostril. When the particles swirl around an axis, a centrifugal force acts on the particles 
and drives them toward the wall. The centrifugal force has a direct relationship with the 




Figure 6.11:  (a) The effect of inlet flow parameters on the number of particles (𝑁p) in the 
MM-Ostium region in every time-step when 𝐶f =1; (b) particle retention criterion (𝑁p
∗) in 
the MM-Ostium region under the effect of different inlet flow parameters when 𝑑p = 5 μm 
and 𝐶f = 1. 
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Figure 6.12: Stokes number (St) along the nasal cavity on planes P1-P9. The location of P1-
P9 are illustrated in Figure 6.8 (a). 







where 𝑚p is the particle mass, 𝑢𝑡 is the tangential velocity, and 𝑟 is the radial coordinate. An 
increase in the swirl intensity of the swirling inlet flow increases the tangential flow velocity, 
which increases the centrifugal force acting on the particles (see Figure 6.13). Therefore, 
increasing the swirl number of the inlet flow increases the concentration of particles that are 
driven towards the wall, which can lead the particles to deposit on the wall. Figure 6.14 (a-b) 
presents the total and local deposition efficiencies for different inlet flow parameters. This 
Figure shows that the swirling flow has the effect of increasing the deposition of particles on 
the wall, where the maximum total deposition efficiency occurs when Sn = 0.9. Figure 6.14 
(b) reveals that the maximum particle deposition in zones 1 and 2 (nostril and vestibule, 
respectively) occurs in Sn = 0.9, which implies the effect of centrifugal force on the particles 
in these regions, contributing to an increase in total deposition efficiency.  






(c)  (d)  
 
 
Figure 6.13:  (a) An overview of NC-MS geometry (G2) representing two cross-sections (CS1 
and CS2) on nostril; (b) a top view of the cross-section representing the rotation of the inlet 
flow; (c) tangential velocity contours in CS1 and CS2 for different swirl numbers (Sn); (d) 
tangential velocity profiles on Lines 1 and 2 for different Sn. 
The effect of the centrifugal force on the particles can be seen in Figure 6.15 (a). This 
Figure illustrates the distribution of the particles in plane P2 for different inlet swirl numbers. 
According to this figure, the application of swirling inlet flow led the particles in the central 
area of the nostril to move towards the wall due to the centrifugal force. Also, the central area 
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from 𝑆n = 0.6 to 𝑆n = 0.9. This implies that the centrifugal force on the particles was also 
enhanced when the swirl number increased. The results showed that, despite the 
approximately similar flow behaviour in the NC-MS geometry on planes P4-P9 (i.e., zones 
4-9) for all the inlet flow preconditioning, the particle transport patterns under the effect of 
swirling inlet flow and non-swirling inlet flow are not identical. This could be due to the 
effect of flow behaviour on particle transport patterns in the first two zones (i.e., nostril and 
vestibule). 
 (a) (b) 
 
Figure 6.14: The effect of inlet flow parameters on (a) total deposition efficiency ( T); and 
(b) local deposition efficiency per unit of area ( i).  
Figure 6.15 (a-b) compares the particle distribution pattern between the non-swirling 
and swirling inlet flows in planes P2 and P3. The particle distribution patterns in planes P2 
and P3 are similar to the flow streamlines in those planes (see Figure 6.10 (a-b)), where the 
Stokes number is very lower than unity. For swirling inlet flows, the particle distribution 
patterns in plane P4 (see Figure 6.15 (c)) are not similar to the flow streamlines in plane P4 
(see Figure 6.10 (c)), even though the highest Stokes number in the nasal valve (the zone 
between P3 and P4) is much lower than unity (𝑆𝑡 = 0.02) The reason for the differences 
between the particle distribution patterns and flow streamlines in plane P4 are rooted in the 
particle distribution pattern formed in the upstream flow in the vestibule (zone 2). In other 
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words, the particle distribution patterns that were formed under the effect of swirling flow in 
the nostril (zone 1) and vestibule regions were partially extended to the nasal valve. 
Comparing the particle distribution patterns illustrated in Figure 6.15 (b) and Figure 
6.15  (c), it can be seen that the areas in plane P3 that are empty of particles, due to the swirling 
flow, were extended to plane P4. Figure 6.15  (d) shows that for the cases with swirling inlet 
flow there is an area in the main passage of plane P5 that is almost devoid of particles, while 
no swirling flow in that region is observed in the streamlines of that plane (Figure 6.15 (e)). 
Hence, it can be inferred that the particle transport pattern in the vestibule was extended not 
only to the nasal valve but also to the areas beyond the nasal valve (zone 3). 
In conclusion, the swirling inlet flow undergoes many changes when it passes through 
the nasal valve where the swirl intensity of the inlet swirling flow is almost damped. The 
effect of swirling flow on the particles before entering the nasal valve forms a specific particle 
distribution pattern. The particle distribution pattern in the nostril and vestibule not only does 
not disappear in the nasal valve but also partly extends to the regions beyond the nasal valve. 
Accordingly, the differences in 𝑁p
∗ between the non-swirling inlet flow and swirling flows 
presented in Figure 6.11 (a-b) can be explained: the concentration of particles (𝐶p) in the 
upper part of the plane P3 for 𝑆n = 0.9 (𝐶p = 7.8%) is lower than that of 𝑆n = 0.6 (𝐶p =
11.6%) (see Figure 6.15 (b)). So, they contribute to a lower concentration of particles in the 
MM-Ostium region for 𝑆n = 0.9 given that the particle distribution pattern in plane P3 is 
partly extended to the regions beyond the nasal valve. Therefore, the particle retention 
criterion in the MM-Ostium region for 𝑆n = 0.9 is lower than for other cases, as presented in 
Figure 6.11 (a-b). 
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Figure 6.15: Accumulative particle distribution and instantaneous velocity contours under 
the effect of non-swirling and swirling flows on different planes: (a) P2, (b) P3, (c) P4, and 
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6.4.3  Effect of fullness coefficient on the particle transport 
pattern 
The effect of the fullness coefficient (𝐶f) on the particle transport/deposition pattern in the 
NC-MS combination (G2) was investigated under the effect of non-swirling (𝑆n = 0) and 
swirling (𝑆n = 0.6) inlet flows. Figure 6.16 illustrates an overview of the accumulative 
particle distribution in plane P3 for different swirling numbers and 𝐶f. According to this 
figure, when 𝐶f decreases the concentration of particles in the core flow increases. In this 
study, the core flow is defined as the part of the flow where the velocity magnitude and the 
velocity gradient are significantly higher and lower than other parts of the flow, respectively. 
The core flow regions in plane P3 for 𝑆n = 0 and 𝑆n = 0.6  are illustrated in Figure 6.16. 
  𝐶f = 0.3   𝐶f = 0.5   𝐶f = 0.7  𝐶f = 0.9  𝐶f = 1  
 
  














Figure 6.16: Accumulative particle distribution and instantaneous velocity contours in plane 
P3 for different fullness coefficient (𝐶f) under the effect of non-swirling and swirling inlet 
flows. 
Velocity magnitude [m/s] 
Core flow 
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Given the Stokes number in this study is much lower than unity along the NC region, 
the particles in the NC can follow the flow. Accordingly, when the concentration of particles 
in the core flow region increases, the number of particles that can be transported beyond the 
anterior region increases. When a portion of the particles is distributed out of the core flow 
region, they need a longer time to be transported to the location beyond the anterior region 
because the velocity magnitude in that region is much lower than the core flow. To better 
understand the effect of 𝐶f on the particle transport pattern in the NC, Figure 6.17 (a-b) 
presents an instantaneous particle distribution in the NC for different fullness-coefficient. The 
particles were coloured, based on the particle velocity magnitude.  
Figure 6.17 (a-b) shows that all the injected particles were transported beyond the 
anterior region for 𝐶f ≤ 0.7, demonstrating that the particles were almost transported through 
the core flow region. However, for 𝐶f = 0.9 and 𝐶f = 1, some particles remained in the 
anterior region with very low velocity, which shows these particles were not in the core flow 
in the anterior region (see the colour of particles in the anterior region in Figure 6.17 (a-b)). 
The particles that are not in the core flow region are likely to deposit on the wall due to the 
low velocity-magnitude, which contribute to moving the particles towards the wall and 
eventually depositing there.  
Figure 6.18 presents the effect of 𝐶f on the total deposition efficiency ( T) and the 
local deposition efficiency per unit of area ( 𝑖) for different inlet flow parameters. It can be 
seen from Figure 6.18 (a) that for non-swirling flows, an increase in 𝐶f increases the total 
deposition efficiency from an increased concentration of the particles in the region outside of 
the core flow. This Figure also shows that the total deposition efficiency in swirling inlet 
flows is higher than for non-swirling flows. This is due to the centrifugal forces acting on the 
particles in the core flow, which drive them towards the wall.  
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In continuous drug delivery, such as drug delivery using nebulisers, the deposition of 
the particles in the anterior region increases gradually, which can contribute to forming 
droplets dripping from the nostril as waste. To overcome this problem, a 70% decrease in 𝐶f 
is recommended for the NC-MS geometry of this study. To generalise this result A series of 
different realistic NC-MS models should be analysed. 
Figure 6.19 (a-c) illustrates the number of particles in the MM-Ostium region (as a 
function of particle time) and the related 𝑁p
∗ under the effect of swirling and non-swirling 
inlet flows for different 𝐶f when d𝑝 = 5 μm. It can be seen from Figure 6.19 (c) that the effect 
of 𝐶f on 𝑁p
∗ for swirling inlet flows is different from non-swirling inlet flows in the MM-
Ostium region. This Figure shows that 𝑁p
∗ has an inverse relationship with 𝐶f when 𝑆n = 0.6. 
However, 𝑁p
∗ monotonically increases by increasing  𝐶f for non-swirling inlet flow (𝑆n = 0). 
According to Figure 6.19 (c), the highest 𝑁p
∗ for the MM-Ostium region (𝑁p
∗ = 8.55 s) when 
𝐶f = 0.3 and Sn = 0.6 is approximately 45% greater than a case with Sn = 0, 𝐶f = 1 (a 
common inlet configuration). Therefore, we can infer that when 𝐶f = 0.3 and Sn = 0.6, the 
efficiency of acoustic drug delivery to the MS might be increased by up to 45% when 
compared with an acoustic drug delivery with a common inlet configuration. It should be 
noted that these results are valid for the NC-MS geometry (G2) of this study. A series of 
different realistic NC-MS models should be analysed to generalise the effect of the particles’ 
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 (a) 𝑺𝒏 = 𝟎  (b)  𝑺𝒏 = 𝟎. 𝟔  









































Figure 6.17: Instantaneous particle distributions in the NC for different particles’ fullness 
coefficient (𝐶f) under the effect of (a) non-swirling inlet flow, and (b) swirling inlet flow. 
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Figure 6.18: (a) The effect of fullness coefficient (𝐶f) and inlet flow parameters on the total 
deposition efficiency ( T); (b) the effect of 𝐶f on local deposition efficiency per unit of area 
( i) for a non-swirling inlet flow (𝑆n = 0); (c) the effect of 𝐶f on i for a swirling inlet flow 












Figure 6.19: The effect of fullness coefficient (𝐶f) on the number of particles that exist in the 
MM-Ostium region in every time-step when (a) 𝑆n = 0 ; and (b) 𝑆n = 0.6; (c) the effect of 
𝐶f on the particles’ retention criterion (𝑁p
∗) in the MM-Ostium region for non-swirling and 
swirling inlet flows. 
 Conclusion 
The main aim of the present study is to investigate the effect of inlet flow parameters and 
nozzle diameter (characterised by fullness coefficient) at the inlet on the airflow behaviour 
and drug (particle) delivery to the maxillary sinus (MS). For parametric studies, two CFD 
models using hybrid RANS-LES model and laminar solver were developed and validated 
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against the available experimental data. Exploiting the Eulerian-Lagrangian approach, the 
particle trajectories were predicted using a discrete phase model (DPM). Given the low 
particle volume fraction, a one-way coupling method between the fluid and particle phases 
was used in the particle tracking simulation. Artificial turbulence with intensities of TIin=0.15 
and TIin=0.3, as well as two swirl intensities with swirl numbers of 𝑆n =0.6 and 𝑆n =0.9, 
were applied at the inlet flow with a flow rate of 7 L/min. The effect of these parameters, as 
well as the effect of fullness coefficients of 𝐶f=0.3, 0.5, 0.7, 0.9, and 1 on the flow behaviour, 
particle retention criterion (𝑁p
∗), and particle deposition in the MM-Ostium region, were 
investigated. The results were compared with a laminar non-swirling inlet flow for 𝐶f =1. An 
increase in particle retention criterion in the MM-Ostium region was calculated to quantify 
the increase in the drug delivery to the MS region.  
One of the more significant findings to emerge from this study is that the turbulence and the 
swirl applied to the inlet flow were significantly damped when the flow passes through the 
nasal cavity. This implies that the nasal valve plays the role of airway resistance. The results 
showed that a turbulent inlet flow has a negligible effect on the particle deposition in the NC 
and drug delivery to the MM-Ostium regions is negligible. However, the deposition of 
particles increases with an increase in the swirl intensity of the inlet flow, which comes from 
the increasing effect of centrifugal force acting on the particles in a swirling flow. This study 
also found that that the drug delivery (quantified by 𝑁p
∗) to the MM-Ostium region increases 
by using a swirling inlet flow at a moderate swirl number, i.e., 𝑆n =0.6. It was also found that 
the variation of fullness coefficient affects the drug delivery to the MM-Ostium region 
significantly. 𝑁p
∗ in the MM-Ostium region increases with a decrease in the fullness 
coefficient. The highest 𝑁p
∗ in the MM-Ostium region in the NC-MS model of this study 
occurs under the effect of swirling inlet flow (𝑆n =0.6) with 𝐶f = 0.3, which is 45% greater 
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than 𝑁p
∗ for a non-swirling inlet flow (𝑆n =0) with a normal particle release pattern (i.e., 𝐶f = 
1). The reason for the best performance with 𝑆n =0.6 and 𝐶f = 0.3 is that it is directed to the 
left joint after which the centrifugal force pushed the particles to the walls and thus the ostium.  
In continuous drug delivery, such as drug delivery using nebulisers, the deposition of the 
particles in the anterior region increases gradually, which can contribute to forming droplets 
dripping from the nostril as waste. To overcome this problem, a decrease in 𝐶f is 
recommended. It should be noted that the outcome of the current study is subjected to the 
following limitation: the humidity of the air in the nasal cavity was neglected, the nebulised 
droplets were considered as inert particles, the nose-sinus geometry was adapted from a 
healthy subject, and an isothermal condition was assumed. Also, the particles were released 
at the initial time step while they were monodispersed. 
  Acknowledgements 
Financial support for the project has been provided by the Australian Government Research 
Training Program (RTP), and the Beacon of Enlightenment PhD Scholarship provided by the 
University of Adelaide. The authors would like to acknowledge the support of the School of 
Mechanical Engineering, Phoenix High-Performance Computing (HPC). The authors are 
grateful to A/Prof Kiao Inthavong (RMIT University, Australia) and Dr Haribalan Kumar 
(Aukland University, New Zealand) for the provision of STL files related to the nose 
geometry. 
  References 
Adamczyk, W. P., Klimanek, A., Białecki, R. A., Węcel, G., Kozołub, P., & Czakiert, T. 
(2014). Comparison of the standard Euler–Euler and hybrid Euler–Lagrange 
approaches for modeling particle transport in a pilot-scale circulating fluidized bed. 
Particuology, 15, 129-137.  
Chapter 6. Effect of the inlet flow parameters and nozzle diameter on drug delivery to … 
238 
ANSYS®. (2020). ANSYS Fluent - CFD Software | ANSYS. In. 
Ari, A., de Andrade, A. D., Sheard, M., AlHamad, B., & Fink, J. B. (2015). Performance 
comparisons of jet and mesh nebulizers using different interfaces in simulated 
spontaneously breathing adults and children. Journal of Aerosol Medicine and 
Pulmonary Drug Delivery, 28(4), 281-289.  
Bahadur, S., & Pathak, K. (2012). Physicochemical and physiological considerations for 
efficient nose-to-brain targeting. Expert Opinion on Drug Delivery, 9(1), 19-31.  
Bassett, A. B. (1888). A Treatise on Hydrodynamics: Volume one: Dover. 
Bell, I. R., & Koithan, M. (2012). A model for homeopathic remedy effects: Low dose 
nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a 
complex adaptive system. BMC Complementary and Alternative Medicine, 12(1), 1-
21.  
Berger, W. E., Godfrey, J. W., & Slater, A. L. (2007). Intranasal corticosteroids: The 
development of a drug delivery device for fluticasone furoate as a potential step 
toward improved compliance. Expert Opinion on Drug Delivery, 4(6), 689-701.  
Chen, S. B., & Ye, X. (2000). Faxen's laws of a composite sphere under creeping flow 
conditions. Journal of Colloid and Interface Science, 221(1), 50-57.  
Cheng, Y., Holmes, T., Gao, J., Guilmette, R., Li, S., Surakitbanharn, Y., & Rowlings, C. 
(2001). Characterization of nasal spray pumps and deposition pattern in a replica of 
the human nasal airway. Journal of Aerosol Medicine, 14(2), 267-280.  
Drettner, B., Falck, B., & Simon, H. (1977). Measurements of the air conditioning capacity 
of the nose during normal and pathological conditions and pharmacological influence. 
Acta Oto-laryngologica, 84(1-6), 266-277.  
Durand, M., Pourchez, J., Aubert, G., Le Guellec, S., Navarro, L., Forest, V., Rusch, P., & 
Cottier, M. (2011). Impact of acoustic airflow nebulization on intrasinus drug 
deposition of a human plastinated nasal cast: New insights into the mechanisms 
involved. International Journal of Pharmaceutics, 421(1), 63-71.  
Fluent Theory Guide. (2020). ANSYS® Fluent, Release 2020 R1, Help System, ANSYS, Inc. 
In. 
Häuβermann, S., Bailey, A., Bailey, M., Etherington, G., & Youngman, M. (2002). The 
influence of breathing patterns on particle deposition in a nasal replica cast. Journal 
of Aerosol Science, 33, 923-933.  
Hilton, C., Wiedmann, T., Martin, M. S., Humphrey, B., Schleiffarth, R., & Rimell, F. (2008). 
Differential deposition of aerosols in the maxillary sinus of human cadavers by 
particle size. American Journal of Rhinology & Allergy, 22(4), 395-398.  
Hreiz, R., Gentric, C., & Midoux, N. (2011). Numerical investigation of swirling flow in 
cylindrical cyclones. Chemical Engineering Research and Design, 89(12), 2521-
2539.  
Inthavong, K., Ge, Q., Se, C. M., Yang, W., & Tu, J. (2011). Simulation of sprayed particle 
deposition in a human nasal cavity including a nasal spray device. Journal of Aerosol 
Science, 42(2), 100-113.  
Inthavong, K., Tian, Z., Li, H., Tu, J., Yang, W., Xue, C., & Li, C. G. (2006). A numerical 
study of spray particle deposition in a human nasal cavity. Aerosol Science and 
Technology, 40(11), 1034-1045.  
Chapter 6. Effect of the inlet flow parameters and nozzle diameter on drug delivery to … 
239 
Inthavong, K., Tu, J., & Heschl, C. (2011a). Micron particle deposition in the nasal cavity 
using the v2–f model. Computers & Fluids, 51(1), 184-188.  
Inthavong, K., Tu, J., & Heschl, C. (2011b). Micron particle deposition in the nasal cavity 
using the V2F model. Computers & Fluids, 51(1), 184-188.  
Inthavong, K., Wen, J., Tian, Z., & Tu, J. (2008). Numerical study of fibre deposition in a 
human nasal cavity. Journal of Aerosol Science, 39(3), 253-265.  
Keck, T., Leiacker, R., Heinrich, A., Kühnemann, S., & Rettinger, G. (2000). Humidity and 
temperature profile in the nasal cavity. Rhinology, 38(4), 167-171.  
Kelly, J. T., Asgharian, B., Kimbell, J. S., & Wong, B. A. (2004). Particle deposition in human 
nasal airway replicas manufactured by different methods. Part I: Inertial regime 
particles. Aerosol Science and Technology, 38(11), 1063-1071.  
Kimbell, J. S., Segal, R. A., Asgharian, B., Wong, B. A., Schroeter, J. D., Southall, J. P., 
Dickens, C. J., Brace, G., & Miller, F. J. (2007). Characterization of deposition from 
nasal spray devices using a computational fluid dynamics model of the human nasal 
passages. Journal of Aerosol Medicine, 20(1), 59-74.  
Kimura, K. (2016). Wind loads. In A. Pipinato (Ed.), Innovative Bridge Design Handbook 
(pp. 37-48). Boston: Butterworth-Heinemann. 
Kolev, N. I. (2011). Drag, lift, and virtual mass forces. In N. I. Kolev (Ed.), Multiphase Flow 
Dynamics 2 (pp. 31-85). Berlin, Heidelberg: Springer. 
Krstić, M. (2006). Mixing control for jet flows. In G. D. Roy (Ed.), Combustion Processes in 
Propulsion (pp. 87-96). Burlington: Butterworth-Heinemann. 
Kumar, H., Jain, R., Douglas, R. G., & Tawhai, M. H. (2016). Airflow in the human nasal 
passage and sinuses of chronic rhinosinusitis subjects. PloS One, 11(6), 1-14.  
Landahl, M. T., Mollo‐Christensen, E., & Korman, M. S. (1989). Turbulence and random 
processes in fluid mechanics (2nd ed.). Cambridge: Cambridge University Press. 
Laube, B. L. (2007). Devices for aerosol delivery to treat sinusitis. Journal of Aerosol 
Medicine, 20(1), 5-18.  
Leclerc, L., El-Merhie, A., Navarro, L., Prévôt, N., Durand, M., & Pourchez, J. (2015). Impact 
of acoustic airflow on intrasinus drug deposition: New insights into the vibrating 
mode and the optimal acoustic frequency to enhance the delivery of nebulized 
antibiotic. International Journal of Pharmaceutics, 494(1), 227-234.  
Leclerc, L., Pourchez, J., Aubert, G., Leguellec, S., Vecellio, L., Cottier, M., & Durand, M. 
(2014). Impact of airborne particle size, acoustic airflow and breathing pattern on 
delivery of nebulized antibiotic into the maxillary sinuses using a realistic human 
nasal replica. Pharmaceutical Research, 31(9), 2335-2343.  
Lin, H.-L., Wan, G.-H., Chen, Y.-H., Fink, J. B., Liu, W.-Q., & Liu, K.-Y. (2012). Influence 
of nebulizer type with different pediatric aerosol masks on drug deposition in a model 
of a spontaneously breathing small child. Respiratory Care, 57(11), 1894-1900.  
Loudon, C., & Tordesillas, A. (1998). The use of the dimensionless Womersley number to 
characterize the unsteady nature of internal flow. Journal of Theoretical Biology, 
191(1), 63-78.  
Maniscalco, M., Pelaia, G., & Sofia, M. (2013). Exhaled nasal nitric oxide during humming: 
Potential clinical tool in sinonasal disease? Biomarkers in Medicine, 7(2), 261-266.  
Chapter 6. Effect of the inlet flow parameters and nozzle diameter on drug delivery to … 
240 
Maniscalco, M., Sofia, M., Weitzberg, E., & Lundberg, J. (2006). Sounding airflow enhances 
aerosol delivery into the paranasal sinuses. European Journal of Clinical 
Investigation, 36(7), 509-513.  
Maul, G. A. (2019). Pressure gradient force. In C. W. Finkl & C. Makowski (Eds.), 
Encyclopedia of Coastal Science (pp. 1390-1392). Cham: Springer International 
Publishing. 
Möller, W., Schuschnig, U., Bartenstein, P., Meyer, G., Häussinger, K., Schmid, O., & 
Becker, S. (2014). Drug delivery to paranasal sinuses using pulsating aerosols. 
Journal of Aerosol Medicine and Pulmonary Drug Delivery, 27(4), 255-263.  
Morsi, S., & Alexander, A. (1972). An investigation of particle trajectories in two-phase flow 
systems. Journal of Fluid Mechanics, 55(2), 193-208.  
Mygind, N., & Vesterhauge, S. (1978). Aerosol distribution in the nose. Rhinology, 16(2), 
79-88.  
Navarro, L., Leclerc, L., & Pourchez, J. (2019). Does acoustic overlay of music improve 
aerosol penetration into maxillary sinuses? Online Journal of Otolaryngology and 
Rhinology, 1(4), 1-3.  
Ounis, H., Ahmadi, G., & McLaughlin, J. B. (1991). Brownian diffusion of submicrometer 
particles in the viscous sublayer. Journal of Colloid and Interface Science, 143(1), 
266-277.  
Pattle, R. (1961). The retention of gases and particles in the human nose. Inhaled Particles 
and Vapours, 1, 302-309.  
Pourmehran, O., Arjomandi, M., Cazzolato, B., Ghanadi, F., & Tian, Z. (2020). The impact 
of geometrical parameters on acoustically driven drug delivery to maxillary sinuses. 
Biomechanics and Modeling in Mechanobiology, 19(2), 557-575.  
Pourmehran, O., Arjomandi, M., Cazzolato, B., & Tian, Z. (2020). Effect of particle diameter 
and density on acoustic drug delivery to maxillary sinus – a sensitivity study. Paper 
presented at the 22nd Australasian Fluid Mechanics Conference (AFMC2020), 
Brisbane, Australia.  
Rissler, J., Swietlicki, E., Bengtsson, A., Boman, C., Pagels, J., Sandström, T., Blomberg, A., 
& Löndahl, J. (2012). Experimental determination of deposition of diesel exhaust 
particles in the human respiratory tract. Journal of Aerosol Science, 48, 18-33.  
Schwarzkopf, J. D., Sommerfeld, M., Crowe, C. T., & Tsuji, Y. (2011). Multiphase Flows 
with Droplets and Particles (2nd ed.): CRC press. 
Shang, Y., Inthavong, K., & Tu, J. (2015). Detailed micro-particle deposition patterns in the 
human nasal cavity influenced by the breathing zone. Computers & Fluids, 114, 141-
150.  
Shi, H., Kleinstreuer, C., & Zhang, Z. (2006). Laminar airflow and nanoparticle or vapor 
deposition in a human nasal cavity model. Journal of Biomechanical Engineering, 
128(5), 697-706.  
Shi, H., Kleinstreuer, C., & Zhang, Z. (2007). Modeling of inertial particle transport and 
deposition in human nasal cavities with wall roughness. Journal of Aerosol Science, 
38(4), 398-419.  
Chapter 6. Effect of the inlet flow parameters and nozzle diameter on drug delivery to … 
241 
Suman, J. D., 
Laube, 
B. L., 
& Dalby, R. (1999). Comparison of nasal deposition and clearance of aerosol 
generated by a nebulizer and an aqueous spray pump. Pharmaceutical Research, 
16(10), 1648-1652.  
Tian, Z., Inthavong, K., & Tu, J. (2008). Deposition of inhaled wood dust in the nasal cavity. 
Inhalation Toxicology, 19(14), 1155-1165.  
Tian, Z., Tu, J., & Yeoh, G. (2005). Numerical simulation and validation of dilute gas-particle 
flow over a backward-facing step. Aerosol Science and Technology, 39(4), 319-332.  
Tong, X., Dong, J., Shang, Y., Inthavong, K., & Tu, J. (2016). Effects of nasal drug delivery 
device and its orientation on sprayed particle deposition in a realistic human nasal 
cavity. Computers in Biology and Medicine, 77, 40-48.  
Van Strien, J., Shrestha, K., Gabriel, S., Lappas, P., Fletcher, D. F., Singh, N., & Inthavong, 
K. (2021). Pressure distribution and flow dynamics in a nasal airway using a scale 
resolving simulation. Physics of Fluids, 33(1), 1-14.  
Wichers, L. B., Rowan III, W. H., Nolan, J. P., Ledbetter, A. D., McGee, J. K., Costa, D. L., 
& Watkinson, W. P. (2006). Particle deposition in spontaneously hypertensive rats 
exposed via whole-body inhalation: Measured and estimated dose. Toxicological 
Sciences, 93(2), 400-410.  
Wofford, M., Kimbell, J., Frank, D., Dhandha, V., McKinney, K., Fleischman, G., Ebert, C., 
Zanation, A., & Senior, B. (2015). A computational study of functional endoscopic 
sinus surgery and maxillary sinus drug delivery. Rhinology, 53(1), 41-48.  
Xi, J., & Longest, P. W. (2008). Numerical predictions of submicrometer aerosol deposition 
in the nasal cavity using a novel drift flux approach. International Journal of Heat 
and Mass Transfer, 51(23-24), 5562-5577.  
Xi, J., Si, X., Peters, S., Nevorski, D., Wen, T., & Lehman, M. (2017). Understanding the 
mechanisms underlying pulsating aerosol delivery to the maxillary sinus: In vitro tests 
and computational simulations. International Journal of Pharmaceutics, 520(1), 254-
266.  
Xi, J., Zhang, Z., & Si, X. (2015). Improving intranasal delivery of neurological 
nanomedicine to the olfactory region using magnetophoretic guidance of microsphere 
carriers. International Journal of Nanomedicine, 10(1), 1211-1222.  
Yang, Y., Sze To, G. N., & Chao, C. Y. (2012). Estimation of the aerodynamic sizes of single 
bacterium-laden expiratory aerosols using stochastic modeling with experimental 
validation. Journal of Aerosol Science and Technology, 46(1), 1-12.  
Zhao, K., Scherer, P. W., Hajiloo, S. A., & Dalton, P. (2004). Effect of anatomy on human 
nasal air flow and odorant transport patterns: Implications for olfaction. Chemical 












Chapter 7. Conclusion and future work 
244 
 
Acoustic drug delivery is a novel, non-invasive technique for delivery of medications to the 
sinuses, in particular the maxillary sinuses. ADD operates using the pressure differences 
between the maxillary sinuses and the nasal cavity arising from the oscillation of the air plug 
in the ostium under the effect of an external acoustic wave applied to the nostril. ADD has 
been demonstrated to increase the efficiency of drug delivery to the MS compared with 
conventional non-acoustic drug delivery techniques. There being only a handful scientific 
research papers in the area of acoustic drug delivery focusing on the feasibility of the ADD 
in experiments and numerical studies, the underlying mechanism of drug delivery to the MS 
and recognition of the efficient parameters for increasing ADD efficiency are the key topic 
of research. In the research presented in this thesis, a series of experiments were conducted, 
and numerical models were developed to understand the underlying mechanism of ADD. 
Moreover, several different, related parameters of acoustic drug delivery to the MS were 
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examined. The following sections present the significance of the study and propose some 
suggestions for future research. 
 Significance of the present work 
Since 1950, ADD has been used clinically at two fixed frequencies of 45 Hz or 100 Hz. 
Several researchers have shown an increase of 2- to 4-fold in the efficiency of drug delivery 
to the sinuses under the effect of those input frequencies. However, due to the similarity of 
the NC-MC combination and a Helmholtz resonator, researchers have recently hypothesised 
that the highest drug delivery to the MS takes place at the resonance frequency of the NC-
MC combination. Subsequently, a small number of studies have exploited the fundamental 
governing equation of a Helmholtz resonator to estimate the resonance frequency of the NC-
MS.  Applying this resonance frequency to the nostril for assessment, an increase of 3- to 5-
fold in drug delivery to the MS was reported when compared with non-ADD. Such an increase 
in drug delivery efficiency is still insufficient for the treatment of CRS. The main goal of the 
current study was to develop a deep understanding of the mechanisms underlying acoustic 
drug delivery to maxillary sinuses in order to increase the efficiency of this delivery 
technique. In addition to the aero-acoustic analysis, the effects of inlet airflow parameters and 
nozzle diameter on the flow structure in the NC and drug delivery to the MS were 
investigated. 
The main outcomes and significance of this research can be described as follows: 
1. As a starting point for this work, it was necessary to determine the resonance 
frequency of the NC-MS combination as accurately as possible. To do so, different 
numerical models, including computational aero-acoustics (CAA) using CFD, finite 
element analysis (FEA), and the classic Helmholtz resonator equation were developed 
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to predict the resonance frequency of a simplified NC-MS combination. The 
resonance frequency obtained by the numerical models were compared with in-house 
experimental data. It was found that the FEA and the classic Helmholtz resonator 
equation overestimate the resonance frequency of the NC-MS combination with an 
unacceptable deviation (≥ 20%) from the experiments, whereas CAA-CFD predicts 
the resonance frequency with an acceptable deviation, between 0.6% and 8%, from 
the experiment. Hence, CAA-CFD simulation provides a much more accurate 
prediction of the resonance frequency of the NC-MS combination compared with 
more commonly-used methods, and is rooted in the governing underlying equations 
used in these numerical approaches. CAA-CFD can resolve this aero-acoustic 
problem better than FEA because it can model the nonlinear phenomena, in particular 
near the wall and the edge of a solid body, while in FEA, only the linearized Euler 
equations are resolved. 
2. Using the validated CAA-CFD model, the effects of various geometric parameters 
such as the ostium length/diameter, MS volume/shape, and the NC width on the 
resonance frequency of 25 simplified NC-MS models were investigated. The results 
showed that the NC width and the MS shape have negligible effects on the resonance 
frequency of the NC-MS combination. It was also shown that there is a direct 
relationship between the resonance frequency of the NC-MS combination and the 
ostium diameter, while there is an inverse relationship between the resonance 
frequency and the square root of the ostium length and the MS volume. Hence, it is 
inferred that acoustic drug delivery to the MS is independent from the shape of the 
MS and the size of the NC; however, it depends highly on the ostium and MS sizes. 
Accordingly, given that the size of the ostium and MS in every patient is different, 
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administration of ADD with a fixed acoustic frequency (e.g., 45 Hz and 100Hz) for 
every patient cannot guarantee optimal drug delivery to the MS. 
3. The effect of the ostium size on the damping ratio of the oscillation of the air plug in 
the ostium was also investigated experimentally. The results indicated that the 
damping ratio has an inverse relationship with the diameter of the ostium, and a 
monotonic relationship with the length of the ostium. This indicates that the amplitude 
of the input acoustic wave should be adjusted with the damping ratio to achieve 
improved ADD efficiency. More specifically, given that an increase in the damping 
ratio reduces the magnitude of the oscillation of the air plug in the ostium, the pressure 
amplitude of the acoustic source should be increased to counter the effect of the 
damping.  
4. A CAA-CFD model was developed to predict the resonance frequency of a realistic 
NC-MS combination, as well as to conduct aero-acoustic analysis at the resonance 
frequency. The CAA-CFD model was validated against the experimental data. The 
acoustic analysis of the CAA-CFD model revealed that not only does the air plug in 
the ostium oscillate at the resonance frequency of the NC-MS combination, but also 
a portion of the air plug in the middle meatus oscillates. This indicates that to increase 
the efficiency of ADD, not only should the number of particles in the ostium be 
increased, but also the number of particles in the middle meatus in proximity to the 
ostium.  
5. A validated CFD model was further developed to predict the particle trajectories under 
the effect of input acoustic wave applied to the inlet in a simplified NC-MS 
combination. Particle tracking was modelled using a discrete phase model (DPM). 
Particles were distributed in the simplified NC-MS combination, and then the effects 
of different aero-acoustic parameters, including the frequency and amplitude of the 
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acoustic wave applied to the inlet on the efficiency of the ADD to the MS, were 
investigated. The results of this study indicate that the efficiency of ADD highly 
depends on the acoustic frequency and amplitude applied to the inlet. It was found 
that maximum ADD efficiency occurs when an acoustic wave, driven at the resonance 
frequency of the NC-MS model, is applied to the inlet. The ADD efficiency has a 
monotonic relationship with the amplitude of the inlet acoustic wave. It was also 
shown that an increase in the mean flow rate of the inlet airflow decreases the ADD 
efficiency because the mean flow increases the damping ratio of the oscillation of the 
air plug in the ostium, which contributes to reducing the amplitude of the oscillation 
of the air plug in the ostium. 
6.  A CFD model was developed to understand the effect of particle diameter and density 
on ADD efficiency using a simplified NC-MS geometry. The evidence from this study 
suggests that the efficiency of ADD can be enhanced by reducing the particle size 
from 12 µm to 2 µm. Indeed, a decrease in the diameter of the particles decreases the 
acoustic Stokes number, which contributes to increasing the amplitude of the motion 
of the particles in the ostium when an external acoustic wave is applied.  
In practice, the drugs are used as droplets in ADD, so the ADD efficiency may 
decrease through an orthokinetic collision of droplets. In fact, the droplets can 
undergo orthokinetic collisions in the presence of an acoustic field. This collusion 
may lead to a coalescence where the diameter of the particle can increase. An increase 
in the particle diameter decreases the particle entrainment coefficient, resulting in a 
decrease in ADD efficiency. To prevent an orthokinetic collision in the presence of 
an acoustic field, the droplets should be of uniform size.  
7. An experiment was designed and fabricated to investigate the effect of aero-acoustic 
parameters’ drug deposition in the MS using a realistic 3D-printed NC-MS model. 
Chapter 7. Conclusion and future work 
249 
Nebulised 2.5 wt% NaF was used as a drug tracer. One of the more significant findings 
to emerge from this study is that applying an acoustic wave to the nostril at the 
resonance frequency of the NC-MS combination can significantly increase the 
deposition of aerosols in the MS. For the NC-MS model used in this study, 
superimposing an input frequency of 328 Hz and amplitude of 126 dB re 20µPa on 
nebulised aerosol (12 µm) entering the nostril with a particle flow rate of 0.267 
mL/min increased the concentration of NaF deposited in the MS 75-fold. The 
experimental data showed that increasing the input acoustic amplitude increased the 
aerosol deposition in the MS. However, increasing the amplitude above 120 dB re 
20µPa did not have a significant effect on the aerosol deposition, which might imply 
that at certain acoustic amplitudes a saturation point for aerosol deposition is reached. 
The present study confirms previous findings and contributes additional evidence that 
supports the idea that the maximum efficiency of drug delivery to the MS occurs at 
the resonance frequency of the NC-MS combination. 
8. A CFD model was developed to investigate the effect of inlet flow parameters and the 
nozzle diameter on the airflow behaviour and drug (particle) delivery to the MM-
Ostium region in a realistic NC-MS model. To conduct the parametric studies, two 
CFD models using a hybrid RANS-LES model and laminar solver were developed 
and cross-validated with the available experimental data. One of the more significant 
findings to emerge from this study is that the artificial turbulence and the swirl applied 
to the inlet flow were significantly damped when the flow passes through the nasal 
cavity. This implies that the nasal valve plays the role of airway resistance. The results 
showed that the effect of turbulent inlet flow on the particle deposition in the NC and 
drug delivery to the MM-Ostium region is negligible. However, the deposition of 
particles increases with an increase in the swirl intensity of the inlet flow, which 
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comes from the increasing effect of centrifugal force acting on the particles in a 
swirling flow. It was also found that the fullness coefficient 𝐶f (i.e., the ratio of nozzle 
diameter to the inlet diameter) affects the drug delivery to the MM-Ostium region. It 
was found that an increase in 𝐶f decreases the drug delivery efficacy to the MM-
Ostium region. An increase in the particle retention criterion in the MM-Ostium 
region was calculated to quantify the increase in the drug delivery to the MS region. 
 Recommendation for future work 
The work presented in this thesis was focused on the development of a fundamental 
understanding of the underlying mechanism of ADD to determine the most important 
geometric and aero-acoustic parameters, as well as the inlet flow and particle release 
preconditions, affecting the efficiency of ADD for drug delivery to the MS.  Despite the 
significant knowledge developed in the field of acoustic drug delivery to the MS, further 
studies are required to move from concept to commercialisation. Some suggestions for future 
work are as follows: 
1. In this study, a simplified and realistic model of NC-MS was used for the parametric 
study. However, in practice, other sinuses such as the frontal, ethmoid, and sphenoid 
sinuses are also infected in some CRS patients. Further work needs to be done to 
establish whether ADD can be an advantageous approach for drug delivery to those 
sinuses. To do so, a realistic nose model, including the NC and all paranasal sinuses, 
is required to undertake parametric studies. The material used in this mode should be 
identical to the human nose-sinus tissue since the impedance of this model is 
important in the prediction of the resonance frequency of the nose-sinus combination.  
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2. The current study showed that the efficiency of ADD depends highly on the acoustic 
frequency applied to the nostril (inlet) such that when driving at the resonance 
frequency, the ADD efficiency increases significantly (>50-fold compared with non-
ADD). Hence, it is imperative to predict the resonance frequency of the NC-MS 
combination as accurately as possible, which has been carried out in the current study 
using experimental and numerical methods. However, there are some limitations to 
both methods. In the experimental method, a hole was made in the wall of the MS (in 
a 3D printed model) to install a microphone for detecting the acoustic signals in the 
MS, which is not feasible in practice. To tackle this problem, further research is 
needed to develop an experimental method for predicting the resonance frequency of 
the NC-MS combination without making a hole in the MS wall. The use of a two-
microphone method in the prediction of the resonance frequency of the NC-MS 
combination might be helpful. In the two-microphone method, the incident and 
reflective acoustic signals can be analysed to predict the resonance frequency of the 
NC-MS combination rather than the detection of the acoustic signals in the MS.  
3. The prediction of the resonance frequency of a realistic NC-MS combination using a 
CAA-CFD simulation requires significant computational resources and time. An 
approach to tackle this issue could be the use of machine learning techniques such as 
Artificial Neural Networks (ANN), which might provide rapid estimation, instead of 
directly simulating the CAA-CFD models. Further investigation and experimentation 
into the feasibility of machine learning techniques in the prediction of the resonance 
frequency of the NC-MS combination are strongly recommended. 
4. The effects of orthokinetic collisions of particles on the acoustic Stokes number and 
ADD efficiency have been investigated in the current study qualitatively. However, 
future research should concentrate on investigation of orthokinetic collision impacts 
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on ADD quantitatively, which would enable determination of the optimum size and 
distribution of the particles. 
 
